Клинические рекомендации «Интраокулярная ретинобластома» (ID КР71/1). Одобрены Научно-практическим Советом Минздрава РФ. Год утверждения: 2020 год.
http://cr.rosminzdrav.ru/recomend/71_1

PDQ Pediatric Treatment Editorial Board. Retinoblastoma Treatment (PDQ®): Health Professional Version. 2021 Sep 21. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002–. PMID: 26389442.
https://www.ncbi.nlm.nih.gov/books/NBK66006/

PDQ Pediatric Treatment Editorial Board. Retinoblastoma Treatment (PDQ®): Patient Version. 2021 Oct 7. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002–. PMID: 26389197.
https://pubmed.ncbi.nlm.nih.gov/26389197/

Retinoblastoma - Current Therapeutic Challenges and Promising New Approaches. Special Issue. Cancers 2021
https://www.mdpi.com/journal/cancers/special_issues/Retinoblastoma

А

Алексеева Е.А., Бабенко О.В., Козлова В.М., Ушакова Т.Л., Казубская Т.П., Танас А.С., Карандашева К.И., Стрельников В.В., Залетаев Д.В. Преимущества высокопроизводительного параллельного секвенирования в выявлении соматического мозаицизма при спорадической ретинобластоме. Медицинская генетика. 2020. Т. 19. № 6 (215). С. 6-7.
https://www.elibrary.ru/item.asp?id=44127160

Алексеева Е.А., Карандашева К.О., Бабенко О.В., Козлова В.М., Ушакова Т.Л., Казубская Т.П., Танас А.С., Залетаев Д.В., Стрельников В.В. Соматический мозаицизм при спорадической ретинобластоме. Медицинская генетика. 2021. Т. 20. № 4(225). С. 9-18.
DOI 10.25557/2073-7998.2021.04.9-18

Алексеева Е.А., Козлова В. М., Бабенко О.В., Ушакова Т.Л., Казубская Т.П., Чеснокова Г.Г., Танас А.С., Залетаев Д.В., Стрельников В.В. Спектр нарушений гена RB1 при ретинобластоме у российских пациентов // Медицинская генетика. 2021. Т. 20. № 8(229). С. 11-20.
DOI 10.25557/2073-7998.2021.08.11-20

Артеменко Ю.В., Панферова Т.Р., Михайлова Е.В., Кюн Ю., Ушакова Т.Л., Поляков В.Г. Методы визуализации в дифференциальной диагностике ретинобластомы, болезни Коатса и первичного персистирующего гиперпластического стекловидного тела. Российский журнал детской гематологии и онкологии. 2022;9(1):11–20.
https://doi.org/10.21682/2311-1267-2022-9-1-11-20

Б

Бабкина А.В., Кулыгин Б.Б. Современные представления о ретинобластоме у детей. Научный альманах. 2020, № 4-1 (66).
https://www.elibrary.ru/item.asp?id=43025221

Базарбаева А.А., Кәрімова М., Таубалдиева З.Е. Анализ результатов лечения ретинобластомы у детей. Педиатрия и детская хирургия. 2020. № 1 (99). С. 13-17.
https://www.elibrary.ru/download/elibrary_44063343_42129189.pdf

Белоусова Е.И., Матинян Н.В., Мартынов Л.А., Ушакова Т.Л., Гьокова Е.В. Эффективность и безопасность ретробульбарной блокады 0,5% ропивакаином при проведении операции энуклеации глазного яблока у детей. Детская хирургия. 2020. Т. 24. № S1. С. 25.
http://www.fesmu.ru/elib/Article.aspx?id=391153

Белоусова Е.И., Матинян Н.В., Ушакова Т.Л., Поляков В.Г. Ретробульбарная блокада при энуклеации глазного яблока у детей с ретинобластомой. Офтальмохирургия. 2021. № 2. С. 52-57.
DOI 10.25276/0235-4160-2021-2-52-57

Белоусова Е.И., Матинян Н.В., Цинцадзе А.А., Мартынов Л.А., Кузнецов Д.А., Ковалева Е.А., Ушакова Т.Л., Поляков В.Г. Ультразвуковая навигация при выполнении ретробульбарной блокады у детей с ретинобластомой при энуклеации глазного яблока. Регионарная анестезия и лечение острой боли. 2021. Т. 15. № 2. С. 127-136.
https://doi.org/10.17816/1993-6508-2021-15-2-127-136
https://rjraap.com/1993-6508/article/view/90096

Боброва Н.Ф., Сорочинская Т.А., Молчанюк Н.И., Братишко А.Ю.
Ультраструктурные изменения сетчатки кролика при однократном интравитреальном введении различных доз мелфалана.
Офтальмологический журнал. 2020. № 4 (495). С. 50-55.
https://www.elibrary.ru/item.asp?id=44155830

Боброва Н.Ф., Сорочинская Т.А., Тронина С.А., Братишко А.Ю. Новая методика органосохранного лечения ретинобластомы. Современные технологии в офтальмологии. 2021. № 1(36). С. 215-220.
DOI 10.25276/2312-4911-2021-1-215-220

Бровкина А.Ф., Яровая Г.А., Цыбикова Н.Д. МикроРНК в офтальмологии. Офтальмология. 2021. Т. 18. № 2. С. 188-197.
DOI 10.18008/1816-5095-2021-2-188-197

В

Володин Д.П., Котельникова А.В., Котова Е.С., Яровой А.А.
Дифференциальная диагностика ретинобластомы и симулирующих состояний (псевдоретинобластом)
Медицинский вестник Башкортостана. 2020. Т. 15. № 4 (88). С. 44-47.
DOI: https://doi.org/10.25276/2307-6658-2020-4-51-58
https://eyepress.ru/article.aspx?44174

Володин Д.П., Котова Е.С., Чочаева А.М., Котельникова А.В., Яровой А.А. Транспупиллярная лазерная термотерапия ретинобластомы. Российская детская офтальмология. 2021. № 3. С. 54-60.
DOI: https://doi.org/10.25276/2307-6658-2021-3-54-60
https://eyepress.ru/article.aspx?46269

Г

Гараев Т.И., Матненко Т.Ю., Кучкова Ю.Е. Заболеваемость ретинобластомой в Омской области по данным БУЗОО «КОБ им. В. П. Выходцева». В сборнике: Неделя молодежной науки - 2021. Материалы Всероссийского научного форума с международным участием, посвященного медицинским работникам, оказывающим помощь в борьбе с коронавирусной инфекцией. Тюмень, 2021. С. 257.
https://www.elibrary.ru/item.asp?id=45682805

Гурьянова И.Е., Любушкин А.В., Макаревич О.О., Литвинова Д.Ю., Вертёлко В.Р., Волочник Е.В., Полякова Е.А., Мигас А.А., Конопля Н.Е. Первые результаты проведения генетического скрининга и изучения генотип-фенотипических корреляций у пациентов с ретинобластомой из Беларуси // Вопросы гематологии/онкологии и иммунопатологии в педиатрии. 2022, Т. 21. № 2, С. 78-88.
doi 10.24287/1726-1708-2022-21-2-78-88
https://www.elibrary.ru/download/elibrary_48697428_53152596.pdf

Гурьянова И.Е., Макаревич О.О., Литвинова Д.Ю., Мигас А.А., Конопля Н.Е. Роль генетических нарушений гена RB1 в патогенезе ретинобластомы. Евразийский онкологический журнал. 2021. Т. 9. № 2. С. 113-126.


Д

Долгушин Б.И., Берников С.Н., Буйденок Ю.В., Валиев А.К., Виршке Э.Р., Григорьевская З.В., Карпова М.С., Косырев В.Ю., Кудашкин Н.Е., Кукушкин А.В., Лаптева М.Г., Макаров Е.С., Маринов Д.Т., Маркович А.А., Мартынов Л.А., Матинян Н.В., Наркевич Б.Я., Нечипай А.М., Перегудов Н.А., Петухова И.Н., Погребняков И.В., Понедельникова Н.В., Притула С.И., Сергеева О.Н., Стилиди И.С., Трофимов И.А., Тулин П.Е., Тюрин И.Е., Федорова А.В., Францев Д.Ю., Черкасов В.А., Шолохов В.Н. Интервенционная радиология в онкологии. ИД МГУ, 2022.
ISBN: 978-5-88429-265-9. Т. 3. С. 783-795.

З

Завадский С. Л. Бионические глазные протезы как средство реабилитации при потере обоих глазных яблок. Вестник офтальмологии. 2021. Т. 137. № 1. С. 35-39.
DOI 10.17116/oftalma202113701135

И

Иванова С.В., Кулева С.А., Садовникова Н.Н., Комиссаров М.И., Чистякова М.Н., Хохлова А.В., Щеголева Н.А. Принципы терапии интраокулярной ретинобластомы. РМЖ. Клиническая офтальмология. 2020. Т. 20. № 4. С. 197-203.
doi: 10.32364/2311-7729-2020-20-4-197-203
https://www.elibrary.ru/item.asp?id=44326007

Иванова С.В., Кулева С.А., Садовникова Н.Н., Комиссаров М.И., Чистякова М.Н., Хохлова А.В., Щеголева Н.А. Ретинобластома. Часть 1. Клинико-диагностические аспекты. РМЖ. Клиническая офтальмология. 2020. Т. 20. № 3. С. 159-164.
https://www.rmj.ru/articles/oftalmologiya/Retinoblastoma_Chasty_1_Kliniko-diagnosticheskie_aspekty/

К

Коробова Л.С., Матинян Н.В., Мартынов Л.А., Кузнецов Д.А., Цинцадзе А.А., Ковалева Е.А. Анестезиологическое обеспечение при энуклеации глазного яблока в педиатрической онкохирургии // Отражение. 2022, № 1(13). С. 55-59.
doi 10.25276/2686-6986-2022-1-55-59
https://eyepress.ru/article.aspx?47655

Котельникова А.В., Володин Д.П., Яровая В.А., Чочаева А.М., Яровой А.А. Окклюзионная терапия как метод улучшения зрительных функций у детей, перенесших лечение по поводу ретинобластомы. Российская детская офтальмология. 2021. №4. С. 42-46.

Котельникова А.В., Котова Е.С., Володин Д.П., Ушакова Т.Л., Яровой А.А.
Первичное эндопротезирование глазницы при энуклеации по поводу ретинобластомы. Российская детская офтальмология. 2021. № 1. С. 44-49.
doi: 10.25276/2307-6658-2021-l-44-49
https://www.elibrary.ru/item.asp?id=44888607

Котова Е.С., Яровой А.А., Бузуртанов М.Б. Эффективность локального лечения ретинобластомы на крайней периферии глазного дна.
Современные технологии в офтальмологии. 2020. № 3 (34). С. 110-111.
doi: 10.25276/2312-4911-2020-3-110-111
https://eyepress.ru/article.aspx?43403

Котова Е.С., Яровой А.А., Володин Д.П., Котельникова А.В. Брахитерапия ретинобластомы (обзор литературы). Российский журнал детской гематологии и онкологии. 2021. Т. 8. № 1. С. 50-56.
doi: 10.21682/2311-1267-2021-8-1-50-56
https://www.elibrary.ru/item.asp?id=45081117

М

Макаревич О.О. Интравитреальные инъекции в лечении ретинобластомы. Вестник Витебского государственного медицинского университета. Том 19, номер 3.
DOI: 10.22263/2312-4156.2020.3.7.
https://www.elibrary.ru/item.asp?id=42992359

Макаревич О.О. Ретинобластома: клинические проявления и особенности диагностики у детей. Педиатрия. Восточная Европа. 2020. Т. 8. № 2.
doi: 10.34883/PI.2020.8.2.010
https://elibrary.ru/item.asp?id=43154294

Макаревич О.О. Транспупиллярная термотерапия в лечении ретинобластомы. Евразийский онкологический журнал.
DOI: 10.34883/PI.2020.8.1.019
https://elibrary.ru/item.asp?id=42705485

Н

Науменко Л.В., Малиновский Г.Ф., Красный С.А., Жиляева Е.П., Бараш А.Н., Жерко И.Ю. Использование аллотрансплантата из подкожно-жировой клетчатки с апоневрозом подошвы для формирования опорно-двигательной культи при энуклеации. Новости хирургии. 2021. Т. 29. № 2. С. 191-197.
doi: 10.18484/2305-0047.2021.2.191
https://www.elibrary.ru/item.asp?id=45746866

П

Погребняков И.В., Ушакова Т.Л., Трофимов И.А., Горовцова О.В., Матинян Н.В., Виршке Э.Р., Поляков В.Г., Долгушин Б.И. Осложнения селективной интраартериальной химиотерапии у детей с интраокулярной ретинобластомой // Онкологический журнал: лучевая диагностика, лучевая терапия. 2021. Т.4. № 2. С. 69-83.
DOI 10.37174/2587-7593-2021-4-2-69-83.
https://www.elibrary.ru/item.asp?id=46181348

Р

Ретинобластома. Covid-19. Российский журнал детской гематологии и онкологии (РЖДГиО). Специальный выпуск, 2020.
https://cloud.mail.ru/public/5zHE/3wR92vLQh

С

Саакян С.В., Иванова О.А., Тадевосян С.С., Цыганков А.Ю., Ольхова Л.В., Ушакова Т.Л., Поляков В.Г. Выживаемость больных ретинобластомой по данным когортного исследования двух центров РФ. Российский офтальмологический журнал. 2021; 14(1):47-55.
https://doi.org/10.21516/2072-0076-2021-14-1-47-55

Саакян С.В., Иванова О.А., Тадевосян С.С., Цыганков А.Ю., Ольхова Л.В., Ушакова Т.Л., Поляков В.Г. Результаты пятилетней выживаемости при комбинированном лечении больных ретинобластомой. Российский общенациональный офтальмологический форум. 2020. Т. 2. С. 342-345.
https://www.elibrary.ru/item.asp?id=44450844

Саакян С.В., Мякошина Е.Б., Исмаилова Д.М. Токсическое влияние цитостатиков на изменения морфометрических параметров сетчатки и хориоидеи на фоне химиотерапии ретинобластомы.
Эффективная фармакотерапия. 2021. Т. 17. № 8. С. 12-15.
doi: 10.33978/2307-3586-2021-17-8-12-15
https://www.elibrary.ru/item.asp?id=45049320

Саакян С.В., Мякошина Е.Б., Поляков В.Г., Ушакова Т.Л., Исмаилова Д. М. Оптическая когерентная томография в доклинической диагностике изменений диска зрительного нерва после химиотерапии у детей с ретинобластомой. Российский офтальмологический журнал. №2. 2020.
DOI: 10.21516/2072-0076-2020-13-2-53-58
https://www.elibrary.ru/item.asp?id=42870509
https://roj.igb.ru/jour/article/view/431/294

Саакян С.В., Тадевосян С.С., А.Ю. Цыганков А.Ю. Анализ структуры заболеваемости ретинобластомой у детей. Российская педиатрическая офтальмология. 2020. Т.15, №4. С.5-10.
DOI: https://doi.org/10.17816/rpo2020-15-4-5-10.
https://www.elibrary.ru/item.asp?id=45615985

Саакян С.В., Тадевосян С.С., Цыганков А.Ю., Иванова О.А. Вторые опухоли у больных ретинобластомой в отдаленном периоде наблюдения (серия клинических случаев). Head and Neck/Голова и шея. Российское издание. Журнал Общероссийской общественной организации Федерация специалистов по лечению заболеваний головы и шеи. 2021. Т. 9. № 1. С. 83-90.
DOI: 10.25792/HN.2021.9.1.83-90
https://www.elibrary.ru/item.asp?id=44945729

Саакян С.В., Хорошилова-Маслова И.П., Тадевосян С.С., Цыганков А.Ю.1, Захарова Г.П., Иванова О.А., Пантелеева О.Г., Жаруа А.А. Морфогенез ретинобластомы при локальном введении цитостатиков. Офтальмология. 2021. Т. 18. № 3.
DOI 10.18008/1816-5095-2021-3-508-517

Саакян С.В., Цыганков А.Ю., Тадевосян С.С., Макарова А.А., Коголева Л.В., Тацков Р.А. Аметропии у детей с ретинобластомой. Офтальмология. 2020;17(1):76-80.
https://doi.org/10.18008/1816-5095-2020-1-76-80

Саакян С.В., Цыганков А.Ю., Хорошилова-Маслова И.П., Моисеева Н.И., Карамышева А.Ф., Жильцова М.Г., Амирян А.Г., Тадевосян С.С. Разработка модели внутриглазной ретинобластомы invivo // Бюллетень экспериментальной биологии и медицины. 2020, Т. 169, № 3, март.
https://www.elibrary.ru/item.asp?id=42518484

Саакян С.В., Хорошилова-Маслова И.П., Тадевосян С.С., Цыганков А.Ю., Захарова Г.П., Иванова О.А., Жаруа А.А. Клинико-морфологическое исследование ретинобластомы после локальной химиотерапии. Российский общенациональный офтальмологический форум. 2020. Т. 2. С. 346-350.
https://www.elibrary.ru/item.asp?id=44450845

Саакян С.В., Хорошилова-Маслова И.П., Тадевосян С.С., Цыганков А.Ю., Захарова Г.П., Иванова О.А., Жаруа А.А. Морфогенез ретинобластомы при локальном введении цитостатиков. Точка зрения. Восток - Запад. 2020. № 3.
doi: 10.25276/2410-1257-2020-3-68-70
https://elibrary.ru/item.asp?id=43076292
https://eyepress.ru/article.aspx?42537

Садовникова Н.Н., Чистякова М.Н., Кулева С.А., Иванова С.В., Баранова Н.А. Ретинобластом. В книге "Неонатальная офтальмология: Руководство для врачей" / Н. А. Баранова, В. В. Бржеский, О. В. Дискаленко [и др.]. Москва, 2021. 288 с.
DOI 10.33029/9704-6152-5-NOF-2021-1-288.

Сайдашева Э.И., Фомина Н.В., Иова А.С., Буяновская С.В. Ретинобластома у детей. Российская педиатрическая офтальмология. 2021. Т. 16. № 1. С. 47-52.
DOI 10.17816/rpo2021-16-1-47-52

Смарцев А.С., Назаренко А.О., Сидоренко Е.Е., Адуева У.Г. Совместная работа онкологов и офтальмологов при лечении агрессивной двусторонней ретинобластомы. Российский педиатрический журнал. 2021. Т. 24. № 4. С. 277.

Степанян Н.Г., Сидорова Н.В., Рубанская М.В., Тупицын Н.H., Матинян Н.В., Киргизов К.И., Варфоломеева С.Р. Оптимизация методов сбора периферических гемопоэтических стволовых клеток у детей с онкологическими заболеваниями: обзор литературы. Российский журнал детской гематологии и онкологии (РЖДГиО). 2020;7(2):78-85.
https://doi.org/10.21682/2311-1267-2020-7-2-78-85

Т

Терлецкая Е.Н., Медведев Ю.А., Петрук П.С. Применение имплантатов из пористого никелида титана для формирования опорно-двигательной культи глазного яблока после эвисцерации. Голова и шея. Российский журнал = Head and neck. Russian Journal. 2022;10(2):19–24
doi: 10.25792/HN.2022.10.2.19–24
https://www.elibrary.ru/download/elibrary_48486668_99637124.pdf


У

Умарова Б.З. Анализ патологических изменений и их роль в ранней диагностике ретинобластомы. Новый день в медицине. 2020. № 4 (32). С. 452-454.
https://www.elibrary.ru/item.asp?id=45759436

Умарова Б.З. Скрининг в ранней диагностике ретинобластомы. Экономика и социум. №6-2 (73). Узбекистан.
https://www.elibrary.ru/item.asp?id=44002068

Умарова Б.З., Икрамов А.Ф., Исламов З.С. Содержание МДА в слёзной жидкости у больных ретинобластомой. Современные технологии в офтальмологии. 2020. № 3 (34). С. 45-46.
doi: 10.25276/2312-4911-2020-3-45-46
https://www.elibrary.ru/item.asp?id=44346105

Умарова Б.З., Исламов З.С., Икрамов А.Ф. Содержание общего белка в слезной жидкости у больных ретинобластомой. Современные технологии в офтальмологии. 2020. № 3 (34). С. 44-45.
doi: 10.25276/2312-4911-2020-3-44-45
https://eyepress.ru/article.aspx?43338

Ушакова Т.Л., Волкова А.В., Горовцова О.В., Яровой А.А., Яровая В.А., Котова Е.С., Мaтинян Н.В., Цинцадзе А.А., Трофимов И.А., Погребняков И.В., Долгушин Б.И., Поляков В.Г. Роль трехкомпонентной селективной интраартериальной химиотерапии при неудачах стандартного органосохраняющего лечения детей с интраокулярной ретинобластомой. Российский журнал детской гематологии и онкологии, выпуск №4, 2020.
https://doi.org/10.21682/2311-1267-2020-7-4-15-34

Ушакова Т.Л., Тузова Е.А., Шутова А.Д., Горовцова О.В., Гаспарян Т.Г., Бекяшев А.Х., Поляков В.Г. Расширенные хирургические вмешательства у детей с ретинобластомой при инвазии зрительного нерва. Российский журнал детской гематологии и онкологии. 2021. Т. 8. № 2. С. 50-60.
DOI 10.21682/2311-1267-2021-8-2-50-60

Ю

Юсупов А.Ф., Мирхаликов Ф.Р. Транспупиллярная термотерапия при системной ПХТ-резистентных ретинобластомах. Современные технологии в офтальмологии. 2022. № 1(41). С. 250-253.
doi 10.25276/2312-4911-2022-1-250-253

Я

Яровой А.А., Володин Д.П., Яровая В.А., Котова Е.С., Чочаева А.М., Котельникова А.В. Роль метода транспупиллярной лазерной термотерапии в системе органосохраняющего лечения ретинобластомы // Лазерная медицина. 2021. Т. 25. № S3. С. 39.
DOI 10.37895/2071-8004-2021-25-3S-39

Яровой А.А., Володин Д.П., Яровая В.А., Котова Е.С., Чочаева А.М., Котельникова А.В. Транспупиллярная лазерная термотерапия: эффективность в лечении кавитарной ретинобластомы Российская детская офтальмология. 2021. № 4. С. 11-17.

Яровой А.А., Володин Д.П., Яровая В.А., Ушакова Т.Л., Котова Е.С., Чочаева А.М., Поляков В.Г. Лазерная транспупиллярная термотерапия ретинобластомы.
Российский журнал детской гематологии и онкологии. 2021. №3. С. 50-60.
https://doi.org/10.21682/2311-1267-2021-8-3-43-49

Яровой А.А., Голанов А.В., Ушакова Т.Л., Костюченко В.В., Яровая В.А., Котова Е.С., Поляков В.Г. Стереотаксическая радиохирургия «Гамма-нож» при интраокулярной ретинобластоме: результаты пяти лет применения. Офтальмохирургия. 2021. № 1. С. 46-56.
doi: 10.25276/0235-4160-2021-1-39-45
https://www.elibrary.ru/item.asp?id=45538352

Яровой А.А., Горшков И.М., Ушакова Т.Л., Яровая В.А., Котова Е.С., Котельникова А.В. Хирургическое лечение гемофтальма с одновременной ирригацией мелфалана у пациентов с ретинобластомой. Российская детская офтальмология. № 2.
doi: 10.25276/2307-6658-2020-2-20-25
https://elibrary.ru/item.asp?id=43044874
https://eyepress.ru/article.aspx?42554

Яровой А.А., Клеянкина С.С., Зубарева С.А., Ушакова Т.Л., Яровая В.А., Котельникова А.В., Котова Е.С. Ретробульбарная инфузионная терапия интраокулярных осложнений локального лечения ретинобластомы. Российская детская офтальмология. 2020. № 2.
doi: 10.25276/2307-6658-2020-2-26-30
https://elibrary.ru/item.asp?id=43044875
https://eyepress.ru/article.aspx?42555

Яровой А.А., Козлова В.М., Яровая В.А., Котельникова А.В., Астарханова Д.С. Клинические особенности и течение ретиноцитомы. Российская детская офтальмология. 2020. № 1. С. 24-28.
https://doi.org/10.25276/2307-6658-2020-1-24-28

Яровой А.А., Котова Е.С., Котельникова А.В., Яровая В.А.
Дифференциальная диагностика ретинита Коатса и ретинобластомы
Медицинский вестник Башкортостана. 2020. Т. 15. № 4 (88). С. 44-47.
https://www.elibrary.ru/download/elibrary_44521850...

Яровой А.А., Ушакова Т.Л., Голубева О.В., Левашов И.А., Михайлова С.Н., Яровая В.А., Поляков В.Г. Ретинобластома: история одного пациента
Российский журнал детской гематологии и онкологии. 2020. Т. 7. № 2.
doi: 10.21682/2311-1267-2020-7-2-134-9
https://elibrary.ru/item.asp?id=43089362

Яровой А.А., Ушакова Т.Л., Иванова Н.В., Горовцова О.В., Котельникова А.В., Яровая В.А., Поляков В.Г. Первичное эндопротезирование орбиты как способ косметической реабилитации детей с ретинобластомой. Современные технологии в офтальмологии. 2020. № 4 (35). С. 175-176.
DOI: https://doi.org/10.25276/2312-4911-2020-4-175-176
https://eyepress.ru/article.aspx?43809

Яровой А.А., Яровая В.А., Володин Д.П., Котельникова А.В., Котова Е.С., Городецкая Ю.Б. Псевдоретинобластомы: спектр патологии и частота в различных возрастных группах. Анализ 14-летнего опыта. Российская детская офтальмология. 2021. № 2. С. 9-14.
DOI 10.25276/2307-6658-2021-2-9-14

Яровой А.А., Яровая В.А., Осокин И.Г., Котова Е.С., Володин Д.П. Результаты хирургии катаракты у детей с ретинобластомой. Офтальмохирургия. 2021. № 3.
DOI 10.25276/0235-4160-2021-3-65-70.
https://eyepress.ru/article.aspx?46216

A

Abdelbaki M.S., Abu-Arja M.H., Davidson T.B., Fangusaro J.R., Stanek J.R., Dunkel I.J., Dhall G, Gardner SL, Finlay JL. Pineoblastoma in children less than six years of age: The Head Start I, II, and III experience. // Pediatric Blood & Cancer. 2020 Mar 18.
DOI: 10.1002/pbc.28252
https://pubmed.ncbi.nlm.nih.gov/32187454/?from_term=retinoblastoma&from_sort=date&from_pos=2

Abramson D.H. Cell Free DNA (cfDNA) in the Blood of Retinoblastoma Patients The Robert M. Ellsworth Lecture. Ophthalmic Genet. 2022 Apr 5:1-5. Epub ahead of print.
PMID: 35382685.
doi: 10.1080/13816810.2021.2004433

Abramson D.H., Bian Y., Belinsky I., Francis J.H. An in-utero presentation of trilateral retinoblastoma. Ophthalmology. Retina. 2020 Dec 26:S2468-6530(20)30504-2.
doi: 10.1016/j.oret.2020.12.017.
https://pubmed.ncbi.nlm.nih.gov/33373716/

Abramson D.H., Bian Y., Belinsky I., Francis JH. An In Utero Presentation of Trilateral Retinoblastoma. Ophthalmol Retina. 2021 Aug;5(8):831-832.
doi: 10.1016/j.oret.2020.12.017

Abramson D.H., Gobin Y.P., Dunkel I.J., Francis J.H. Successful Treatment of Massive Choroidal Invasion in Retinoblastoma with Intraarterial Chemotherapy (Ophthalmic Artery Chemosurgery). Ophthalmology. Retina. 2020 Dec 28:S2468-6530(20)30505-4.
doi: 10.1016/j.oret.2020.12.018.
https://pubmed.ncbi.nlm.nih.gov/33383259/

Abramson D.H., Gobin Y.P., Dunkel I.J., Francis J.H. Successful Treatment of Massive Choroidal Invasion in Retinoblastoma with Intra-arterial Chemotherapy (Ophthalmic Artery Chemosurgery). Ophthalmol Retina. 2021 Sep;5(9):936-939.
doi: 10.1016/j.oret.2020.12.018

Abramson D.H., Gobin Y.P., Francis J.H. Orbital Retinoblastoma Treated with Intra-arterial Chemotherapy. Ophthalmology. 2021 Oct;128(10):1437.
doi: 10.1016/j.ophtha.2021.03.018
https://www.aaojournal.org/article/S0161-6420(21)00204-9/fulltext

Abramson D.H., Haque S., Francis J.H. Prelaminar and Postlaminar Invasion of Retinoblastoma. Ophthalmology. Retina. 2021 Apr;5(4):387.
doi: 10.1016/j.oret.2020.12.015.
https://pubmed.ncbi.nlm.nih.gov/33814046/

Abramson D.H., Haque S., Francis J.H. Unilateral Retinoblastoma Metastatic to the Skull and Both Orbits. Ophthalmology Retina. 2020 Oct;4
doi: 10.1016/j.oret.2020.04.019.
https://pubmed.ncbi.nlm.nih.gov/33019985/

Abruzzo T., Abraham K., Karani K.B., Geller J.I., Vadivelu S., Racadio J.M., Zhang B., Correa Z.M. Correlation of Technical and Adjunctive Factors with Quantitative Tumor Reduction in Children Undergoing Selective Ophthalmic Artery Infusion Chemotherapy for Retinoblastoma. AJNR. American journal of neuroradiology. 2020 Dec 24.
doi: 10.3174/ajnr.A6905.
https://pubmed.ncbi.nlm.nih.gov/33361377/

Abusayf M.M., Alkatan H.M., Elkhamary S., Almesfer S.A., Maktabi A.M.Y.
Histopathological assessment of optic nerve invasion guided by radiological findings in enucleated globes with retinoblastoma. BMC Ophthalmology. 2020 Sep 29.
doi: 10.1186/s12886-020-01654-z.
https://pubmed.ncbi.nlm.nih.gov/32993566/

de Aguirre Neto J.C., Antoneli C.B., Ribeiro K.B., Castilho M.S., Novaes P.E., Chojniak M.M., Arias V. Retinoblastoma in children older than 5 years of age
Pediatric blood & cancer. 2007 Mar;48(3):292-5.
doi: 10.1002/pbc.20931.
https://pubmed.ncbi.nlm.nih.gov/16847922/

Agarwal K., Vinekar A., Chandra P., Padhi T.R., Nayak S., Jayanna S., Panchal B., Jalali S., Das T. Imaging the pediatric retina: An overview. Indian J Ophthalmol. 2021 Apr;69(4):812-823. PMID: 33727440; PMCID: PMC8012979.
doi: 10.4103/ijo.IJO_1917_20

Ahmad S., Azarcon C.P., Hubbard G.B., Wells J.R. Unilateral Xanthocoria and Retinal Vascular Anomalies in a 3-Year-Old Boy: Retinoblastoma or Coats Disease? J Pediatr Ophthalmol Strabismus. 2022 May-Jun;59(3):e33-e34.
doi: 10.3928/01913913-20220420-01

Akabane M., Hashimoto M., Takazawa Y., Hattori D., Koyama R., Imamura T. Leiomyosarcoma of the splenic vein with a history of bilateral retinoblastoma: A case report and review of the literature. Mol Clin Oncol. 2022 Feb;16(2):35.
doi: 10.3892/mco.2021.2468.

Akaeda S., Hirota Y., Fukui Y., Aikawa S., Shimizu-Hirota R., Kaku T., Gebril M., Hirata T., Hiraoka T., Matsuo M., Haraguchi H., Saito-Kanatani M., Takeda N., Fujii T., Osuga Y. Retinoblastoma protein promotes uterine epithelial cell cycle arrest and necroptosis for embryo invasion. EMBO Rep. 2021 Feb 3;22(2):e50927. Epub 2021 Jan 5.
doi: 10.15252/embr.202050927

Akdemir Aktaş H., Ergun K.M., Tatar İ., Arat A., Hayran K.M.
Evaluation of the anastomoses between the ophthalmic artery and the middle meningeal artery by superselective angiography. Surgical and radiologic anatomy : SRA. 2020 Aug 16.
doi: 10.1007/s00276-020-02546-z.
https://pubmed.ncbi.nlm.nih.gov/32803306/

Aktaş H.A., Balcı S., Tatar İ., Varan A., Kıratlı H., Arat A. Dual ophthalmic arteries: a new case. Surg Radiol Anat. 2022 May 22. Epub ahead of print. PMID: 35598200.
doi: 10.1007/s00276-022-02959-y
Agarwal K., Vinekar A., Chandra P., Padhi T.R., Nayak S., Jayanna S., Panchal B., Jalali S., Das T. Imaging the pediatric retina: An overview. Indian J Ophthalmol. 2021 Apr;69(4):812-823. PMID: 33727440; PMCID: PMC8012979.
doi: 10.4103/ijo.IJO_1917_20

Alekseeva E.A., Babenko O.V., Kozlova V.M., Ushakova T.L., Kazubskaya T.P., Nemtsova M.V., Chesnokova G.G., Mikhaylenko D.S., Bure I.V., Kalinkin A.I., Kuznetsova E.B., Tanas A.S., Kutsev S.I., Zaletaev D.V., Strelnikov V.V. Parental Origin of the RB1 Gene Mutations in Families with Low Penetrance Hereditary Retinoblastoma. Cancers. 2021, № 13, P.5068.-72.
https://doi.org/10.3390/cancers13205068

Alghofaili R. S., Almesfer S. A. Bilateral Retinoblastoma Presenting in an in vitro Fertilization Infant with Retinopathy of Prematurity. Case reports in ophthalmology, 12(1), 306–310. 2021 Apr 30;12(1):306-310.
doi: 10.1159/000513181
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138227/

Alkatan H.M., AlQahtani F.S., Maktabi A.M. Enucleated globes with advanced retinoblastoma: correlation of histopathological features and reclassification of tumors according to the 8th edition of the American Joint Committee on Cancer (AJCC). International Ophthalmology. 2020 Mar 19.
doi: 10.1007/s10792-020-01342-3.
https://pubmed.ncbi.nlm.nih.gov/32193778/?from_term=retinoblastoma&from_sort=pubdate&from_size=50&from_pos=34

Alkatan H.M., Al-Dahmash S.A., Almesfer S.A., AlQahtani F.S., Maktabi A.M.Y.
High-risk features in primary versus secondary enucleated globes with advanced retinoblastoma: a retrospective histopathological study. International ophthalmology. 2020 Jul 6.
doi: 10.1007/s10792-020-01472-8
https://pubmed.ncbi.nlm.nih.gov/32632618/

Allaman-Pillet N., Schorderet D.F. Piperlongumine promotes death of retinoblastoma cancer cells. Oncotarget. 2021 Apr 27;12(9):907-916.
doi: 10.18632/oncotarget.27947

Al Saiegh F., Chalouhi N., Sweid A., Mazza J., Mouchtouris N., Khanna O., Tjoumakaris S., Gooch R, Shields CL, Rosenwasser R, Jabbour P. Intra-arterial chemotherapy for retinoblastoma via the transradial route: Technique, feasibility, and case series. Clinical Neurology and Neurosurgery. 2020 Apr 6
DOI: 10.1016/j.clineuro.2020.105824
https://pubmed.ncbi.nlm.nih.gov/32283473/?from_term=retinoblastoma&from_sort=date&from_pos=1

Alvarez-Suarez D.E., Tovar H., Hernández-Lemus E., Orjuela M., Sadowinski-Pine S., Cabrera-Muñoz L., Camacho J., Favari L., Hernández-Angeles A., Ponce-Castañeda M.V. Discovery of a transcriptomic core of genes shared in 8 primary retinoblastoma with a novel detection score analysis. J Cancer Res Clin Oncol. 2020 May 30.
doi: 10.1007/s00432-020-03266-y.
Online ahead of print. PMID: 32474753

Amin S., AlJboor M., Toro M.D., Rejdak R., Nowomiejska K., Nazzal R., Mohammad M., Al-Hussaini M., Khzouz J., Banat S., AlJabari R., Jaradat I., Mehyar M., Sultan I., AlNawaiseh I., Yousef Y.A.
Management and Outcomes of Unilateral Group D Tumors in Retinoblastoma. Clinical ophthalmology. 2021 Jan 7;15:65-72.
doi: 10.2147/OPTH.S282741.
https://pubmed.ncbi.nlm.nih.gov/33447011/

El Amrani Z., Elalaoui S.C., Jdioui W., Sbiti A., Ratbi I., Liehr T., Sefiani A., Natiq A. Complex translocation leading to13q interstitial deletion in a Moroccan child with retinoblastoma and intellectual disability. Ophthalmic Genet. 2022 Jun 6:1-4. Epub ahead of print. PMID: 35658784.
doi: 10.1080/13816810.2022.2083183

Ancona-Lezama D., Dalvin L.A., Shields C.L. Modern treatment of retinoblastoma: A 2020 review. Indian journal of ophthalmology. 2020 Nov;68(11):2356-2365.
doi: 10.4103/ijo.IJO_721_20.
https://pubmed.ncbi.nlm.nih.gov/33120616/

Ancona-Lezama D., Garza-Garza L.A., Ruiz-Lozano R.E., Shields C.L., Villagomez-Valdez L.G., De-Leija-Portilla J.O. Diffuse infiltrative retinoblastoma with retinal detachment in "cinnamon-roll" configuration: a case report. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus / American Association for Pediatric Ophthalmology and Strabismus. 2020 Dec 18:S1091-8531(20)30315-3.
doi: 10.1016/j.jaapos.2020.10.004.
https://pubmed.ncbi.nlm.nih.gov/33348043/

Arshad R., Barani M., Rahdar A., Sargazi S., Cucchiarini M., Pandey S., Kang M. Multi-Functionalized Nanomaterials and Nanoparticles for Diagnosis and Treatment of Retinoblastoma. Biosensors. 2021 Mar 26;11(4):97.
doi: 10.3390/bios11040097.
https://pubmed.ncbi.nlm.nih.gov/33810621/

Arslan-Carlon V., Walline M.C., Seier K., Tan K.S., Abramson D.H. Hemodynamic Changes Associated with Mydriatic Eye Drop Administration in Anesthetized Pediatric Patients. Ocular oncology and pathology. 2020 May, 6.
doi: 10.1159/000500593.
https://pubmed.ncbi.nlm.nih.gov/32509766/

Aschero R., Francis J.H., Ganiewich D., Gomez-Gonzalez S., Sampor C., Zugbi S., Ottaviani D., Lemelle L., Mena M., Winter U., Correa Llano G., Lamas G., Lubieniecki F., Szijan I., Mora J., Podhajcer O., Doz F., Radvanyi F., Abramson D.H., Llera A.S., Schaiquevich P.S., Lavarino C., Chantada G.L. Recurrent Somatic Chromosomal Abnormalities in Relapsed Extraocular Retinoblastoma.
Cancers (Basel). 2021 Feb 8;13(4):673.
doi: 10.3390/cancers13040673.
https://pubmed.ncbi.nlm.nih.gov/33567541/

Attiku Y., Rishi P. Miliary tuberculosis presenting as bilateral pseudo-retinoblastoma. GMS Ophthalmol Cases. 2021 Jul 28;11:Doc12.
doi: 10.3205/oc000185

Aubry A., Pearson J.D., Huang K., Livne-Bar I., Ahmad M., Jagadeesan M., Khetan V., Ketela T., Brown K.R., Yu T., Lu .S, Wrana J.L., Moffat J., Bremner R. Functional genomics identifies new synergistic therapies for retinoblastoma. ONCOGENE. 2020 Jun 22.
doi: 10.1038/s41388-020-1372-7
https://pubmed.ncbi.nlm.nih.gov/32572160/

Aubry A., Yu T., Bremner R. Preclinical studies reveal MLN4924 is a promising new retinoblastoma therapy. Cell Death Discov. 2020 Jan 20;6:2.
DOI: 10.1038/s41420-020-0237-8.
https://www.nature.com/articles/s41420-020-0237-8

B

Babu V.S., Mallipatna A., Sa D., Dudeja G., Kannan R., Shetty R., Nair A.P., Gundimeda S., Chaurasia S.S., Verma N.K., Lakshminarayanan R., Heymans S., Barathi V.A., Guha N., Ghosh A. Integrated Analysis of Cancer Tissue and Vitreous Humor from Retinoblastoma Eyes Reveals Unique Tumor-Specific Metabolic and Cellular Pathways in Advanced and Non-Advanced Tumors. Cells. 2022 May 18;11(10):1668.
doi: 10.3390/cells11101668

Bakker M.A., Toom D.T., Damen T.H.C., Sleddens HFBM, Meijssen I.C., Deloose S., Kliffen M., Dinjens WNM. Anisometric Cell and Dysplastic Lipomas in a Retinoblastoma Patient. International journal of surgical pathology. 2020 May 4.
DOI: 10.1177/1066896920917220
https://pubmed.ncbi.nlm.nih.gov/32362169/?from_term=retinoblastoma&from_sort=date&from_page=5&from_pos=10

Balaji S., Santhi R., Kim U., Muthukkaruppan V., Priya C.G., Vanniarajan A. Cancer Stem Cells with Overexpression of Neuronal Markers Enhance Chemoresistance and Invasion in Retinoblastoma. Current cancer drug targets. 2020 May 4
DOI: 10.2174/1568009620666200504112711
https://pubmed.ncbi.nlm.nih.gov/32364077/?from_term=retinoblastoma&from_sort=date&from_page=5&from_pos=9

Banderali U., Jain M., Thakur S., Jayanthan A., Belke D.D., Giles W.R., Narendran A. The T-type Calcium Channel Cav3.1 in Y79 Retinoblastoma Cells is Regulated by the Epidermal Growth Factor Receptor via the MAPK Signaling Pathway. Curr Eye Res. 2021 Oct 21:1-10.
doi: 10.1080/02713683.2021.1988982

Bansal R., Aishwarya A., Rao R., Christy M.C., Sen M., Regani H., Bagai P., Reddy V.A., Mulay K., Bongoni P., Honavar S.G. Impact of COVID-19 nationwide lockdown on retinoblastoma treatment and outcome: A study of 476 eyes of 326 children. Indian J Ophthalmol. 2021 Oct;69(10):2617-2624.
doi: 10.4103/ijo.IJO_2243_21

Bao X.Y., Sun M., Peng T.T., Han D.M. TRIB3 promotes proliferation, migration, and invasion of retinoblastoma cells by activating the AKT/mTOR signaling pathway. Cancer biomarkers : section A of Disease markers. 2021 Apr 21.
doi: 10.3233/CBM-200050.
https://pubmed.ncbi.nlm.nih.gov/33896816/

Bas Z., Dalvin L.A., Tadepalli S., Rao R., Shah A., Leahey A.M., Shields C.L. Outcomes of Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma Based on Patient Age in 964 Eyes of 554 Patients. Asia-Pacific journal of ophthalmology. 2021 Jan 19.
doi: 10.1097/APO.0000000000000360.
https://pubmed.ncbi.nlm.nih.gov/33481399/

Batu Oto B., Sarıcı A.M., Kızılkılıç O. Superselective intra-arterial chemotherapy treatment for retinoblastoma: clinical experience from a tertiary referral centre. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2020 Jun 8.
doi: 10.1016/j.jcjo.2020.04.009
https://pubmed.ncbi.nlm.nih.gov/32527493/

Belson P.J., Eastwood J.A., Brecht M.L., Kim J.W., Hays R.D., Pike N.A. Health-Related Quality of Life in Adolescent and Young Adult Retinoblastoma Survivors. J Pediatr Hematol Oncol Nurs. 2022 Jun 8:27527530221073766. Epub ahead of print. PMID: 35674414.
doi: 10.1177/27527530221073766

Berdugo J., Rooper L.M., Chiosea SI. RB1, p16, and Human Papillomavirus in Oropharyngeal Squamous Cell Carcinoma. Head Neck Pathol. 2021 Dec;15(4):1109-1118.
doi: 10.1007/s12105-021-01317-5.

Bereimipour A., Satarian L., Taleahmad S. Investigation of Key Signaling Pathways Associating miR-204 and Common Retinopathies. Biomed Res Int. 2021 Oct 4;2021:5568113.
doi: 10.1155/2021/5568113

Berry J.L., Munier F.L., Gallie B.L., Polski A., Shah S., Shields C.L., Gombos D.S., Ruchalski K., Stathopoulos C., Shah R., Jubran R., Kim J.W., Mruthyunjaya P., Marr B.P., Wilson M.W., Brennan R.C., Chantada G.L., Chintagumpala M.M., Murphree A.L. Response criteria for intraocular retinoblastoma: RB-RECIST. Pediatric blood & cancer. 2021 Feb 23:e28964.
doi: 10.1002/pbc.28964.
https://pubmed.ncbi.nlm.nih.gov/33624399/

Berry J.L., Munier F.L., Gallie B.L., Polski A., Shah S., Shields C.L., Gombos D.S., Ruchalski K., Stathopoulos C., Shah R., Jubran R., Kim J.W., Mruthyunjaya P., Marr B.P., Wilson M.W., Brennan R.C., Chantada G.L., Chintagumpala M.M., Murphree A.L. Response criteria for intraocular retinoblastoma: RB-RECIST. Pediatric blood & cancer. 2021 May;68(5):e28964.
doi: 10.1002/pbc.28964.
https://pubmed.ncbi.nlm.nih.gov/33624399/

Bhaduri A., Das S., Bansal S., Shree N. Smartphone Wide-Field Fundus Photography in Retinoblastoma With a Nasal Endoscope. Indian journal of ophthalmology. 2020 Jul.
doi: 10.4103/ijo.IJO_1666_19.
https://pubmed.ncbi.nlm.nih.gov/32587146/
http://www.ijo.in/temp/IndianJOphthalmol6871255-3887954_104759.pdf

Biewald E., Kiefer T., Geismar D., Schlüter S., Manthey A., Westekemper H., Wulff J., Timmermann B., Ketteler P., Schönberger S., Metz K.A., Ting S., Göricke S., Bechrakis N.E., Bornfeld N. Feasibility of Proton Beam Therapy as a Rescue Therapy in Heavily Pre-Treated Retinoblastoma Cancers. 2021 Apr 13;13(8):1862.
doi: 10.3390/cancers13081862.
https://pubmed.ncbi.nlm.nih.gov/33924716/

Blitzer A.L., Schechet S.A., Shah H.A., Blair M.P. Retinoblastoma presenting as pseudohypopyon and preserved visual acuity. Am J Ophthalmol Case Rep. 2021 Jun 23;23:101141.
doi: 10.1016/j.ajoc.2021.101141
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242958/

Blixt M.K.E., Hellsand M., Konjusha D., Zhang H., Stenfelt S., Åkesson M., Rafati N., Tararuk T., Stålhammar G., All-Eriksson C., Ring H., Hallböök F. MYCN induces cell-specific tumorigenic growth in RB1-proficient human retinal organoid and chicken retina models of retinoblastoma. Oncogenesis. 2022 Jun 21;11(1):34. PMID: 35729105; PMCID: PMC9213451.
doi: 10.1038/s41389-022-00409-3

Boddu D., Thankamony P., Prakasam R., Sugath S., Kumar A., Nair S. Successful Treatment of Late Isolated Bone Metastasis in a Patient with Bilateral Retinoblastoma Using an Unconventional Method. Ocul Oncol Pathol. 2021 Sep;7(4):262-266.
doi: 10.1159/000514620

Bogan C.M., Kaczmarek J.V., Pierce J.M., Chen S.C., Boyd K.L., Calcutt M.W., Bridges T.M., Lindsley C.W., Nadelmann J.B., Liao A., Hsieh T., Abramson D.H., Francis J.H., Friedman D.L., Richmond A., Daniels A.B. Evaluation of intravitreal topotecan dose levels, toxicity and efficacy for retinoblastoma vitreous seeds: a preclinical and clinical study. The British journal of ophthalmology. 2021 May 10:bjophthalmol-2020-318529.
doi: 10.1136/bjophthalmol-2020-318529.
https://pubmed.ncbi.nlm.nih.gov/33972235/

Bogan C.M., Pierce J.M., Doss S.D., Tao Y.K., Chen S.C., Boyd K.L., Liao A., Hsieh T., Abramson D.H., Francis J.H., Friedman D.L., Richmond A., Daniels A.B. Intravitreal melphalan hydrochloride vs propylene glycol-free melphalan for retinoblastoma vitreous seeds: Efficacy, toxicity and stability in rabbits models and patients. Experimental eye research. 2021 Jan 11;204:108439.
doi: 10.1016/j.exer.2021.108439.
https://pubmed.ncbi.nlm.nih.gov/33444583/

Borah N.A., Sradhanjali S., Barik M.R., Jha A., Tripathy D., Kaliki S., Rath S., Raghav S.K., Patnaik S., Mittal R., Reddy M.M. Aurora Kinase B Expression, Its Regulation and Therapeutic Targeting in Human Retinoblastoma. Investigative ophthalmology & visual science. 2021 Mar 1;62(3):16.
doi: 10.1167/iovs.62.3.16.
https://pubmed.ncbi.nlm.nih.gov/33704359/

Bornfeld N., Lohmann D., Bechrakis N.E., Biewald E. [Retinoblastoma]. // Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft. Ophthalmologe. 2020 Mar 23.
DOI: 10.1007/s00347-020-01081-x.
https://pubmed.ncbi.nlm.nih.gov/32206913/?from_term=retinoblastoma&from_sort=date&from_pos=3

Bossacoma F., Cuadrado-Vilanova M., Vinent J., Correa M.G., Gavrus D., Castillo-Ecija H., Catala-Mora J., Mora J., Schaiquevich P., Chantada G.L., Carcaboso AM. Optimizing the storage of chemotherapeutics for ophthalmic oncology: stability of topotecan solution for intravitreal injection. Ophthalmic genetics. 2020 Jun 3.
doi: 10.1080/13816810.2020.1776336
https://pubmed.ncbi.nlm.nih.gov/32490703/

Bourkiza R., Cumberland P., Fabian I.D., Abeysekera H., Parulekar M., Sagoo M.S., Rahi J., Reddy M.A. Role of ethnicity and socioeconomic status (SES) in the presentation of retinoblastoma: findings from the UK. BMJ Open Ophthalmology. 2020 May 15.
DOI: 10.1136/bmjophth-2019-000415
https://pubmed.ncbi.nlm.nih.gov/32432168/?from_term=retinoblastoma&from_sort=date&from_page=2&from_pos=2

Bowman R.J.C., Foster A., Stacey A., Keren-Froim N., Bascaran C., Kivelä T.T., Munier F., Fabian I.D. International travel to obtain medical treatment for primary retinoblastoma: A global cohort study. International journal of cancer. 2020 Oct 18.
doi: 10.1002/ijc.33350.
https://pubmed.ncbi.nlm.nih.gov/33070355/

Bowman R.J.C., Foster A., Stacey A., Keren-Froim N., Bascaran C., Kivelä T.T., Munier F., Fabian I.D. International travel to obtain medical treatment for primary retinoblastoma: A global cohort study. International journal of cancer. 2021 Apr 15;148(8):1858-1866.
doi: 10.1002/ijc.33350.
https://pubmed.ncbi.nlm.nih.gov/33070355/

Burges M., Qaddoumi I., Brennan R.C., Krull L., Sahr N., Rodriguez-Galindo C., Jeha S., Wilson M.W. Assessment of Retinoblastoma Capacity in the Middle East, North Africa, and West Asia Region. JCO Global Oncology. 2020 Oct; 6.
doi: 10.1200/GO.20.00321.
https://pubmed.ncbi.nlm.nih.gov/33064626/

Busch M., Miroschnikov N., Dankert J.T., Wiesehöfer M., Metz K., Stephan H., Dünker N. Impact of RARα and miR-138 on retinoblastoma etoposide resistance. Tumour Biol. 2021;43(1):11-26.
doi: 10.3233/TUB-200072.

C

Calotti M., Yaghy A., Shields C.L. Painful Glaucoma and Pseudohypopyon in a Child with Retinoblastoma. Ophthalmology. Glaucoma. 2020 Nov-Dec;3(6):480.
doi: 10.1016/j.ogla.2020.07.004
https://www.ophthalmologyglaucoma.org/article/S2589-4196(20)30186-1/pdf

Cancela M.B., Zugbi S., Winter U., Martinez A.L., Sampor C., Sgroi M., Francis J.H., Garippa R., Abramson D.H., Chantada G., Schaiquevich P. A decision process for drug discovery in retinoblastoma. Investigational new drugs. 2020 Nov 16.
doi: 10.1007/s10637-020-01030-0
https://pubmed.ncbi.nlm.nih.gov/33200242/

Cao M., Wang S., Zou J., Wang W. Bioinformatics analyses of retinoblastoma reveal the retinoblastoma progression subtypes. PeerJ. 2020 May 21.
doi: 10.7717/peerj.8873
https://pubmed.ncbi.nlm.nih.gov/32509443/

Cao Y., Zhou M., Tian M., Lv H.B. The Safety and Effectiveness of Melphalan-Based Intra-Arterial Chemotherapy for Retinoblastoma: An Updated Single-Arm Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med. 2022 Feb 14;2022:3156503. PMID: 35198033; PMCID: PMC8860512.
doi: 10.1155/2022/3156503

Carbone E. T-type calcium channels as therapeutic targets for treating "giant" retinoblastoma cancer cells. Pflugers Arch. 2021 Sep 7.
doi: 10.1007/s00424-021-02620-4

Carnevale J.A., Goldberg J., Kocharian G., Rivera M., Giantini L.A., Garton A., Ramos A., Francis J.H., Abramson D.H., Pierre Gobin Y. Intra-arterial chemotherapy for retinoblastoma. J Neurointerv Surg. 2022 May 18.
doi: 10.1136/neurintsurg-2022-018957

Castela G., Providência J., Monteiro M., Silva S., Brito M., Murta J.N., Correa Z., Castelo Branco M. Treatment of Advanced Retinoblastoma in Children Evacuated from Low-Income Countries: Experience from a National Referral Center in Portugal. Clin Ophthalmol. 2021 Dec 21;15:4765-4773.
doi: 10.2147/OPTH.S343919

Castela G., Providencia J., Monteiro M., Silva S., Brito M., Sá J., Oliveiros B., Murta J.N., Correa Z., Branco M.C. Characterization of the Portuguese population diagnosed with retinoblastoma. Sci Rep. 2022 Mar 14;12(1):4378. PMID: 35288594; PMCID: PMC8921246.
doi: 10.1038/s41598-022-08326-6

Castro-Magdonel B.E., Orjuela M., Alvarez-Suarez D.E., Camacho J., Cabrera-Muñoz L., Sadowinski-Pine S., Medina-Sanson A., Lara-Molina C., García-Vega D., Vázquez Y., Durán-Figueroa N., Orozco-Romero M.J., Hernández-Ángeles A., Ponce-Castañeda M.V. Circulating miRNome Detection Analysis Reveals 537 miRNAS in Plasma, 625 in Extracellular Vesicles and a Discriminant Plasma Signature of 19 miRNAs in Children With Retinoblastoma From Which 14 Are Also Detected in Corresponding Primary Tumors. PLoS One. 2020 Apr 14.
DOI: 10.1371/journal.pone.0231394
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156076/

Catlin J.P., Marziali L.N., Rein B., Yan Z., Feltri M.L., Schaner Tooley C.E. Age-related neurodegeneration and cognitive impairments of NRMT1 knockout mice are preceded by misregulation of RB and abnormal neural stem cell development. Cell Death Dis. 2021 Oct 28;12(11):1014.
doi: 10.1038/s41419-021-04316-0

Chai P., Luo Y., Yu J., Li Y., Yang J., Zhuang A., Fan J., Han M., Jia R. Clinical characteristics and germline mutation spectrum of RB1 in Chinese patients with retinoblastoma: A dual-center study of 145 patients. Experimental eye research. 2021 Apr;205:108456.
doi: 10.1016/j.exer.2021.108456
https://pubmed.ncbi.nlm.nih.gov/33493472/

Chai P., Jia R., Li Y., Zhou C., Gu X., Yang L., Shi H., Tian H., Lin H., Yu J., Zhuang A., Ge S., Jia R., Fan X. Regulation of epigenetic homeostasis in uveal melanoma and retinoblastoma. Prog Retin Eye Res. 2021 Dec 1:101030.
doi: 10.1016/j.preteyeres.2021.101030

Chakumatha E., Weijers J., Banda K., Bailey S., Molyneux E., Chagaluka G., Israels T. Outcome at the end of treatment of patients with common and curable childhood cancer types in Blantyre, Malawi. Pediatric blood & cancer. 2020 May 11.
DOI: 10.1002/pbc.28322
https://pubmed.ncbi.nlm.nih.gov/32391955/?from_term=retinoblastoma&from_sort=date&from_page=4&from_pos=6

Chaudhary R., Tiwari T., Sharma R., Goyal S. Retinoblastoma with significant intravitreal haemorrhage: a rare presentation. BMJ Case Rep. 2021 Sep 17;14(9):e246288.
doi: 10.1136/bcr-2021-246288

Chaudhary S., Shah S., Lavaju P., Shrestha B.G., Pant A.R., Badhu B.P. Profile of Destructive Ocular Surgery and its Indications: A Twelve-Year Review from Eastern Nepal. J Nepal Health Res Counc. 2021 Sep 6;19(2):246-251.
doi: 10.33314/jnhrc.v19i2.3150

Chawla B., Bhaskaran K., Dada T., Bajaj M.S., Kashyap S., Shende D. Evaluation of the role of ultrasound biomicroscopy in advanced retinoblastoma: A prospective study on Asian Indian children. Ophthalmic Genetics. 2020 Mar 16.
DOI: 10.1080/13816810.2020.1737946
https://pubmed.ncbi.nlm.nih.gov/32176559/?from_term=retinoblastoma&from_sort=pubdate&from_size=50&from_pos=40

Chen N.N., Chao D.L., Li X.G. Circular RNA has_circ_0000527 participates in proliferation, invasion and migration of retinoblastoma cells via miR-646/BCL-2 axis. Cell Biochemistry & Function. 2020 Apr 7.
DOI: 10.1002/cbf.3535
https://pubmed.ncbi.nlm.nih.gov/32266733/?from_term=retinoblastoma&from_sort=date&from_page=2&from_pos=3

Chen P.Y., Kao L.Y., Chao A.N., Wu W.C., Sun M.H., Su W.W., Liu C.H. Retinoblastoma in Taiwan: survival and clinical characteristics. Japanese journal of ophthalmology. 2021 May 4.
doi: 10.1007/s10384-021-00836-6
https://pubmed.ncbi.nlm.nih.gov/33948759/

Chen Q., Zhang B., Dong Y., Mo X., Zhang L., Xia J., Zhang J., Zhang S. Evaluating primary intra-arterial chemotherapy versus intravenous plus intra-arterial chemotherapy for advanced intraocular retinoblastoma. // Cancer Chemotherapy and Pharmacology. 2020 Mar 2.
DOI: 10.1007/s00280-020-04036-w
https://www.ncbi.nlm.nih.gov/pubmed/32123960

Chen S., Chen X., Luo Q., Liu X., Wang X., Cui Z., He A., He S., Jiang Z., Wu N., Chen P., Yu K., Zhuang J. Retinoblastoma cell-derived exosomes promote angiogenesis of human vesicle endothelial cells through microRNA-92a-3p. Cell Death Dis. 2021 Jul 13;12(7):695.
doi: 10.1038/s41419-021-03986-0

Chen S., Chen X., Qiu J., Chen P., Han X., Wu Y., Zhuang J., Yang M., Wu C., Wu N., Yang Y., Ge J., Yu K., Zhuang J. Exosomes derived from retinoblastoma cells enhance tumour deterioration by infiltrating the microenvironment. Oncology reports. 2021 Jan;45(1):278-290.
doi: 10.3892/or.2020.7858
https://pubmed.ncbi.nlm.nih.gov/33416154/

Chen W.J., Sun C.X., Li W. Mechanism of FGF7 Gene Silencing in Regulating Viability, Apoptosis, Invasion of Retinoblastoma Cell Line HXO-Rb44 and Angiogenesis. European review for medical and pharmacological sciences. 2020 Apr 24
DOI: 10.26355/eurrev_202004_20814
https://pubmed.ncbi.nlm.nih.gov/32329827/?from_term=retinoblastoma&from_sort=date&from_pos=7

Chen X., Chen S., Jiang Z., Gong Q., Tang D., Luo Q., Liu X., He S., He A., Wu Y., Qiu J., Li Y., Wang X., Yu K., Zhuang J. Ubiquitination-Related miRNA-mRNA Interaction Is a Potential Mechanism in the Progression of Retinoblastoma. Invest Ophthalmol Vis Sci. 2021 Aug 2;62(10):3.
doi: 10.1167/iovs.62.10.3

Chen Y., Lu B., Liu L., Pan X., Jiang C., Xu H. Long non-coding RNA PROX1-AS1 knockdown upregulates microRNA-519d-3p to promote chemosensitivity of retinoblastoma cells via targeting SOX2. Cell Cycle. 2021 Sep 29:1-12.
doi: 10.1080/15384101.2021.1971352

Chen Y., Zhu X., Wang K., Zou W., Zhou F. Tubeimoside II inhibits TGF-β1-induced metastatic progression of human retinoblastoma cells through suppressing redoxosome-dependent EGFR activation. Chem Biol Interact. 2021 Feb 1;335:109367. Epub 2021 Jan 4.
doi: 10.1016/j.cbi.2021.109367

Che S., Wu S., Yu P. Lupeol induces autophagy and apoptosis with reduced cancer stem-like properties in retinoblastoma via phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin inhibition. J Pharm The Journal of pharmacy and pharmacology. 2021 Apr 9:rgab060.
doi: 10.1093/jpp/rgab060
https://pubmed.ncbi.nlm.nih.gov/33836050/

Choi W.J., Jo D.H., Kang H.J., Shin H.Y., Yu Y.S., Kim J.H. Development of New Solitary Retinoblastoma Tumors during and after Chemotherapy. Korean journal of ophthalmology : KJO. 2021 Feb;35(1):73-79.
doi: 10.3341/kjo.2020.0115
https://pubmed.ncbi.nlm.nih.gov/33596616/

Cho S.J., Kim J.H., Baik S.H., Sunwoo L., Bae Y.J., Choi B.S. Diagnostic performance of MRI of post-laminar optic nerve invasion detection in retinoblastoma: A systematic review and meta-analysis. Neuroradiology. 2020 Aug 31
doi: 10.1007/s00234-020-02538-1
https://pubmed.ncbi.nlm.nih.gov/32865636/

Cho S.J., Kim J.H., Baik S.H., Sunwoo L., Bae Y.J., Choi B.S. Diagnostic performance of MRI of post-laminar optic nerve invasion detection in retinoblastoma: A systematic review and meta-analysis. Neuroradiology. 2021 Apr;63(4):499-509.
doi: 10.1007/s00234-020-02538-1
https://pubmed.ncbi.nlm.nih.gov/32865636/

Chou J.F., Ford J.S., Kleinerman R.A., Abramson D.H., Francis J.H., Sklar C.A., Oeffinger K.C., Robison L.L., Dunkel I.J., Friedman D.N. General cancer screening practices among adult survivors of retinoblastoma: Results from the Retinoblastoma Survivor Study. Pediatric blood & cancer. 2021 Jan 26:e28873.
doi: 10.1002/pbc.28873
https://pubmed.ncbi.nlm.nih.gov/33501778/

Chou J.F., Ford J.S., Kleinerman R.A., Abramson D.H., Francis J.H., Sklar C.A., Oeffinger K.C., Robison L.L., Dunkel I.J., Friedman D.N. General cancer screening practices among adult survivors of retinoblastoma: Results from the Retinoblastoma Survivor Study. Pediatric blood & cancer. 2021 Apr;68(4):e28873.
doi: 10.1002/pbc.28873
https://pubmed.ncbi.nlm.nih.gov/33501778/

Cho Y.J., Jung D.E., Oh Y., Nam K., Lee H.C., Jeon Y., Cho Y.D., Kim T.K. Heart rate variability and oxygen reserve index during cardiorespiratory events in patients undergoing ophthalmic arterial chemotherapy: a prospective observational study. Journal of clinical monitoring and computing. 2021 Mar 18.
doi: 10.1007/s10877-021-00687-z
https://pubmed.ncbi.nlm.nih.gov/33733371/

Clarissa A., Sutandi N., Fath A.A. Stem-Cell Therapy Following High-Dose Chemotherapy in Advanced Retinoblastoma: A Systematic Review. Asia-Pacific journal of ophthalmology. 2021 Jan 19.
doi: 10.1097/APO.0000000000000372
https://pubmed.ncbi.nlm.nih.gov/33481395/

Cobbs L.V., Francis J.H., Dunkel I.J., Gobin Y.P., Brodie S.E., Abramson D.H. Retinoblastoma management in 13q deletion syndrome patients using super-selective chemotherapies and other cancer-directed interventions. Pediatric blood & cancer. 2020 Dec 23:e28845.
doi: 10.1002/pbc.28845
https://pubmed.ncbi.nlm.nih.gov/33355996/\

Cobbs L.V., Francis J.H., Dunkel I.J., Gobin Y.P., Brodie S.E., Abramson D.H. Retinoblastoma management in 13q deletion syndrome patients using super-selective chemotherapies and other cancer-directed interventions. Pediatric blood & cancer. 2021 May;68(5):e28845.
doi: 10.1002/pbc.28845
https://pubmed.ncbi.nlm.nih.gov/33355996/

Collin J., Queen R., Zerti D., Steel D.H., Bowen C., Parulekar M., Lako M. Dissecting the Transcriptional and Chromatin Accessibility Heterogeneity of Proliferating Cone Precursors in Human Retinoblastoma Tumors by Single Cell Sequencing-Opening Pathways to New Therapeutic Strategies?
Investigative ophthalmology & visual science. 2021 May 3;62(6):18.
doi: 10.1167/iovs.62.6.18
https://pubmed.ncbi.nlm.nih.gov/34003213/

Conroy L.R., Dougherty S., Kruer T., Metcalf S., Lorkiewicz P., He L., Yin X., Zhang X., Arumugam S., Young LEA, Sun R.C., Clem B.F. Loss of Rb1 Enhances Glycolytic Metabolism in Kras-Driven Lung Tumors In Vivo. ancers (Basel). 2020 Jan 17;12(1). pii: E237.
DOI: 10.3390/cancers12010237

Cuadrado-Vilanova M., Liu J., Paco S., Aschero R., Burgueño V., Sirab N., Pascual-Pasto G., Correa G., Balaguer-Lluna L., Castillo-Ecija H., Perez-Jaume S., Muñoz-Aznar O., Roldan M., Suñol M., Schaiquevich P., Aerts I., Doz F., Cassoux N., Lubieniecki F., Benitez-Ribas D., Lavarino C., Mora J., Chantada G.L., Catala-Mora J, Radvanyi F, Carcaboso AM. Identification of immunosuppressive factors in retinoblastoma cell secretomes and aqueous humor from patients. J Pathol. 2022 Mar 7. Epub ahead of print. PMID: 35254670.
doi: 10.1002/path.5893

Cui X., Liang T., Ji X., Shao Y., Zhao P., Li X. LINC00488 Induces Tumorigenicity in Retinoblastoma by Regulating microRNA-30a-5p/EPHB2 Axis. Ocul Immunol Inflamm. 2022 Apr 11:1-9. Epub ahead of print. PMID: 35404750.
doi: 10.1080/09273948.2022.2037659

D

Dai H., Zeng W., Zeng W., Yan M., Jiang P., Li Y., Zhang W., Ke M. HELZ2 promotes K63-linked polyubiquitination of c-Myc to induce retinoblastoma tumorigenesis. Med Oncol. 2021 Nov 10;39(1):11.
doi: 10.1007/s12032-021-01603-w

Dai X.Z., Wang L.Y., Shan Y., Qian J., Xue K., Ye J. Clinicopathological analysis of 719 pediatric and adolescents' ocular tumors and tumor-like lesions: a retrospective study from 2000 to 2018 in China. International journal of ophthalmology. 2020 Dec 18;13(12):1961-1967.
doi: 10.18240/ijo.2020.12.1
https://pubmed.ncbi.nlm.nih.gov/33344197/

Dalvi N., Kleinerman R.A., Epelman S., Abramson D.H., Dunkel I.J. Low-grade glioma: A rare second tumor in retinoblastoma survivors. Pediatric blood & cancer. 2020 Oct 16.
doi: 10.1002/pbc.28770
https://pubmed.ncbi.nlm.nih.gov/33063942/

Dalvin L.A., Bas Z., Tadepalli S., Rao R., Vaidya S., Pacheco R., Shields C.L. Risk Factors for Tumor Recurrence Following Primary Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma in 869 Eyes of 551 Patients. Journal of pediatric ophthalmology and strabismus. 2020 Jul 1.
doi: 10.3928/01913913-20200417-01
https://pubmed.ncbi.nlm.nih.gov/32687206/

Daniels A.B., Froehler M.T., Kaczmarek J.V., Bogan C.M., Santapuram P.R., Pierce J.M., Chen S.C., Schremp E.A., Boyd K.L., Tao Y.K., Calcutt M.W., Koyama T., Richmond A., Friedman D.L. Efficacy, Toxicity, and Pharmacokinetics of Intra-Arterial Chemotherapy Versus Intravenous Chemotherapy for Retinoblastoma in Animal Models and Patients. Transl Vis Sci Technol. 2021 Sep 1;10(11):10.
doi: 10.1167/tvst.10.11.10

Daniels A.B., Patel S.N., Milam R.W., Kohanim S., Friedman D.L., Koyama T.
Effect of Intravenous Chemotherapy Regimen on Globe Salvage Success Rates for Retinoblastoma Based on Disease Class-A Meta-Analysis. Cancers (Basel). 2021;13(9):2216. 2021 May 6.
doi:10.3390/cancers13092216
https://pubmed.ncbi.nlm.nih.gov/34066325/

Daniels A.B., Pierce J.M., Chen S.C. Complete preclinical platform for intravitreal chemotherapy drug discovery for retinoblastoma: Assessment of pharmacokinetics, toxicity and efficacy using a rabbit model. MethodsX. 2021 Apr 20;8:101358.
doi: 10.1016/j.mex.2021.101358

Das A., Ranjan R., Shah P.K. Coexistent Retinoblastoma and Retinopathy of Prematurity in a Preterm Infant.
https://pubmed.ncbi.nlm.nih.gov/33339056/

Das D., Bhattacharjee K., Barman M.J., Bhattacharjee H., Maity S., Bandyopadhyay D., Thakur S., Deshmukh S., Garg M., Deka A. Pathologic evidence of retinoblastoma seeds supported by field emission scanning electron microscopy and Raman spectroscopy. Indian J Ophthalmol. 2021 Dec;69(12):3612-3617.
doi: 10.4103/ijo.IJO_436_21

Dave N., Vural A.S., Piras I.S., Winslow W., Surendra L., Winstone J.K., Beach T.G., Huentelman M.J., Velazquez R. Identification of retinoblastoma binding protein 7 (Rbbp7) as a mediator against tau acetylation and subsequent neuronal loss in Alzheimer's disease and related tauopathies. Acta Neuropathol. 2021 Aug;142(2):279-294.
doi: 10.1007/s00401-021-02323-1
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270842/

Dave T.V., Nayak A., Palo M., Goud Y., Tripuraneni D., Gupta S. Custom ocular prosthesis-related concerns: patient feedback survey-based report vis-à-vis objective clinical grading scales. Orbit. 2021 Oct;40(5):357-363.
doi: 10.1080/01676830.2020.1797826

Davies H.R., Broad K.D., Onadim Z., Price E.A., Zou X., Sheriff I., Karaa E.K., Scheimberg I., Reddy M.A., Sagoo M.S., Ohnuma S.I., Nik-Zainal S. Whole-Genome Sequencing of Retinoblastoma Reveals the Diversity of Rearrangements Disrupting RB1 and Uncovers a Treatment-Related Mutational Signature. Cancers. 2021 Feb 11;13(4):754.
doi: 10.3390/cancers13040754
https://pubmed.ncbi.nlm.nih.gov/33670346/

Deike-Hofmann K., von Lampe P., Eerikaeinen M., Ting S., Schlüter S., Schlemmer H.P., Bechrakis N.E., Forsting M., Radbruch A. Anterior chamber enhancement predicts optic nerve infiltration in retinoblastoma. Eur Radiol. 2022 May 7.
doi: 10.1007/s00330-022-08778-4

Del Carmen Bernal-Díaz Z., Murillo-Maldonado M.A., Pérez-Villanueva H., Reyes-López A., Ramírez-Ortiz M.A. Ocular preservation in patients with bilateral retinoblastoma before chemotherapy in situ era: A report from a Mexican Retinoblastoma Reference Hospital. Pediatric blood & cancer. 2020 Aug 3
doi: 10.1002/pbc.28625
https://pubmed.ncbi.nlm.nih.gov/32743978/

Delrish E., Jabbarvand M., Ghassemi F., Amoli F.A., Atyabi F., Lashay A., Soleimani M., Aghajanpour L., Dinarvand R. Efficacy of topotecan nanoparticles for intravitreal chemotherapy of retinoblastoma.
Experimental eye research. 2021 Jan 13;204:108423.
doi: 10.1016/j.exer.2020.108423
https://pubmed.ncbi.nlm.nih.gov/33453276/

Del Sole M.J., Clausse M., Nejamkin P., Cancela B., Del Río M., Lamas G., Lubieniecki F., Francis J.H., Abramson D.H., Chantada G., Schaiquevich P. Ocular and systemic toxicity of high-dose intravitreal topotecan in rabbits: Implications for retinoblastoma treatment. Exp Eye Res. 2022 Mar 8;218:109026. Epub ahead of print. PMID: 35276184.
doi: 10.1016/j.exer.2022.109026

Demirci H., Wang Y., Li Q., Lin C.M., Kotov N.A., Grisolia A.B.D., Guo J.L.
Penetration of Carbon Nanotubes into the Retinoblastoma Tumor after Intravitreal Injection in LH BETA T AG Transgenic Mice Reti-noblastoma Model.
Journal of ophthalmic & vision research. 2020 Oct 25;15(4):446-452.
doi: 10.18502/jovr.v15i4.7778
https://pubmed.ncbi.nlm.nih.gov/33133434/

Deng X., Cheng Y., Zhu X.M., Linghu D.D., Zhao M.W., Liang J.H. [Evaluation the risk of optic nerve invasion associated with optic nerve obscuration in advanced retinoblastoma]. Chinese journal of ophthalmology. 2020 Sep 11.
doi: 10.3760/cma.j.cn112142-20200318-00197

Dhingra H., Arya D., Taluja A., Das S., Mahajan A. A study analyzing the health-related quality of life of retinoblastoma survivors in India. Indian journal of ophthalmology. 2021 Jun;69(6):1482-1486.
doi: 10.4103/ijo.IJO_2428_20
https://pubmed.ncbi.nlm.nih.gov/34011724/

Diatewa B.M., Maneh N., Domingo A.S., Amouzou D., Gnansa K., Bawerima W., Ayikoue Y.F., Mewamba Wamba R. Le rétinoblastome au Centre Hospitalier Universitaire-Campus de Lomé, Togo, de 2014 à 2018 [Retinoblastoma at the Campus-University Teaching Hospital in Lomé, Togo, from 2014 to 2018]. J Fr Ophtalmol. 2022 Jun 23:S0181-5512(21)00592-1. French. Epub ahead of print. PMID: 35753853.
doi: 10.1016/j.jfo.2021.08.014

Ding F., Jiang K., Sheng Y., Li C., Zhu H. LncRNA MIR7-3HG executes a positive role in retinoblastoma progression via modulating miR-27a-3p/PEG10 axis. Exp Eye Res. 2020 Feb 5;193:107960.
DOI: 10.1016/j.exer.2020.107960

Dittner-Moormann S., Reschke M., Abbink F.C.H., Aerts I., Atalay H.T., Fedorovna Bobrova N., Biewald E., Brecht IB, Caspi S, Cassoux N., Castela G., Diarra Y., Duncan C., Ebinger M., Garcia Aldana D., Hadjistilianou D., Kepák T., Klett A., Kiratli H., Maka E., Opocher E., Pawinska-Wasikowska K., Rascon J., Russo I., Rutynowska-Pronicka O., Sábado Álvarez C., Pacheco S.S.R., Svojgr K., Timmermann B., Vishnevskia-Dai V., Eggert A., Ritter-Sovinz P., Bechrakis N.E., Jenkinson H., Moll A., Munier F.L., Popovic M.B., Chantada G., Doz F., Ketteler P. Adjuvant therapy of histopathological risk factors of retinoblastoma in Europe: A survey by the European Retinoblastoma Group (EURbG). Pediatric blood & cancer. 2021 Mar 15:e28963.
doi: 10.1002/pbc.28963
https://pubmed.ncbi.nlm.nih.gov/33720495/

Doege A., Steens R., Dünker N., Busch M.A. Retinoblastoma Cell Growth In Vitro and Tumor Formation In Ovo-Influence of Different Culture Conditions. Methods Protoc. 2022 Mar 2;5(2):21. PMID: 35314658; PMCID: PMC8938814.
doi: 10.3390/mps5020021

Domínguez-Varela I.A., Aguilera-Partida J.A., Dalvin L.A., Garza-Garza L.A., Thompson-García L.M., Barbosa-Quintana Á., Ancona-Lezama D. Retinoblastoma in an older Hispanic child masquerading as pars planitis: A case report.
European journal of ophthalmology. 2021 Feb 10:1120672121994487.
doi: 10.1177/1120672121994487
https://pubmed.ncbi.nlm.nih.gov/33567900/

Dong Y., Wan G., Yan P., Qian C., Li F., Peng G. Long noncoding RNA LINC00324 promotes retinoblastoma progression by acting as a competing endogenous RNA for microRNA-769-5p, thereby increasing STAT3 expression. Aging. 2020 May 5
DOI: 10.18632/aging.103075
https://pubmed.ncbi.nlm.nih.gov/32369777/?from_term=retinoblastoma&from_sort=date&from_page=5&from_pos=4

Döpper H., Horstmann M., Menges J., Bozet M., Kanber D., Steenpass L. Biallelic and monoallelic deletion of the RB1 promoter in six isogenic clonal H9 hESC lines. Stem Cell Research. 2020 Mar 29;45:101779.
DOI: 10.1016/j.scr.2020.101779
https://pubmed.ncbi.nlm.nih.gov/32268247/?from_term=retinoblastoma&from_sort=date&from_page=2&from_pos=2

Drager O., Metz K., Busch M., Dunker N. Role of L1CAM in retinoblastoma tumorigenesis: identification of novel therapeutic targets. Mol Oncol. 2022 Feb;16(4):957-981. PMID: 34228897; PMCID: PMC8847994.
doi: 10.1002/1878-0261.13054

E

Echegaray J.J., Al-Zahrani Y.A., Singh A. Episcleral brachytherapy for retinoblastoma. Br J Ophthalmol 2020; 104(2):208–13.
doi: 10.1136/bjophthalmol-2019-313985
https://pubmed.ncbi.nlm.nih.gov/31122912/

Eiset S.E., Funding M., Racher H., Heegaard S., Gallie B., Urbak S.F., Gregersen P.A. Metachronous, non-pineal, trilateral retinoblastoma in a patient with a seemingly reduced-expressivity RB1 germline deletion. Clin Case Rep. 2022 Mar 18;10(3):e05498. PMID: 35340648; PMCID: PMC8933631.
doi: 10.1002/ccr3.5498

Elfalah M., Al Nawaiseh T., Atoum D, AlKhassawneh A., Mohammad M., AlNawaiseh I., Yousef YA. Improving Medical Students' Awareness About Retinoblastoma: A Practical Strategy. Clin Ophthalmol. 2022 Jun 7;16:1807-1814. PMID: 35698597; PMCID: PMC9188477.
doi: 10.2147/OPTH.S355876

El Hamichi S., Acon D., Kon Graversen V., Gold A.S., Berrocal A.M., Murray T.G.
Acute Orbital Compromise after Intra-Arterial Chemotherapy in a Complex Retinoblastoma Associated with 13q Deletion Syndrome. Pediatric Neurosurgery. 2020 Nov 11:1-4.
doi: 10.1159/000511019
https://pubmed.ncbi.nlm.nih.gov/33176321/

El Zomor H., Nour R., Saad A., Taha H., Shelil A.E., Aleieldin A., Saad Zaghloul M., Alfaar A.S. Unilateral retinoblastoma; natural history and an age-based protocol in 248 patients. Eye. 2020 Nov 13.
doi: 10.1038/s41433-020-01275-2
https://pubmed.ncbi.nlm.nih.gov/33188294/

Enrico T.P., Stallaert W., Wick E.T., Ngoi P., Wang X., Rubin S.M., Brown N.G., Purvis J.E., Emanuele M.J. Cyclin F drives proliferation through SCF-dependent degradation of the retinoblastoma-like tumor suppressor p130/RBL2. Elife. 2021 Dec 1;10:e70691.
doi: 10.7554/eLife.70691

Escudero A., Ferreras C., Rodriguez-Salas N., Corral D., Rodriguez L., Pérez-Martínez A. Cancer predisposing syndrome: a retrospective cohort analysis in a pediatric and multidisciplinary genetic cancer counseling unit. Int J Clin Oncol. 2022 Feb 21. Epub ahead of print. PMID: 35190929.
doi: 10.1007/s10147-022-02133-9

Eulo V., Lesmana H., Doyle L.A., Nichols K.E., Hirbe A.C. Secondary Sarcomas: Biology, Presentation, and Clinical Care. // American Society of Clinical Oncology. 2020 Mar.
DOI: 10.1200/EDBK_280985. PMID: 32213089
https://pubmed.ncbi.nlm.nih.gov/32213089/?from_term=retinoblastoma&from_sort=date&from_pos=1

F

Fabian I.D., Khetan V., Stacey A.W., Allen Foster, Ademola-Popoola D.S., Berry J.L., Cassoux N., Chantada G.L., Hessissen L., Kaliki S., Kivela T.T., Luna-Fineman S., Munier F.L., Reddy M.A., Rojanaporn D., Blum S., Sherief S.T., Staffieri S.E., Theophile T., Waddell K., Ji X., Astbury N.J., Bascaran C., Burton M., Zondervan M., Bowman R.; Global Retinoblastoma Study Group. Sex, gender, and retinoblastoma: analysis of 4351 patients from 153 countries. Eye (Lond). 2021 Jul 16.
doi: 10.1038/s41433-021-01675-y

Fabian I.D., Stacey A.W., Bowman R., Khetan V., Blum S., Keren-Froim N., Staffieri S., Foster A.; Global Retinoblastoma Study Group. Retinoblastoma management during the COVID-19 pandemic: A report by the Global Retinoblastoma Study Group including 194 centers from 94 countries. Pediatric blood & cancer. 2020 Aug 6
doi: 10.1002/pbc.28584
https://pubmed.ncbi.nlm.nih.gov/32762025/

Fabian I.D., Stacey A.W., Foster A., Kivelä T.T., Munier F.L. etc. Travel burden and clinical presentation of retinoblastoma: analysis of 1024 patients from 43 African countries and 518 patients from 40 European countries. The British journal of ophthalmology. 2020 Sep 15.
doi: 10.1136/bjophthalmol-2020-316613
https://pubmed.ncbi.nlm.nih.gov/32933936/

Fabius A.W.M., van Hoefen Wijsard M., van Leeuwen F.E., Moll A.C. Subsequent Malignant Neoplasms in Retinoblastoma Survivors. Cancers. 2021 Mar 10;13(6):1200.
doi: 10.3390/cancers13061200
https://pubmed.ncbi.nlm.nih.gov/33801943/

Fang X., Chen J., Wang Y., Zhao M., Zhang X., Yang L., Ni X., Zhao J., Gallie B.L. RB1 germline mutation spectrum and clinical features in patients with unilateral retinoblastomas. Ophthalmic genetics. 2021 Jun 30:1-7.
doi: 10.1080/13816810.2021.1946703
https://pubmed.ncbi.nlm.nih.gov/34190019/

Fang X., Chen J., Wang Y., Zhao M., Zhang X., Yang L., Ni X., Zhao J., Gallie B.L. RB1 germline mutation spectrum and clinical features in patients with unilateral retinoblastomas. Ophthalmic Genet. 2021 Oct;42(5):593-599.
doi: 10.1080/13816810.2021

Fang X., Wang H., Ma X., Guo Y., Yang W., Hu S., Qiu Y., Zhao J., Ni X. Clinical Features of Children with Retinoblastoma and Neuroblastoma. Journal of ophthalmology. 2020 Jul 10.
doi: 10.1155/2020/9315784
https://pubmed.ncbi.nlm.nih.gov/32695501/

Fang X., Wang Y., Yin J., Guo Y., Jia L., Zhang C., Jin M., Ni X., Zhao J. Clinical features and survival of Chinese children with trilateral retinoblastoma during 2006-2019: A retrospective multicenter study. American journal of ophthalmology. 2020 Oct 10.
doi: 10.1016/j.ajo.2020.10.002
https://pubmed.ncbi.nlm.nih.gov/33049241/

Faranoush M., Mehrvar N., Tashvighi M., Fabian I.D., Zloto O., Bascaran C., Ghorbani R., Ghasemi F., Naseripour M., Sedaghat A., Alebouyeh M., Mehrvar A. Retinoblastoma presentation, treatment and outcome in a large referral centre in Tehran: a 10-year retrospective analysis. Eye. 2020 May 4
DOI: 10.1038/s41433-020-0907-z
https://pubmed.ncbi.nlm.nih.gov/32367000/?from_term=retinoblastoma&from_sort=date&from_page=5&from_pos=6

Farouk Sait S., Haque S., Karimi S., Rebeiz K.J., Francis J.H., Marr B.P., Abramson D.H., Souweidane M.M., Dunkel I.J. A Potential Role For Apparent Diffusion Coefficient in the Diagnosis of Trilateral Retinoblastoma. Journal of Pediatric Hematology/Oncology. 2020 Apr
DOI: 10.1097/MPH.0000000000001523
https://pubmed.ncbi.nlm.nih.gov/31259824/?from_term=retinoblastoma&from_sort=pubdate&from_size=50&from_pos=14

Feng W., Zhu R., Ma J., Song H. LncRNA ELFN1-AS1 Promotes Retinoblastoma Growth and Invasion via Regulating miR-4270/SBK1 Axis. Cancer management and research. 2021 Feb 5;13:1067-1073.
doi: 10.2147/CMAR.S281536
https://pubmed.ncbi.nlm.nih.gov/33574704/

Feng X., Gong J., Li Q., Xing C., Pan J., Zou R., Zheng L., Chen F. Identification and functional annotation of differentially expressed long noncoding RNAs in retinoblastoma. Exp Ther Med. 2021 Dec;22(6):1447. Epub 2021 Oct 14. 3.
doi: 10.3892/etm.2021.10882

Feng Y., Zhou C., Jia R., Wang Y., Fan X.Quality of Life (QoL) and Psychosocial Outcomes in Adult Survivors of Unilateral Retinoblastoma (RB) in China. Journal of Ophthalmology. 2020 Mar 12
DOI: 10.1155/2020/4384251
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125462/

Fernandez J.P., Haider A.A., Vajzovic L., Ponugoti A., Kelly M.P., Materin M.A. Optical Coherence Tomography Angiography Microvascular Variations in Pre- and Posttreatment of Retinoblastoma Tumors. Ocul Oncol Pathol. 2021 Oct;7(5):330-339. doi: 10.1159/000515142. Epub 2021 Jun 2.
PMID: 34722489; PMCID: PMC8531827.

Finger P.T., Tomar A.S. Retinoblastoma outcomes: a global perspective. Lancet Glob Health. 2022 Jan 27:S2214-109X(21)00598-2. Epub ahead of print.
doi: 10.1016/S2214-109X(21)00598-2

Fitoussi R., Stolowy N., Levy C., Beylerian M., Comet A., Lesueur A., Denis D. Rétinoblastome avec présentation initiale trompeuse chez une enfant de 7 ans [Retinoblastoma with misleading initial presentation in a 7-year-old child]. J Fr Ophtalmol. 2021 Aug 6:S0181-5512(21)00403-4. French.
doi: 10.1016/j.jfo.2021.03.018

Flegg K., Gelkopf M.J., Johnson S.A., Dimaras H.; Canadian Retinoblastoma Research Advisory Board Priority Setting Steering Committee. The top 10 retinoblastoma research priorities in Canada as determined by patients, clinicians and researchers: a patient-oriented priority-setting partnership. CMAJ open. 2020 Jun 9.
doi: 10.9778/cmajo.20190221
https://pubmed.ncbi.nlm.nih.gov/32518094/

Fowle H., Zhao Z., Xu Q., Wasserman J.S., Wang X., Adeyemi M., Feiser F., Kurimchak A.N., Atar D., McEwan B.C., Kettenbach A.N., Page R., Peti W., Dunbrack R.L. Jr., Graña X. PP2A/B55α substrate recruitment as defined by the retinoblastoma-related protein p107. Elife. 2021 Oct 18;10:e63181.
doi: 10.7554/eLife.63181

De Francesco S., Galluzzi P., Bracco S., Di Maggio A., Sgheri A., Hadijstilianou T.
Rescue intra-arterial chemotherapy in unilateral multirelapsed peripapillary retinoblastoma: Decision making and the role of MRI. European journal of ophthalmology. 2020 Sep 9.
doi: 10.1177/1120672120957586
https://pubmed.ncbi.nlm.nih.gov/32907373/

De Francesco S., Sgheri A., Di Maggio A., Rana F., Anna Maria P., Alessandra R., Hadjistilianou T. Bilateral Retinoblastoma and Osteogenesis Imperfecta, a Very Rare Association: Two Cases. European Journal of Ophthalmology. 2020 Apr 21.
DOI: 10.1177/1120672120919344
https://pubmed.ncbi.nlm.nih.gov/32314604/?from_term=retinoblastoma&from_sort=date&from_page=2&from_pos=3

Francis J.H., Richards A.L., Mandelker D.L., Berger M.F., Walsh M.F., Dunkel I.J., Donoghue M.T.A, Abramson D.H. Molecular Changes in Retinoblastoma beyond RB1: Findings from Next-Generation Sequencing. Cancers. 2021 Jan 5;13(1):149.
doi: 10.3390/cancers13010149
https://pubmed.ncbi.nlm.nih.gov/33466343/

Friedman D.N., Hsu M., Moskowitz C.S., Francis J.H., Lis E., Fleischut M.H., Oeffinger K.C., Walsh M., Tonorezos E.S., Sklar C.A., Abramson D.H., Dunkel I. Whole-body magnetic resonance imaging as surveillance for subsequent malignancies in preadolescent, adolescent, and young adult survivors of germline retinoblastoma: An update. J. Pediatr Blood Cancer. 2020 Jul;67(7):e28389. Epub 2020 May 9.
doi: 10.1002/pbc.28389
PMID: 32386119

Friedman E.L., Froehler M.T., Daniels A.B. Orbital Swelling in a Child With Retinoblastoma Following Intra-arterial Chemotherapy. JAMA Ophthalmology. 2021 Jan 21.
doi: 10.1001/jamaophthalmol.2020.4675
https://pubmed.ncbi.nlm.nih.gov/33475694/

Froehler M.T., Feldman M.J., Poitras B., Daniels A.B. Angiographic investigation of orbital vascular variations in the rabbit and implications for endovascular intra-arterial chemotherapy models. Journal of neurointerventional surgery. 2020 Sep 11
doi: 10.1136/neurintsurg-2020-016460
https://pubmed.ncbi.nlm.nih.gov/32917761/

Fu C., Wang S., Jin L., Zhang M., Li M. CircTET1 inhibits retinoblastoma progression via targeting miR-492 and miR-494-3p through Wnt/beta-catenin signaling pathway. Current eye research. 2020 Oct 27.
doi: 10.1080/02713683.2020.1843685.
https://pubmed.ncbi.nlm.nih.gov/33108919/

Fu C., Wang S., Jin L., Zhang M., Li M. CircTET1 Inhibits Retinoblastoma Progression via Targeting miR-492 and miR-494-3p through Wnt/β-catenin Signaling Pathway. Current eye research. 2021 May 7:1-10.
doi: 10.1080/02713683.2020.1843685
https://pubmed.ncbi.nlm.nih.gov/33108919/

Fu K., Zhang K., Zhang X. LncRNA HOTAIR facilitates proliferation and represses apoptosis of retinoblastoma cells through the miR-20b-5p/RRM2/PI3K/AKT axis. Orphanet J Rare Dis. 2022 Mar 5;17(1):119.. PMID: 35248107; PMCID: PMC8898492.
doi: 10.1186/s13023-022-02206-y

G

Galardi A., Colletti M., Lavarello C., Di Paolo V., Mascio P., Russo I., Cozza R., Romanzo A., Valente P., De Vito R., Pascucci L., Peinado H., Carcaboso A.M., Petretto A., Locatelli F., Di Giannatale A. Proteomic Profiling of Retinoblastoma-Derived Exosomes Reveals Potential. Biomarkers of Vitreous Seeding. Cancers. 2020 Jun 12.
doi: 10.3390/cancers12061555
https://pubmed.ncbi.nlm.nih.gov/32545553/

Gal C., Carelli F.N., Appert A., Cerrato C., Huang N., Dong Y., Murphy J., Frapporti A., Ahringer J. DREAM represses distinct targets by cooperating with different THAP domain proteins. Cell Rep. 2021 Oct 19;37(3):109835.
doi: 10.1016/j.celrep.2021.109835

Le Gall J., Dehainault C, Benoist C., Matet A., Lumbroso-Le Rouic L., Aerts I., Jiménez I., Schleiermacher G., Houdayer C., Radvanyi F., Frouin E., Renault V., Doz F., Stoppa-Lyonnet D., Gauthier-Villars M., Cassoux N., Golmard L. Highly Sensitive Detection Method of Retinoblastoma Genetic Predisposition and Biomarkers. J Mol Diagn. 2021 Oct 15:S1525-1578(21)00323-8.
doi: 10.1016/j.jmoldx.2021.08.014

Le Gall J., Dehainault C., Benoist C, Matet A., Lumbroso-Le Rouic L., Aerts I., Jiménez I., Schleiermacher G., Houdayer C., Radvanyi F., Frouin E., Renault V., Doz F., Stoppa-Lyonnet D., Gauthier-Villars M., Cassoux N., Golmard L. Highly Sensitive Detection Method of Retinoblastoma Genetic Predisposition and Biomarkers. J Mol Diagn. 2021 Dec;23(12):1714-1721.
doi: 10.1016/j.jmoldx.2021.08.014

Gallo R.A., Shoag J., Johnson T.E., Solomon D.A., Perry A., Podda A., Lee J.Y., Rong A. Eye-sparing Treatment of Localized Orbital Medulloepithelioma With Neoadjuvant Chemoradiation. J. Ophthalmic Plast Reconstr Surg. 2020 May 14.
doi: 10.1097/IOP.0000000000001703
Online ahead of print. PMID: 32427730

Ganesan B., Parameswaran S., Sharma A., Krishnakumar S. Clinical relevance of B7H3 expression in retinoblastoma. Scientific reports. 2020 Jun 23.
doi: 10.1038/s41598-020-67101-7
https://pubmed.ncbi.nlm.nih.gov/32576886/

Gao M., Cui Z., Zhao D., Zhang S., Cai Q. MicroRNA-9 inhibits proliferation and progression in retinoblastoma cells by targeting PTEN. Genes & genomics. 2021 Jun 15.
doi: 10.1007/s13258-021-01043-w
https://pubmed.ncbi.nlm.nih.gov/34129195/

Gao M., Cui Z., Zhao D., Zhang S., Cai Q. MicroRNA-9 inhibits proliferation and progression in retinoblastoma cells by targeting PTEN. Genes Genomics. 2021 Sep;43(9):1023-1033.
doi: 10.1007/s13258-021-01043-w

Gao X., Jin Z., Tan X., Zhang C., Zou C., Zhang W., Ding J., Das B.C., Severinov K., Hitzeroth I.I., Debata P.R., He D., Ma X., Tian X., Gao Q., Wu J., Tian R., Cui Z., Fan W., Huang Z., Cao C., Bao Y., Tan S., Hu Z. Hyperbranched poly (β-amino ester) based polyplex nanopaticles for delivery of CRISPR/Cas9 system and treatment of HPV infection associated cervical cancer. J Control Release. 2020 Feb 27.
DOI: 10.1016/j.jconrel.2020.02.045

Gao Y., Luo X., Zhang J. LincRNA-ROR is activated by H3K27 acetylation and induces EMT in retinoblastoma by acting as a sponge of miR-32 to activate the Notch signaling pathway. Cancer gene therapy. 2020 May 22
DOI: 10.1038/s41417-020-0181-z
https://pubmed.ncbi.nlm.nih.gov/32439866/?from_term=retinoblastoma&from_sort=date&from_pos=7

Gao Y., Luo X., Zhang J. Sp1-mediated up-regulation of lnc00152 promotes invasion and metastasis of retinoblastoma cells via the miR-30d/SOX9/ZEB2 pathway. Cellular oncology (Dordrecht). 2020 Jun 1.
doi: 10.1007/s13402-020-00522-8
https://pubmed.ncbi.nlm.nih.gov/32488851/

Gao Y.X., Gao H.X., Xu X.Y., Ding F.K. Effects of lncRNA MALAT1 and lncRNA NKILA on proliferation, invasion and apoptosis of retinoblastoma. European review for medical and pharmacological sciences. 2020 Aug;24
doi: 10.26355/eurrev_202008_22626
https://pubmed.ncbi.nlm.nih.gov/32894536/

Gargallo P., Oltra S., Balaguer J., Barranco H., Yáñez Y., Segura V., Juan-Ribelles A., Calabria I., Llavador M., Castel V., Cañete A. Retinoblastoma and mosaic 13q deletion: a case report. Int J Retina Vitreous. 2021 Sep 3;7(1):50.
doi: 10.1186/s40942-021-00321-9

Garza-Garza L.A., Ruiz-Lozano R.E., Rebolledo-Méndez G., Ibarra-Nava I., Morales-Garza H.J., Ancona-Lezama D. Challenge of Retinoblastoma in Mexico in 2020: Perspectives and Solutions. Journal of ophthalmology. 2020 Aug 10
doi: 10.1155/2020/1953602
https://pubmed.ncbi.nlm.nih.gov/32850140/

Geng W., Ren J., Shi H., Qin F., Xu X., Xiao S., Jiao Y., Wang A. RPL41 sensitizes retinoblastoma cells to chemotherapeutic drugs via ATF4 degradation. Journal of cellular physiology. 2020 Aug 11.
doi: 10.1002/jcp.30010
https://pubmed.ncbi.nlm.nih.gov/32783256/

Gerrish A., Bowns B., Mashayamombe-Wolfgarten C., Young E., Court S., Bott J., McCalla M., Ramsden S., Parks M., Goudie D., Carless S., Clokie S., Cole T., Allen S. Non-Invasive Prenatal Diagnosis of Retinoblastoma Inheritance by Combined Targeted Sequencing Strategies. Journal of Clinical Medicine. 2020 Oct 30;9(11):3517.
doi: 10.3390/jcm9113517
https://pubmed.ncbi.nlm.nih.gov/33143217/

Gerrish A., Jenkinson H., Cole T. The Impact of Cell-Free DNA Analysis on the Management of Retinoblastoma. Cancers. 2021 Mar 29;13(7):1570.
doi: 10.3390/cancers13071570
https://pubmed.ncbi.nlm.nih.gov/33805427/

Ghafouri-Fard S., Dashti S., Taheri M., Omrani M.D. TINCR: An lncRNA with dual functions in the carcinogenesis process. Non-coding RNA research. 2020 Jul 9.
doi: 10.1016/j.ncrna.2020.06.003
https://pubmed.ncbi.nlm.nih.gov/32695943/

Gharbaran R., Shi C., Onwumere O., Redenti S. Plumbagin Induces Cytotoxicity via Loss of Mitochondrial Membrane Potential and Caspase Activation in Metastatic Retinoblastoma. Anticancer Res. 2021 Oct;41(10):4725-4732.
doi: 10.21873/anticanres

Ghose N., Kaliki S. Liquid biopsy in Retinoblastoma: A review. Semin Ophthalmol. 2022 May 23:1-7.
doi: 10.1080/08820538.2022.2078165

Global Retinoblastoma Study Group. Global Retinoblastoma Presentation and Analysis by National Income Level. JAMA Oncology. Published Online: February 27, 2020.
DOI:10.1001/jamaoncol.2019.6716

Gohari M., Moghimi M., Aarafi H., Shajari A., Jafari-Nedooshan J., Lookzadeh MH., Mirjalili SR., Neamatzadeh H. Association of MTHFR 677C > T, 1298A > C and MTR 2756A > G Polymorphisms with Susceptibility to Childhood Retinoblastoma: A Systematic Review and Met-Analysis. Fetal and Pediatric Pathology. Feb-2020.
DOI 10.1080/15513815.2020.1721738

Gohari M., Moghimi M., Aarafi H., Shajari A., Jafari-Nedooshan J., Lookzadeh M.H., Mirjalili S.R., Neamatzadeh H. Association of MTHFR 677C > T, 1298A > C and MTR 2756A > G Polymorphisms with Susceptibility to Childhood Retinoblastoma: A Systematic Review and Met-Analysis. Fetal Pediatr Pathol. 2021 Dec;40(6):612-625.
doi: 10.1080/15513815.2020.1721738

Gómez-Romero L., Alvarez-Suarez D.E., Hernández-Lemus E., Ponce-Castañeda M.V., Tovar H. The regulatory landscape of retinoblastoma: a pathway analysis perspective. R Soc Open Sci. 2022 May 18;9(5):220031.
doi: 10.1098/rsos.220031

Goncalves L.F., Ramasubramanian A., Grebe T., Riemann M., Moncrief D., Cornejo P. Prenatal diagnosis of bilateral retinoblastomas by multimodality fetal imaging: case report and review of the literature. Clinical imaging. 2021 Mar 20;78:121-126.
doi: 10.1016/j.clinimag.2021.03.023
https://pubmed.ncbi.nlm.nih.gov/33774578/

Gonzalez M.E., Gaviria M.L., Lopez M., Escudero P.A., Bravo A., Vargas S.A. Eye Salvage with Intra-Arterial and Intra-Vitreal Chemotherapy in Patients with Retinoblastoma: 8-Year Single-Institution Experience in Colombia. Ocul Oncol Pathol. 2021 Jun;7(3):215-223.
doi: 10.1159/000511980

Gregersen P.A., Funding M., Alsner J., Olsen M.H., Overgaard J., Urbak S.F., Staffieri S.E., Lou S. Living with heritable retinoblastoma and the perceived role of regular follow-up at a retinoblastoma survivorship clinic: 'That is exactly what I have been missing'. BMJ Open Ophthalmol. 2021 Sep 12;6(1):e000760.
doi: 10.1136/bmjophth-2021-000760
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438830/

Gregersen P.A., Olsen M.H., Urbak S.F., Funding M., Dalton S.O., Overgaard J., Alsner J. Incidence and Mortality of Second Primary Cancers in Danish Patients With Retinoblastoma, 1943-2013. JAMA Network Open. 2020 Oct 1
doi: 10.1001/jamanetworkopen.2020.22126
https://pubmed.ncbi.nlm.nih.gov/33090227/

Grümme L., Biewald E., Reschke M., Fischhuber K. etc. Comparing efficacy and side effects of two systemic chemotherapy regimens for eye-preserving therapy in children with retinoblastoma. Pediatr Blood Cancer. 2021 Oct 4:e29362.
doi: 10.1002/pbc.29362

Guevarra M.C.B., Eala M.A.B, Dee E.C., Mercado G.J.V., Collantes E.R.A. Looking through the scope: retinoblastoma in the Philippines. Eye (Lond). 2022 Apr 13. Epub ahead of print. PMID: 35418708.
doi: 10.1038/s41433-022-02069-4

Gu H., Wang Y., Huang D., Zhang Y., Zhang W., Hu H., Zhang P., Zhou Y., Yi Y., Han S. Clinical features and imaging manifestations of retinoblastoma with hepatic metastasis. Pediatr Blood Cancer. 2021 Oct;68(10):e28959.
doi: 10.1002/pbc.28959

Guihurt Santiago J., Burgos-Tirado N., Lafontaine D.D., Mendoza Sierra J.C., Camacho R.H., Vecchini Rodríguez C.M., Morales-Tirado V., Flores-Otero J. Adhesion G protein-coupled receptor, ELTD1, is a potential therapeutic target for retinoblastoma migration and invasion. BMC Cancer. 2021 Jan 11;21(1):53.
doi: 10.1186/s12885-020-07768-3
https://pubmed.ncbi.nlm.nih.gov/33430814/

Gui T., Zheng H., Liu M., Xia Z., Ji X., Yin Q., Wang D., Li Y., Chen S. Clinical and magnetic resonance imaging features of 14 patients with trilateral retinoblastoma. Quantitative imaging in medicine and surgery. Quantitative imaging in medicine and surgery. 2021 Apr;11(4):1458-1469.
doi: 10.21037/qims-20-605
https://pubmed.ncbi.nlm.nih.gov/33816182/

Guiying T., Yue L., Chao X., Jinhai Y., Qihua X. Retracted: Antitumor Effects of 8-Deoxylactucin in RB355 Human Retinoblastoma Cells Are Mediated via Apoptosis Induction, Reactive Oxygen Species Production, and Cell Cycle Arrest. Medical science monitor : international medical journal of experimental and clinical research. 2021 Mar 25;27:e932344.
doi: 10.12659/MSM.932344
https://pubmed.ncbi.nlm.nih.gov/33762557/

Gündüz A.K., Mirzayev I., Temel E., Ünal E., Taçyıldız N., Dinçaslan H., Köse S.K., Özalp Ateş F.S., Işık M.U. A 20-year audit of retinoblastoma treatment outcomes. Eye. 2020 May 6.
DOI: 10.1038/s41433-020-0898-9
https://pubmed.ncbi.nlm.nih.gov/32376976/?from_term=retinoblastoma&from_sort=date&from_page=5&from_pos=2

Gunduz A.K., Mirzayev I., Dinçaslan H., Özalp Ateş F.S. Recurrence and new tumor development after frontline intravenous chemotherapy for retinoblastoma: Risk factors and treatment results. Eur J Ophthalmol. 2021 Jun 30:11206721211023311.
doi: 10.1177/11206721211023311

Gündüz A.K., Mirzayev I., Temel E., Ünal E., Taçyıldız N., Dinçaslan H., Köse S.K., Ateş F.S.Ö., Işık M.U. Correction: A 20-year audit of retinoblastoma treatment outcomes. Eye. 2020 Aug 5.
doi: 10.1038/s41433-020-1119-2
https://pubmed.ncbi.nlm.nih.gov/32760009/

Guo L., Bai Y., Ni T., Li Y., Cao R., Ji S., Li S. MicroRNA‑153‑3p suppresses retinoblastoma cell growth and invasion via targeting the IGF1R/Raf/MEK and IGF1R/PI3K/AKT signaling pathways. Int J Oncol. 2021 Jul;59(1):47. Epub 2021 May 26.
doi: 10.3892/ijo.2021.5227

Gupta A.K., Meena J.P., Seth R. Reasons for missed chemotherapy appointments in retinoblastoma patients undergoing chemotherapy: A report from a Tertiary Care Hospital from India. Cancer reports. 2020 Sep 3
doi: 10.1002/cnr2.1279
https://pubmed.ncbi.nlm.nih.gov/32881413/

Gupta H., Malaichamy S., Mallipatna A., Murugan S., Jeyabalan N., Suresh Babu V., Ghosh A., Ghosh A., Santhosh S., Seshagiri S., Ramprasad V.L., Kumaramanickavel G. Retinoblastoma genetics screening and clinical management. BMC Med Genomics. 2021 Jul 22;14(1):188.
doi: 10.1186/s12920-021-01034-6

Gu X., Xie M., Jia R., Ge S. Publication Trends of Research on Retinoblastoma During 2001-2021: A 20-Year Bibliometric Analysis. Front Med (Lausanne). 2021 May 21;8:675703.
doi: 10.3389/fmed.2021.675703

Guzman F, Fazeli Y, Khuu M, Salcido K, Singh S, Benavente CA.
Retinoblastoma Tumor Suppressor Protein Roles in Epigenetic Regulation. Cancers. 2020; 12(10):2807.
https://doi.org/10.3390/cancers12102807

H

Hadjistilianou D., Barchitta M., Defrancesco S. Covid-19 and retinoblastoma: How we manage it. European journal of ophthalmology. 2020 Jun 19.
doi: 10.1177/1120672120936484
https://pubmed.ncbi.nlm.nih.gov/32552159/

Hage El S., Wakim E., Daou L., El Masri J., Salameh P. Epidemiology and Incidence of Retinoblastoma in the Middle East: A Nationwide Study in Lebanon. Cureus. 2021 Oct 12;13(10):e18696.
doi: 10.7759/cureus.18696

Hanbazazh M., Dryja T.P. Molecular Genetics of Intraocular Tumors. Seminars in ophthalmology. 2020 Jun 7.
doi: 10.1080/08820538.2020.1776343
https://pubmed.ncbi.nlm.nih.gov/32507011/

Handayani K., Indraswari B.W., Sitaresmi M.N., Mulatsih S., Widjajanto P.H., Kors W.A., Kaspers G.J., Mostert S. Treatment Outcome of Children with Retinoblastoma in a Tertiary Care Referral Hospital in Indonesia. Asian Pacific journal of cancer prevention : APJCP. 2021 May 1;22(5):1613-1621.
doi:10.31557/APJCP.2021.22.5.1613
https://pubmed.ncbi.nlm.nih.gov/34048193/

Han J.W., Lee C.S., Hahn S.M., Ahn W.K., Kim H.S., Yun H., Lee S.C., Kim B.M., Kim D.J., Lyu C.J. The Efficacy of Alternate Systemic Intravenous Chemotherapy and Intra-Arterial Chemotherapy Approach for Eye Globe Salvage in Retinoblastoma. Cancer Res Treat. 2022 May 24.
doi: 10.4143/crt.2021.1537

Hanks J., Snyder S., Stoolman S. Retinoblastoma: Beyond the red reflex. Nurse Pract. 2021 Sep 1;46(9):10-12.
doi: 10.1097/01.NPR.0000769776.57850.9a
https://journals.lww.com/tnpj/Citation/2021/09000/Retinoblastoma__Beyond_the_red_reflex.2.aspx

Han S., Song L., Chen Y., Hou M., Wei X., Fan D. The long non-coding RNA ILF3-AS1 increases the proliferation and invasion of retinoblastoma through the miR-132-3p/SMAD2 axis. Experimental cell research. 2020 May 11.
DOI: 10.1016/j.yexcr.2020.112087
https://pubmed.ncbi.nlm.nih.gov/32407730/?from_term=retinoblastoma&from_sort=date&from_page=3&from_pos=7

He X., Chai P., Li F., Zhang L., Zhou C., Yuan X., Li Y., Yang J., Luo Y., Ge S., Zhang H., Jia R., Fan X. A novel LncRNA transcript, RBAT1, accelerates tumorigenesis through interacting with HNRNPL and cis-activating E2F3. Molecular cancer. 2020 Jul 15.
doi: 10.1186/s12943-020-01232-3
https://pubmed.ncbi.nlm.nih.gov/32669100/

He X., Feng Y. MicroRNA hsa-miR-657 promotes retinoblastoma malignancy by inhibiting peroxisome proliferator-activated receptor alpha expression. Anticancer Drugs. 2022 Mar 23. Epub ahead of print. PMID: 35324527.
doi: 10.1097/CAD.0000000000001308

Hoang C.Q., Duong H.Q., Nguyen N.T., Nguyen S.AH., Nguyen C., Nguyen B.D., Phung L.T., Nguyen D.T., Pham C.T.M., Le Doan T., Tran M.H. Clinical evaluation of RB1 genetic testing reveals novel mutations in Vietnamese patients with retinoblastoma. Mol Clin Oncol. 2021 Sep;15(3):182.
oi: 10.3892/mco.2021.2344
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278403/

Hobzova R., Kodetova M., Pochop P., Uhlik J., Dunovska K., Svojgr K., Hrabeta J., Feriancikova B., Cocarta A.I., Sirc J. Hydrogel implants for transscleral diffusion delivery of topotecan: In vivo proof of concept in a rabbit eye model. International journal of pharmaceutics. 2021 Jun 24:120832.
doi: 10.1016/j.ijpharm.2021.120832
https://pubmed.ncbi.nlm.nih.gov/34175379/

Hraib M., Mhanna A., Bayerly B., Ghanem A., Alshehabi Z. An atypical clinical/radiological presentation of Retinoblastoma in a 4-year-old child: A case report & educational lessons from Syria. Ann Med Surg (Lond). 2022 May 18;78:103830. PMID: 35734689; PMCID: PMC9206916.
doi: 10.1016/j.amsu.2022.103830

Hsieh J., Molusky M.M., McCabe K.M., Fotakis P., Xiao T., Tascau L., Zeana-Schliep L., DaSilva-Jardine P., Tall A.R. TTC39B destabilizes retinoblastoma protein promoting hepatic lipogenesis in a sex-specific fashion. J Hepatol. 2021 Sep 30:S0168-8278(21)02083-3.
doi: 10.1016/j.jhep.2021.09.021

Hsieh T., Liao A., Francis J.H., Lavery J.A., Mauguen A., Brodie S.E., Abramson D.H. Comparison of efficacy and toxicity of intravitreal melphalan formulations for retinoblastoma. PLoS One. 2020 Jul 1.
doi: 10.1371/journal.pone.0235016
https://pubmed.ncbi.nlm.nih.gov/32609726/

Huang J., Zhang L., Li Z., Lu X. Screening and identification of key biomarkers for retinoblastoma: Evidence from bioinformatics analysis. Medicine (Baltimore) 2020 May.
DOI: 10.1097/MD.0000000000019952
https://pubmed.ncbi.nlm.nih.gov/32443297/?from_term=retinoblastoma&from_sort=date&from_pos=5

Huang X., Wan J., Liu F., Liu Y., Wang L., Zhao S., Wu T., Sun F. P38 Mitogen-Activated Protein Kinase Protects Against Retinoblastoma Through Regulating USP22/SIRT1/SOST Axis. Front Oncol. 2022 Mar 9;12:781247. PMID: 35356205; PMCID: PMC8959650.
doi: 10.3389/fonc.2022.781247

Huang Y., Xue B., Pan J., Shen N. Circ-E2F3 acts as a ceRNA for miR-204-5p to promote proliferation, metastasis and apoptosis inhibition in retinoblastoma by regulating ROCK1 expression. Experimental and molecular pathology. 2021 Apr 18;120:104637.
doi: 10.1016/j.yexmp.2021.104637
https://pubmed.ncbi.nlm.nih.gov/33844975/

Hülsenbeck I., Frank M., Biewald E., Kanber D., Lohmann D.R., Ketteler P.
Introduction of a Variant Classification System for Analysis of Genotype-Phenotype Relationships in Heritable Retinoblastoma. Cancers. 2021 Mar 31;13(7):1605.
doi: 10.3390/cancers13071605
https://pubmed.ncbi.nlm.nih.gov/33807189/

Hussain A.K., Rahul R.A., Carlos R.L., Francisco Z.M., María G.L., Flavia P., Chiara B., Davide B. Globe salvage treatment in group D and group E retinoblastoma. Rom J Ophthalmol. 2021 Jan-Mar;65(1):20-24.
doi: 10.22336/rjo.2021.5

Hussain Z. Impact of Laterality on Cumulative Survival in Patients Diagnosed with Retinoblastoma: A Retrospective Cohort Analysis of 1925 Cases in the Surveillance, Epidemiology, and End Results (SEER) Program. Clinical ophthalmology. 2021 Mar 5;15:991-1001.
doi: 10.2147/OPTH.S298209. eCollection 2021
https://pubmed.ncbi.nlm.nih.gov/33707938/

Hu Y., Zhao M., Li L., Ding J., Gui Y.M., Wei T.W. miR-491-3p is Downregulated in Retinoblastoma and Inhibit Tumor Cells Growth and Metastasis by Targeting SNN. Biochemical genetics. 2020 Oct 23.
doi: 10.1007/s10528-020-10007-w
https://pubmed.ncbi.nlm.nih.gov/33098307/

I

Ishaq H., Patel B.C. Cancer, Retinoblastoma. 2020 Aug 10. StatPearls [Internet].
https://pubmed.ncbi.nlm.nih.gov/31424860/

Ishaq H., Patel B.C. Retinoblastoma. 2021 Aug 11. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan.
PMID: 31424860

Ishaq H., Patel B.C. Retinoblastoma. 2021 Nov 2. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan.
PMID: 31424860


J

Jakati S., Kaliki S. Aqueous seeding in retinoblastoma: Classification and clinicopathological correlation. Ophthalmol Retina. 2021 Dec 24:S2468-6530(21)00398-5.
doi: 10.1016/j.oret.2021.12.013

Jakati S., Patel A., Pathengay A., Kaliki S. Coincidental Retinal Dysplasia in Patients Presenting With Pseudohypopyon: A Series of Two Cases. BMJ Case Reports.
DOI: 10.1136/bcr-2019-233922
https://pubmed.ncbi.nlm.nih.gov/32300034/?from_term=retinoblastoma&from_sort=date&from_page=2&from_pos=7

Jakati S., Vempuluru V.S., Mohamed A., K Mishra D., Kaliki S. Lenticular changes in eyes with advanced
intraocular retinoblastoma: A histopathological study of 48 enucleated eyes. Semin Ophthalmol. 2021 Aug 12:1-5.
doi: 10.1080/08820538.2021.1962367

Janic A., Bowden S., Levy S., Stinson J., Dimaras H. Patient-reported outcome measures for retinoblastoma: a scoping review. Journal of patient-reported outcomes. 2020 Aug 8.
doi: 10.1186/s41687-020-00232-7
https://pubmed.ncbi.nlm.nih.gov/32770435/

Janic A., Vincent A., Stinson J., Dimaras H. Values of Retinoblastoma Survivors and Parents Regarding Treatment Outcomes: A Qualitative Study. JCO Oncol Pract. 2022 Jan 5:OP2100474. Epub ahead of print.
doi: 10.1200/OP.21.00474

Jansen R.W., de Bloeme C.M., Brisse H.J., Galluzzi P., Cardoen L., Göricke S., Maeder P., Cassoux N., Gauthier A., Schlueter S., Hadjistilianou T., Munier F.L., Castelijns J.A., van der Valk P., Moll A.C., de Jong M.C., de Graaf P. MR Imaging Features to Differentiate Retinoblastoma from Coats' Disease and Persistent Fetal Vasculature. Cancers. 2020 Nov 30;12(12):3592.
doi: 10.3390/cancers12123592
https://pubmed.ncbi.nlm.nih.gov/33266342/

Jansen R.W., van der Heide S., Cardoen L., Sirin S., de Bloeme C.M., Galluzzi P., Göricke S., Brisse H.J., Maeder P., Sen S., Biewald E., Castelijns J.A., Moll A.C., van der Valk P., de Jong M.C., de Graaf P.; European Retinoblastoma Imaging Collaboration. MRI can reliably differentiate optic nerve inflammation from tumor invasion in retinoblastoma with orbital cellulitis. Ophthalmology. 2022 Jun 22:S0161-6420(22)00445-6. Epub ahead of print. PMID: 35752210. doi: 10.1016/j.ophtha.2022.06.013

Jeyaprakash K., Shanthini T., Kim U., Muthukkaruppan V., Vanniarajan A. Human papillomavirus in retinoblastoma: A tertiary eye care center study from South India. Indian J Ophthalmol. 2021 Aug;69(8):2111-2115.
doi: 10.4103/ijo.IJO_106_21

Jiang A., Wu W., Xu C., Mao L., Ao S., Guo H., Sun X., Tao J., Sang Y., Huang G. SP2509, a Selective Inhibitor of LSD1, Suppresses Retinoblastoma Growth by Downregulating β-catenin Signaling. Invest Ophthalmol Vis Sci. 2022 Mar 2;63(3):20. PMID: 35297943; PMCID: PMC8944386.
doi: 10.1167/iovs.63.3.20

Jiang H, Jiang Y, Liu Z, Guo Y, Zhang J. Intra-arterial chemotherapy for treatment of very low birthweight infants with retinoblastoma: Two case reports. Medicine (Baltimore). 2021 May 14;100(19):e25870.
doi: 10.1097/MD.0000000000025870

Jiang K., Fan X., Hu Y., Yao S., Liu Y., Zhan C., Lu W., Wei G. Topical instillation of cell-penetrating peptide-conjugated melphalan blocks metastases of retinoblastoma. Biomaterials. 2022 Apr 1;284:121493. Epub ahead of print.
PMID: 35395452.
doi: 10.1016/j.biomaterials.2022.121493

Jiang Y., Xiao F., Wang L., Wang T., Chen L. Circular RNA has_circ_0000034 accelerates retinoblastoma advancement through the miR-361-3p/ADAM19 axis. Molecular and cellular biochemistry. 2020 Aug 25.
doi: 10.1007/s11010-020-03886-5
https://pubmed.ncbi.nlm.nih.gov/32844346/

Jiang Y., Xiao F., Wang L., Wang T., Chen L. Hsa_circ_0099,198 facilitates the progression of retinoblastoma by regulating miR-1287/LRP6 axis. Experimental eye research. 2021 Mar 4;206:108529.
doi: 10.1016/j.exer.2021.108529
https://pubmed.ncbi.nlm.nih.gov/33676964/

Jiang Y., Yam J.C., Chu W.K. Poly ADP Ribose Polymerase Inhibitor Olaparib Targeting Microhomology End Joining in Retinoblastoma Protein Defective Cancer: Analysis of the Retinoblastoma Cell-Killing Effects by Olaparib after Inducing Double-Strand Breaks. Int J Mol Sci. 2021 Oct 1;22(19):10687.
doi: 10.3390/ijms221910687
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508856/

Jia S., Wen X., Zhou M., He X., Han M., Fan J., Jia R., Fan X. Comparison of Intra-Arterial Chemotherapy Efficacy Delivered Through the Ophthalmic Artery or External Carotid Artery in a Cohort of Retinoblastoma Patients. Frontiers in medicine. 2021 Jun 11;8:658305.
doi: 10.3389/fmed.2021.658305
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225945/

Jiménez I., Frouin É., Chicard M., Dehainault C., Le Gall J., Benoist C., Gauthier A., Lapouble E., Houdayer C., Radvanyi F., Bernard V., Brisse H.J., Gauthier-Villars M., Stoppa-Lyonnet D., Baulande S., Cassoux N., Lumbroso L., Matet A., Aerts I., Renault V., Doz F., Golmard L., Delattre O., Schleiermacher G. Molecular diagnosis of retinoblastoma by circulating tumor DNA analysis. Eur J Cancer. 2021 Sep;154:277-287.
doi: 10.1016/j.ejca.2021.05.039

Jiménez I., Laé M, Tanguy M.L., Savignoni A., Gauthier-Villars M., Desjardins L., Cassoux N., Dendale R., Rodriguez J., Doz F., Brisse H.J., Aerts I. Craniofacial second primary tumors in patients with germline retinoblastoma previously treated with external beam radiotherapy: A retrospective institutional analysis. Pediatr Blood Cancer. 2020 Jan
DOI: 10.1002/pbc.28158

Jin L., Ma X., Lei X., Tong J., Wang R. Cyclophosphamide inhibits Pax5 methylation to regulate the growth of retinoblastoma via the Notch1 pathway. Hum Exp Toxicol. 2021 Oct 18:9603271211051601.
doi: 10.1177/09603271211051601

Jo D.H., Lee S., Bak E., Cho C.S., Han Y.T., Kim K., Suh Y.G., Kim J.H. Anti-tumor Activity of Novel STAT3 Inhibitors on Retinoblastoma. Molecular Pharmacology. 2021 May 20:MOLPHARM-AR-2020-000231.
doi: 10.1124/molpharm.120.000231
https://pubmed.ncbi.nlm.nih.gov/34016717/

de Jong M.C., Shaikh F., Gallie B., Kors W.A., Jansen R.W,. Dommering C., de Graaf P., Moll A.C., Dimaras H., Shroff M., Kivelä T.T., Soliman S.E. Asynchronous pineoblastoma is more likely after early diagnosis of retinoblastoma: a meta-analysis. Acta Ophthalmologica. 2021 May 3.
doi: 10.1111/aos.14855
https://pubmed.ncbi.nlm.nih.gov/33939299/

de Jong M.C., Van Der Valk P., Jansen R.W., Abbink F., Bosscha M., Castelijns J.A., Moll A.C., de Graaf P. Full-width postlaminar optic nerve tumor invasion of retinoblastoma as risk-factor for leptomeningeal spread of retinoblastoma. A case report and review of the literature. Ophthalmic Genet. 2020 Feb 19:1-4.
DOI:10.1080/13816810.2020.1727535

Joseph A.K., Guerin J.B., Eckel L.J., Dalvin L.A., Keating G.F., Liebo G.B., Benson J.C., Brinjikji W., Laack N.N., Silvera V.M. Imaging Findings of Pediatric Orbital Masses and Tumor Mimics. Radiographics. 2022 May-Jun;42(3):880-897.
doi: 10.1148/rg.210116

Jubran R.F., Villablanca J.G., Krailo M., Piao J., Huang L., Murphree A.L., O'Brien J., Gombos D., Shields C.L., Meadows A., Chintagumpala M. A Single-Arm Study of Systemic and sub-Tenon Chemotherapy for Groups C and D Intraocular Retinoblastoma: A Children's Oncology Group Study (ARET 0231). Pediatric Blood & Cancer. 2020 June 26.
doi: 10.1002/pbc.28502
https://pubmed.ncbi.nlm.nih.gov/32589362/

Jullien S. Vision screening in newborns and early childhood. BMC Pediatr. 2021 Sep 8;21(Suppl 1):306.
doi: 10.1186/s12887-021-02606-2
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424784/

K

Kaczmarek J.V., Bogan C.M., Pierce J.M., Tao Y.K., Chen S.C., Liu Q., Liu X., Boyd K.L., Calcutt M.W., Bridges T.M., Lindsley C.W., Friedman D.L., Richmond A., Daniels A.B. Intravitreal HDAC Inhibitor Belinostat Effectively Eradicates Vitreous Seeds Without Retinal Toxicity In Vivo in a Rabbit Retinoblastoma Model. Invest Ophthalmol Vis Sci. 2021 Nov 1;62(14):8.
doi: 10.1167/iovs.62.14.8

Kaewkhaw R., Rojanaporn D. Retinoblastoma: Etiology, Modeling, and Treatment. Cancers. 2020 Aug 16
doi: 10.3390/cancers12082304
https://pubmed.ncbi.nlm.nih.gov/32824373/

Kakkassery V., Gemoll T., Kraemer M.M., Sauer T., Tura A., Ranjbar M., Grisanti S., Joachim S.C., Mergler S., Reinhard J. Protein Profiling of WERI-RB1 and Etoposide-Resistant WERI-ETOR Reveals New Insights into Topoisomerase Inhibitor Resistance in Retinoblastoma. Int J Mol Sci. 2022 Apr 6;23(7):4058. PMID: 35409416; PMCID: PMC9000009.
doi: 10.3390/ijms23074058

Kalaiyarasan R., Shende D., Parthiban M., Lomi N. Comparison of peribulbar block and subtenon infiltration in pediatric enucleation for retinoblastoma. Indian J Ophthalmol. 2021 Aug;69(8):2106-2110.
doi: 10.4103/ijo.IJO_2829_20

Kaliki S. Aqueous seeding in intraocular retinoblastoma: A review. Clinical & experimental ophthalmology. 2021 Jun 29.
doi: 10.1111/ceo.13964
https://pubmed.ncbi.nlm.nih.gov/34185374/

Kaliki S. Aqueous seeding in intraocular retinoblastoma: A review. Clin Exp Ophthalmol. 2021 Aug;49(6):606-614.
doi: 10.1111/ceo.13964
https://onlinelibrary.wiley.com/doi/epdf/10.1111/ceo.13964

Kaliki S., Jakati S., Vempuluru V.S., Mallu A., Mishra D.K. Retinoblastoma associated with orbital pseudocellulitis and high-risk retinoblastoma: a study of 32 eyes. Int Ophthalmol. 2021 Aug 6.
doi: 10.1007/s10792-021-01993-w

Kaliki S., Ji X., Zou Y., Rashid R., Sultana S., Taju Sherief S., Cassoux N., Y Diaz Coronado R., Luis Garcia Leon J., López A.M.Z., Polyakov V.G., Ushakova T.L., Rani Roy S., Ahmad A., Al Harby L., Reddy M.A., Sagoo M.S., L. Berry J., Kim J., Polski A., Astbury N.J., Bascaran C., Blum S., Bowman R., Burton M.J., Foster A., Gomel N., Keren-Froim N., Madgar S., W. Stacey A., M. Steinberg D., Mohamed A., Zondervan M., Fabian I.D. Lag Time between Onset of First Symptom and Treatment of Retinoblastoma: An International Collaborative Study of 692 Patients from 10 Countries. Cancers. 2021 Apr 19;13(8):1956.
doi: 10.3390/cancers13081956.
https://pubmed.ncbi.nlm.nih.gov/33921566/

Kaliki S., Maniar A., Kekunnaya R. Cataract surgery in treated retinoblastoma eyes: A study of 29 eyes. European journal of ophthalmology. 2020 Jun 25.
doi: 10.1177/1120672120938575
https://pubmed.ncbi.nlm.nih.gov/32586135/

Kaliki S., Vempuluru V.S., Priya Y., Mohamed A. Risk factors for recurrent retinoblastoma after intravenous chemotherapy. International ophthalmology. 2021 Feb 20.
doi: 10.1007/s10792-021-01759-4
https://pubmed.ncbi.nlm.nih.gov/33611762/

Kaliki S., Shields C.L., Cassoux N., Munier F.L., Chantada G., Grossniklaus H.E., Yoshikawa H., Fabian I.D., Berry J.L., McKenzie J.D., Kimani K., Reddy M.A., Parulekar M., Tanabe M., Furuta M., Grigorovski N., Chevez-Barrios P., Scanlan P., Eagle RC. Jr, Rashid R., Coronado R.D., Sultana S., Staffieri S., Frenkel S., Suzuki S., Ushakova T.L., Ji X. Defining High-Risk Retinoblastoma: A Multicenter Global Survey. JAMA Ophthalmol. 2021 Nov 11:e214732
doi: 10.1001/jamaophthalmol.2021.4732

Kaliki S., Shields C.L., Cassoux N., Munier F.L., Chantada G., Grossniklaus H.E., Yoshikawa H., Fabian I.D., Berry J.L., McKenzie J.D., Kimani K., Reddy M.A., Parulekar M., Tanabe M., Furuta M., Grigorovski N., Chevez-Barrios P., Scanlan P., Eagle R.C. Jr., Rashid R., Coronado R.D., Sultana S., Staffieri S., Frenkel S., Suzuki S., Ushakova T.L., Ji X. Defining High-risk Retinoblastoma: A Multicenter Global Survey. JAMA Ophthalmol. 2022 Jan 1;140(1):30-36.
doi: 10.1001/jamaophthalmol.2021.4732

Kalinaki A., Muwonge H., Balagadde-Kambugu J., Mulumba Y., Ntende J., Ssali G., Nakiyingi L., Nakanjako D., Nalukenge C., Ampaire A.M. Clinical presentation and outcomes in children with retinoblastoma managed at the Uganda Cancer Institute. J Cancer Epidemiol. 2022 Mar 8;2022:8817215. PMID: 35308301; PMCID: PMC8924608.
doi: 10.1155/2022/8817215

Kamarudin A.A., Sayuti N.H., Saad N., Razak NA.A., Esa N.M. Induction of apoptosis by Eleutherine bulbosa (Mill.) Urb. bulb extracted under optimised extraction condition on human retinoblastoma cancer cells (WERI-Rb-1). J Ethnopharmacol. 2021 Oct 21;284:114770. doi: 10.1016/j.jep.2021.114770. Epub ahead of print. PMID: 34688803

Kanukollu V.M., Tripathy K. Leukocoria. StatPearls [Internet]. 2020 Aug 16.
https://pubmed.ncbi.nlm.nih.gov/32809629/

Karimi S., Arabi A., Shahraki T., Ansari I., Safi S. Development of Progressive Chiari I Malformation in a Child with Unilateral Sporadic Retinoblastoma. J Curr Ophthalmol. 2021 Mar 26;33(1):88-90.
doi: 10.4103/JOCO.JOCO_166_20

Karimi S., Arabi A., Shahraki T., Safi S. Central Serous Chorioretinopathy in a Case of Regressed Familial Retinoblastoma. Journal of ophthalmic & vision research. 2020 Oct 25;15(4):559-564.
doi: 10.18502/jovr.v15i4.7802
https://pubmed.ncbi.nlm.nih.gov/33133447/

Kashyap S., Singh L., Kumar N., Singh M.K., Pushker N., Bakhshi S., Sen S., Lomi N., Meel R., Chawla B. Combined association of massive choroidal and optic nerve invasion as a prognostic relevance in primary retinoblastoma: A 10-year study. Asia-Pacific journal of clinical oncology. 2020 Jul 25.
doi: 10.1111/ajco.13348
https://pubmed.ncbi.nlm.nih.gov/32710815/

Kashyap S., Singh L., Kumar N., Singh M.K., Pushker N., Bakhshi S., Sen S., Lomi N., Meel R., Chawla B. Combined association of massive choroidal and optic nerve invasion as a prognostic relevance in primary retinoblastoma: A 10-year study. Asia-Pacific journal of clinical oncology. 2021 Apr;17(2):e100-e108.
doi: 10.1111/ajco.13348
https://pubmed.ncbi.nlm.nih.gov/32710815/

Ketteler P., Hülsenbeck I., Frank M., Schmidt B., Jöckel K.H., Lohmann D.R. The impact of RB1 genotype on incidence of second tumours in heritable retinoblastoma. European journal of cancer. 2020 May 17.
DOI: 10.1016/j.ejca.2020.04.005
https://pubmed.ncbi.nlm.nih.gov/32434110/?from_term=retinoblastoma&from_sort=date&from_pos=10

Khanum A., Mochi Basavaraj T., Dudeja G. Ruptured retinoblastoma: management in a rare case scenario. BMJ Case Rep. 2022 Jun 6;15(6):e248830. PMID: 35667699; PMCID: PMC9171184.
doi: 10.1136/bcr-2022-248830

Khoo S.A., Ong G.Y. Use of Ocular Point-of-Care Ultrasound in a Difficult Pediatric Examination: A Case Report of an Emergency Department Diagnosis of Retinoblastoma. // The Journal of Emergency Medicine. 2020 Mar.
DOI: 10.1016/j.jemermed.2020.01.006
https://pubmed.ncbi.nlm.nih.gov/32204994/?from_term=retinoblastoma&from_sort=date&from_pos=4

Kiefer T., Schlüter S., Bechrakis N.E., Bornfeld N., Göricke S., Ketteler P., Ting S., Geismar D., Biewald E. Intraarterial Chemotherapy for Retinoblastoma - Initial Experiences of a German Reference Centre. Klin Monbl Augenheilkd. 2021 Jul;238(7):788-796. English, German. Epub 2021 Aug 10.
doi: 10.1055/a-1508-6194

Kiernan M., Fabian I.D., Smith V., Sagoo M.S., Reddy M.A. Strabismus as a Presenting Sign in Retinoblastoma. J Pediatr Ophthalmol Strabismus. 2021 Sep-Oct;58(5):324-330.
doi: 10.3928/01913913-20210614-03

Kim C.H., Kim M.J., Park J., Kim J., Kim J.Y., An M.J., Shin G.S., Lee H.M., Kim J.W.
Bisphenol A Exposure Changes the Transcriptomic and Proteomic Dynamics of Human Retinoblastoma Y79 Cells. Genes. 2021 Feb 11;12(2):264.
doi: 10.3390/genes12020264
https://pubmed.ncbi.nlm.nih.gov/33670352/

Kim D.I., Lee H., Kwon S.H., Sung Y.J., Song W.K., Park S. Bilayer Hydrogel Sheet-Type Intraocular Microrobot for Drug Delivery and Magnetic Nanoparticles Retrieval. Advanced healthcare materials. 2020 May 19.
DOI: 10.1002/adhm.202000118
https://pubmed.ncbi.nlm.nih.gov/32431072/?from_term=retinoblastoma&from_sort=date&from_page=2&from_pos=3

Kim H.A., Yoon Y.H., Kim J.G., Lee J.Y. Clinical Features and Long-term Prognosis of Retinoblastoma according to Age at Diagnosis. Korean journal of ophthalmology : KJO. 2020 Jun.
doi: 10.3341/kjo.2019.0097
https://pubmed.ncbi.nlm.nih.gov/32495533/

Kim H.J., Di Nicola M., Augsburger J.J., Williams B.K. Successful salvage intravenous chemotherapy after tandem selective ophthalmic artery infusion chemotherapy in bilateral retinoblastoma. Indian journal of ophthalmology. 2020 Nov;68(11):2618-2620.
doi: 10.4103/ijo.IJO_576_20
https://pubmed.ncbi.nlm.nih.gov/33120714/

Kim M.E., Xu L., Prabakar R.K., Shen L., Peng C.C., Kuhn P., Gai X., Hicks J., Berry JL. Aqueous Humor as a Liquid Biopsy for Retinoblastoma: Clear Corneal Paracentesis and Genomic Analysis. J Vis Exp. 2021 Sep 7;(175).
doi: 10.3791/62939

Kim M.E., Polski A., Xu L., Prabakar R.K., Peng C.C., Reid M.W., Shah R., Kuhn P., Cobrinik D., Hicks J., Berry J.L. Comprehensive Somatic Copy Number Analysis Using Aqueous Humor Liquid Biopsy for Retinoblastoma. Cancers (Basel). 2021 Jul 3;13(13):3340.
doi: 10.3390/cancers13133340

Kim S., Guzman S.J., Jo D.H., Cho C.S., Kim J.H. Giant Y79 retinoblastoma cells contain functionally active T-type calcium channels. Pflugers Arch. 2021 Oct;473(10):1631-1639.
doi: 10.1007/s00424-021-02612-4

King B.A., Sahr N., Sykes A., Wilson M.W., Brennan R.C. Chemoreduction with topotecan and vincristine: Quantifying tumor response in bilateral retinoblastoma patients. Pediatric blood & cancer. 2021 Jan 28:e28882.
doi: 10.1002/pbc.28882
https://pubmed.ncbi.nlm.nih.gov/33507604/

King B.A., Sahr N., Sykes A., Wilson M.W., Brennan R.C. Chemoreduction with topotecan and vincristine: Quantifying tumor response in bilateral retinoblastoma patients. Pediatric blood & cancer. 2021 Apr;68(4):e28882.
doi: 10.1002/pbc.28882
https://pubmed.ncbi.nlm.nih.gov/33507604/

Kiratli H., Koç I., Öztürk E., Varan A., Akyüz C. Comparison of intravitreal melphalan with and without topotecan in the management of vitreous disease in retinoblastoma. Japanese journal of ophthalmology. 2020 May 23.
DOI: 10.1007/s10384-020-00743-2
https://pubmed.ncbi.nlm.nih.gov/32447585/?from_term=retinoblastoma&from_sort=date&from_pos=4

Kleinerman R.A., Schonfeld S.J., Abramson D.H., Francis J.H., Seddon J.M., Morton L.M., Tucker M.A.
Increased risk of skin cancer in 1851 long-term retinoblastoma survivors. The Journal of investigative dermatology. 2021 Jun 18:S0022-202X(21)01334-8.
doi: 10.1016/j.jid.2021.05.021
https://pubmed.ncbi.nlm.nih.gov/34153328/

Kletke S.N., Mallipatna A., Mireskandari K., Gallie B.L., Ali A. Pediatric Cataract Surgery Following Treatment for Retinoblastoma: A Case Series and Systematic Review. Am J Ophthalmol. 2022 Feb 13:S0002-9394(22)00046-0. Epub ahead of print. PMID: 35172168.
doi: 10.1016/j.ajo.2022.02.001

Koç İ., Taylan Şekeroğlu H., Kıratlı H., Lotfisadigh S. Management of cataracts secondary to intravitreal chemotherapy injections for retinoblastoma seeding.European journal of ophthalmology. 2021 Jun 3:11206721211023317.
doi: 10.1177/11206721211023317
https://pubmed.ncbi.nlm.nih.gov/34082595/

Kong L., Sun Y., Chen M., Dai Y., Liu Z. Downregulation of microRNA-320a inhibits proliferation and induces apoptosis of retinoblastoma cells via targeting TUSC3. Experimental and therapeutic medicine. 2020 Nov;20
doi: 10.3892/etm.2020.9137
https://pubmed.ncbi.nlm.nih.gov/32934674/

Kong M., Han Y., Zhao Y., Zhang H.
miR-512-3p Overcomes Resistance to Cisplatin in Retinoblastoma by Promoting Apoptosis Induced by Endoplasmic Reticulum Stress. Medical science monitor : international medical journal of experimental and clinical research. 2020 Jul 9.
doi: 10.12659/MSM.923817
https://pubmed.ncbi.nlm.nih.gov/32641679/

Kothari P., Marass F., Yang J.L., Stewart C.M., Stephens D., Patel J., Hasan M., Jing X., Meng F., Enriquez J., Huberman K., Viale A., Francis J.H., Berger M.F., Shukla N., Abramson D.H., Dunkel I.J., Tsui D.W.Y. Cell-free DNA profiling in retinoblastoma patients with advanced intraocular disease: An MSKCC experience. Cancer medicine. 2020 Jul 7.
doi: 10.1002/cam4.3144
https://pubmed.ncbi.nlm.nih.gov/32633890/

Kruger M., van Elsland S.L., Afungchwi G.M., Bardin R., Njodzeka B., Kouya F., Nfor P., Nana P., Wharin P., Hesseling P.B. Outcome of retinoblastoma treatment protocol in Cameroon as per SIOP-PODC recommendation for a low-income setting. Pediatr Blood Cancer. 2022 Apr 11:e29642. Epub ahead of print. PMID: 35403812.
doi: 10.1002/pbc.29642

Kumar Panigrahi D. P. Correspondence on Turkoglu EB, Erol MK, Karaca BO, Coexistence of torpedo maculopathy and retinoblastoma: Differentiation the lesions with hand held optical coherence tomography, Photodiagnosis and photodynamic therapy 34 (2021) 102331. Photodiagnosis and photodynamic therapy, 102357. 26 May. 2021.
doi:10.1016/j.pdpdt.2021.102357
https://pubmed.ncbi.nlm.nih.gov/34051344/

L

Lal P. Role of radiotherapy in retinoblastoma. Indian J Ophthalmol. 2021 Oct;69(10):2912-2913.
doi: 10.4103/ijo.IJO_1284_21

Lamiot A.K., Trone M.C., Garcin T., Pommier B., Thuret G., Gain P. [Orbital leiomyosarcoma post-irradiated hereditary retinoblastoma: A case study].
Journal français d'ophtalmologie. 2020 Dec 3:S0181-5512(20)30510-6.
doi: 10.1016/j.jfo.2020.04.046
https://pubmed.ncbi.nlm.nih.gov/33280903/

Lande K., Gupta J., Ranjan R., Kiran M., Torres Solis L.F., Solís Herrera A., Aliev G., Karnati R. Exosomes: Insights from Retinoblastoma and Other Eye Cancers. International journal of molecular sciences. 2020 Sep 25
doi: 10.3390/ijms21197055
https://pubmed.ncbi.nlm.nih.gov/32992741/

Lan X., Xu W., Tang X., Ye H., Song X., Lin L., Ren X., Yu G., Zhang H., Wu S. Spectrum of RB1 Germline Mutations and Clinical Features in Unrelated Chinese Patients With Retinoblastoma. // Frontiers in Genetics. 2020 Mar 11;
DOI: 10.3389/fgene.2020.00142
https://pubmed.ncbi.nlm.nih.gov/32218800/?from_term=retinoblastoma&from_sort=date&from_pos=8

Lazari K. Papageorgiou E., Tsironi E.E., Androudi S. Late-onset retinoblastoma in a 12-year-old girl. Postgraduate medical journal. 2021 Feb 15:postgradmedj-2020-139531.
doi: 10.1136/postgradmedj-2020-139531
https://pubmed.ncbi.nlm.nih.gov/33589490/

Lazari K., Papageorgiou E., Tsironi E.E., Androudi S. Late-onset retinoblastoma in a 12-year-old girl. Postgrad Med J. 2022 Feb;98(e1):e43.
doi: 10.1136/postgradmedj-2020-139531

Leahey A.M. Let's Make Retinoblastoma a Zero-Death Cancer. Ophthalmology. Retina. 2020 Jun;4
doi: 10.1016/j.oret.2020.03.016
https://pubmed.ncbi.nlm.nih.gov/32507277/

Leahey A.M., Shields C.L. Chronic myeloid leukemia versus acute myeloid leukemia in patients with retinoblastoma. Oman J Ophthalmol. 2021 Oct 20;14(3):134-135.
doi: 10.4103/ojo.OJO_241_2021

Leclerc R., Olin J. An Overview of Retinoblastoma and Enucleation in Pediatric Patients // AORN J. Wiley-Blackwell, 2020. Vol. 111, № 1. P. 69–79.
https://doi.org/10.1002/aorn.12896
https://aornjournal.onlinelibrary.wiley.com/doi/abs/10.1002/aorn.12896

Lee C., Kim J.K. Genome maintenance in retinoblastoma: Implications for therapeutic vulnerabilities. Oncol Lett. 2022 Jun;23(6):192. Epub 2022 Apr 29. PMID: 35527780; PMCID: PMC9073582.
doi: 10.3892/ol.2022.13312

Lee C., Kim J.K. Chromatin regulators in retinoblastoma: Biological roles and therapeutic applications. Journal of cellular physiology. 2020 Aug 25.
doi: 10.1002/jcp.30022
https://pubmed.ncbi.nlm.nih.gov/32840881/

Lee C., Kim J.K. Chromatin regulators in retinoblastoma: Biological roles and therapeutic applications. Journal of cellular physiology. 2021 Apr;236(4):2318-2332.
doi: 10.1002/jcp.30022. Epub 2020 Aug 25.
https://pubmed.ncbi.nlm.nih.gov/32840881/

Lee D.H., Han J.W., Hahn S.M., Kim B.M., Lyu C.J., Lee S.C., Kim D.J., Lee C.S. Changes in Treatment Patterns and Globe Salvage Rate of Advanced Retinoblastoma in Korea: Efficacy of Intra-Arterial Chemotherapy. J Clin Med. 2021 Nov 20;10(22):5421.
doi: 10.3390/jcm10225421

Lee J.S., Kim J.Y., Jung C., Woo S.J. Iatrogenic Ophthalmic Artery Occlusion and Retinal Artery Occlusion. // Progress in Retinal and Eye Research. 2020 Mar 9.
DOI: 10.1016/j.preteyeres.2020.100848
https://www.ncbi.nlm.nih.gov/pubmed/32165219

Lemaitre S, Anguita R, Sagoo MS, Reddy MA. Medusa head vasculature in retinoblastoma. J Fr Ophtalmol. 2022 Jan 4:S0181-5512(21)00610-0. Epub ahead of print.
doi: 10.1016/j.jfo.2021.06.032

Lemaître S., Lévy-Gabriel C., Pacquement H., Cassoux N. Unilateral retinoblastoma with reactive orbital inflammation: A case report. Journal français d'ophtalmologie. 2020 Dec 11:S0181-5512(20)30556-8.
doi: 10.1016/j.jfo.2020.05.020
https://pubmed.ncbi.nlm.nih.gov/33317854/

Leonini S., Bertelli E., Bracco S., Guasti A. Thoughts on "Estimation of radiation exposure of children undergoing superselective intra-arterial chemotherapy for retinoblastoma treatment: assessment of local diagnostic reference levels as a function of age, sex, and interventional success". Neuroradiology. 2020 Oct 19.
doi: 10.1007/s00234-020-02587-6
https://pubmed.ncbi.nlm.nih.gov/33074360/

Liang T., Fan M., Meng Z., Sun B., Mi S., Gao X. Circ_0000527 Drives Retinoblastoma Progression by Regulating miR-1236-3p/SMAD2 Pathway. Curr Eye Res. 2021 Dec 29:1-10.
doi: 10.1080/02713683.2021.2007535

Liang T., Zhang X., Li J., Hua X., Zhao P., Ji X. Intra-Arterial Chemotherapy as Primary Treatment for Advanced Unilateral Retinoblastoma in China. Front Med (Lausanne). 2022 Apr 7;9:855661. PMID: 35462996; PMCID: PMC9021594. doi: 10.3389/fmed.2022.855661

Liang T.Y., Zhu X.Y., Hua X.M., Ji X.D., Zhao P.Q. Combined intra-arterial chemotherapy and intravitreal melphalan for the treatment of advanced unilateral retinoblastoma. Int J Ophthalmol. 2020 Feb 18;13(2):257-262.
DOI: 10.18240/ijo.2020.02.09

Liao A., Hsieh T., Francis J.H., Lavery J.A., Mauguen A., Brodie S.E., Abramson D.H. Toxicity and efficacy of intravitreal Melphalan for retinoblastoma: 25 µg Versus 30 µg.
DOI:10.1097/IAE.0000000000002782

Li C., Zhao J., Sun W. microRNA-222-Mediated VHL Downregulation Facilitates Retinoblastoma Chemoresistance by Increasing HIF1α Expression. Investigative ophthalmology & visual science. 2020 Aug 3
doi: 10.1167/iovs.61.10.9
https://pubmed.ncbi.nlm.nih.gov/32756923/

Li H., Fan D., Wang W., Zhang X., Song L., Huang Y. MiR-142-5p serves as a tumor suppressor in retinoblastoma cells by regulating MYCN. Biochem Biophys Res Commun. 2021 Oct 15;574:20-26.
doi: 10.1016/j.bbrc.2021.07.099

Li J., Min Y. Pre-clinical evidence that salinomycin is active against retinoblastoma via inducing mitochondrial dysfunction, oxidative damage and AMPK activation. J Bioenerg Biomembr. 2021 Oct;53(5):513-523.
doi: 10.1007/s10863-021-09915-2

Li J., Jing C., Hua X., Liang T., Li J., Zhao P., Ji X. Outcome of salvage intra-arterial chemotherapy for recurrent retinoblastoma. Eye (Lond). 2021 Oct 15.
doi: 10.1038/s41433-021-01693-w

Li K., Han F., Wu Y., Wang X. miR-340 Promotes Retinoblastoma Cell Proliferation, Migration and Invasion Through Targeting WIF1. Onco Targets Ther. 2021 Jun 4;14:3635-3648.
doi: 10.2147/OTT.S302800

Li L., He T., Su Y., Wu L., Chen C. The Results of Pars Plana Vitrectomy in the Treatment of Intraocular Retinoblastoma: A Retrospective Study and Literature Review. Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211048634.
doi: 10.1177/15330338211048634

Li L., Xu B., Li C.R., Zhang M.M., Wu S.J., Dang W.J., Liu J.C., Sun S.G., Zhao W. Anti-proliferation and apoptosis-inducing effects of sodium aescinate on retinoblastoma Y79 cells. International journal of ophthalmology. 2020, Oct 18.
doi: 10.18240/ijo.2020.10.06
https://pubmed.ncbi.nlm.nih.gov/33078103/

Li M., Yang J., Liu K., Yang J., Zhan X., Wang L., Shen X., Chen J., Mao Z. p16 promotes proliferation in cervical carcinoma cells through CDK6-HuR-IL1A axis. J Cancer. 2020 Jan 14;11(6):1457-1467.
DOI: 10.7150/jca.35479. eCollection 2020.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995400/

Lin F.Y., Chintagumpala M.M. Neonatal Retinoblastoma. Clinics in perinatology. 2021 Mar;48(1):53-70.
doi: 10.1016/j.clp.2020.12.001
https://pubmed.ncbi.nlm.nih.gov/33583507/

Lin S.Y., Yen K.G., Zhu H., Moisiuc A., Chilakapati M. Abnormal Red Reflex: Etiologies in a Pediatric Ophthalmology Population. Clinical pediatrics. 2020 Jul
doi: 10.1177/0009922820916892.
https://pubmed.ncbi.nlm.nih.gov/32503396/

Liu A., Ray A. An unusual case of late recurrence of bilateral retinoblastoma. Bone Rep. 2021 Sep 30;15:101135.
doi: 10.1016/j.bonr.2021.101135

Liu B., Gao T., Wu H.Y., Wan M. Erb-B2 receptor tyrosine kinase 2 knockdown inhibits retinoblastoma progression via Wnt/beta-catenin signaling pathway in vitro. Journal of biological regulators and homeostatic agents. 2021 Jan 22;35(1).
doi: 10.23812/20-594-L
https://pubmed.ncbi.nlm.nih.gov/33480220/

Liu C.C., Mohmood A., Hamzah N., Lau J.H., Khaliddin N., Rahmat J. Intra-arterial chemotherapy for retinoblastoma: Our first three-and-a-half years' experience in Malaysia. PloS one. 2020 May 1.
DOI: 10.1371/journal.pone.0232249
https://pubmed.ncbi.nlm.nih.gov/32357178/?from_term=retinoblastoma&from_sort=date&from_page=6&from_pos=1

Liu H., Hua Z. Q., Jin Z. B. Modeling human retinoblastoma using embryonic stem cell-derived retinal organoids. STAR protocols, 2(2), 100444.
doi: 10.1016/j.xpro.2021.100444
https://pubmed.ncbi.nlm.nih.gov/33899024

Liu H., Liu Y., Chen Y., Liu H. Detection of parotid metastasis from retinoblastoma by [18F]FDG PET/CT scan. Revista española de medicina nuclear e imagen molecular. 2021 Jul 31:S2253-654X(21)00028-7. English, Spanish. PMID: 34344630.
doi: 10.1016/j.remn.2021.02.003
https://pubmed.ncbi.nlm.nih.gov/34344630/

Liu H., Xu J., Yang Y., Wang X., Wu E., Majerciak V., Zhang T., Steenbergen R.D.M., Wang H.K., Banerjee N.S., Li Y., Lu W., Meyers C., Zhu J., Xie X., Chow L.T., Zheng Z.M. Oncogenic HPV promotes the expression of the long noncoding RNA lnc-FANCI-2 through E7 and YY1. Proc Natl Acad Sci U S A. 2021 Jan 19;118(3):e2014195118.
doi: 10.1073/pnas.2014195118

Liu H., Zhang Y., Zhang Y.Y., Li Y.P., Hua Z.Q., Zhang C.J., Wu K.C., Yu F., Zhang Y., Su J., Jin Z.B. Human embryonic stem cell-derived organoid retinoblastoma reveals a cancerous origin. Proceedings of the National Academy of Sciences of the United States of America. 2020 Dec 29;117(52):33628-33638.
doi: 10.1073/pnas.2011780117
https://pubmed.ncbi.nlm.nih.gov/33318192/

Liu J., Ottaviani D., Sefta M., Desbrousses C., Chapeaublanc E., Aschero R., Sirab N., Lubieniecki F., Lamas G., Tonon L., Dehainault C., Hua C., Fréneaux P., Reichman S., Karboul N., Biton A., Mirabal-Ortega L., Larcher M., Brulard C., Arrufat S., Nicolas A., Elarouci N., Popova T., Némati F., Decaudin D., Gentien D., Baulande S., Mariani O., Dufour F., Guibert S., Vallot C., Rouic L.L., Matet A., Desjardins L., Pascual-Pasto G., Suñol M., Catala-Mora J., Llano G.C., Couturier J., Barillot E., Schaiquevich P., Gauthier-Villars M., Stoppa-Lyonnet D., Golmard L., Houdayer C., Brisse H., Bernard-Pierrot I., Letouzé E., Viari A., Saule S., Sastre-Garau X., Doz F., Carcaboso A.M., Cassoux N., Pouponnot C., Goureau O., Chantada G., de Reyniès A., Aerts I., Radvanyi F. A high-risk retinoblastoma subtype with stemness features, dedifferentiated cone states and neuronal/ganglion cell gene expression. Nat Commun. 2021 Sep 22;12(1):5578.
doi: 10.1038/s41467-021-25792-0
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458383/

Liu J., Zhang C., Jia B., Dong K., Li M., Qiu D., Li L., Xu B., Sun S., Li C. Panax notoginseng saponins induce apoptosis in retinoblastoma Y79 cells via the PI3K/AKT signalling pathway. Exp Eye Res. 2022 Jan 21:108954. Epub ahead of print.
doi: 10.1016/j.exer.2022.108954

Liu K., Huang J., Liu J., Klionsky D.J., Kang R., Tang D. Induction of autophagy-dependent ferroptosis to eliminate drug-tolerant human retinoblastoma cells. Cell Death Dis. 2022 Jun 2;13(6):521. PMID: 35654783; PMCID: PMC9163041.
doi: 10.1038/s41419-022-04974-8

Liu L., Xiao C., Sun Q. MiRNA-375 inhibits retinoblastoma progression through targeting ERBB2 and inhibiting MAPK1/MAPK3 signalling pathway. Cutan Ocul Toxicol. 2021 Oct 29:1-10.
doi: 10.1080/15569527.2021.1994587

Liu S., Wen C. miR-141-3p promotes retinoblastoma progression via inhibiting sushi domain-containing protein 2. Bioengineered. 2022 Mar;13(3):7410-7424. PMID: 35259051.
doi: 10.1080/21655979.2022.2048770

Liu W., Luo Y., Dai J., Yang L., Huang L., Wang R., Chen W., Huang Y., Sun S., Cao J., Wu J., Han M., Fan J., He M., Qian K., Fan X., Jia R. Monitoring Retinoblastoma by Machine Learning of Aqueous Humor Metabolic Fingerprinting. Small Methods. 2022 Jan;6(1):e2101220.
doi: 10.1002/smtd.202101220

Liu X., He J., Mao L., Zhang Y., Cui W., Duan S., Jiang A., Gao Y., Sang Y., Huang G.
EPZ015666, a selective protein arginine methyltransferase 5 (PRMT5) inhibitor with an antitumour effect in retinoblastoma. Experimental eye research. 2020 Oct 6.
doi: 10.1016/j.exer.2020.108286
https://pubmed.ncbi.nlm.nih.gov/33035554/

Liu X., Li X., Li J. Long Non-coding RNA FEZF1-AS1 Promotes Growth and Reduces Apoptosis Through Regulation of miR-363-3p/PAX6 Axis in Retinoblastoma. Biochemical genetics. 2021 Jan 11.
doi: 10.1007/s10528-020-10026-7
https://pubmed.ncbi.nlm.nih.gov/33432525/

Liu X.M., Li X.F., Li J.C. MiR-146a functions as a potential tumor suppressor in retinoblastoma by negatively regulate neuro-oncological ventral antigen-1. The Kaohsiung journal of medical sciences. 2020 Dec 19.
doi: 10.1002/kjm2.12337
https://pubmed.ncbi.nlm.nih.gov/33340248/

Liu X.M., Li X.F., Li J.C. MiR-146a functions as a potential tumor suppressor in retinoblastoma by negatively regulate neuro-oncological ventral antigen-1.
The Kaohsiung journal of medical sciences. 2021 Apr;37(4):286-293.
doi: 10.1002/kjm2.12337
https://pubmed.ncbi.nlm.nih.gov/33340248/

Li X.H., Shi A.J., Li J., Yuan H.F. Plasma miR-6089 as potential diagnostic biomarker for retinoblastoma. International ophthalmology. 2021 Mar 27.
doi: 10.1007/s10792-021-01808-y
https://pubmed.ncbi.nlm.nih.gov/33772700/

Liu Y., Han Y., Chen S., Liu J., Wang D., Huang Y. Liposome-based multifunctional nanoplatform as effective therapeutics for the treatment of retinoblastoma. Acta Pharm Sin B. 2022 Jun;12(6):2731-2739. Epub 2021 Oct 22. PMID: 35755292; PMCID: PMC9214327.
doi: 10.1016/j.apsb.2021.10.009

Liu Z., Huang Y., Zhang F., Tang H., Wang Y. Autophagy-related gene 7 deficiency caused by miR-154-5p overexpression suppresses the cell viability and tumorigenesis of retinoblastoma by increasing cell apoptosis. Annals of translational medicine. 2020 Nov;8(21):1451.
doi: 10.21037/atm-20-6009
https://pubmed.ncbi.nlm.nih.gov/33313196/

Li Z., Guo Z., Chu D., Feng H., Zhang J., Zhu L., Li J. Effectively suppressed angiogenesis-mediated retinoblastoma growth using celastrol nanomicelles. Drug Deliv. 2020 Dec;27(1):358-366.
DOI: 10.1080/10717544.2020.1730522
https://www.tandfonline.com/…/full/10…/10717544.2020.1730522
https://pubmed.ncbi.nlm.nih.gov/32091275/

Li Z., Guo J., Xu X., Wei W., Xian J. MRI-based radiomics model can improve the predictive performance of postlaminar optic nerve invasion in retinoblastoma. Br J Radiol. 2021 Nov 26:20211027.
doi: 10.1259/bjr.20211027

Li Z., Zhang L., Liu D., Yang Z., Xuan D., Zhang Y. Knockdown of NRMT enhances sensitivity of retinoblastoma cells to cisplatin through upregulation of the CENPA/Myc/Bcl2 axis. Cell Death Discov. 2022 Jan 10;8(1):14.
doi: 10.1038/s41420-021-00622-w

Lo Giudice G., Angelini E., Bini S, Candian T, Crudeli C, Galan A. Outcome of cataract surgery in children affected by malignancies other than retinoblastoma with eye-lens radiation exposure. Eur J Ophthalmol. 2021 Apr 10:11206721211009445.
doi: 10.1177/11206721211009445

Lohmann D.R., Gallie B.L. Retinoblastoma. 2000 Jul 18 [updated 2018 Nov 21]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2020.
PMID: 20301625.
https://pubmed.ncbi.nlm.nih.gov/20301625/

Long K., Yang Y., Lv W., Jiang K., Li Y., Lo ACY, Lam W.C., Zhan C., Wang W. Green Light-Triggered Intraocular Drug Release for Intravenous Chemotherapy of Retinoblastoma. Adv Sci (Weinh). 2021 Aug 27:e2101754.
doi: 10.1002/advs.202101754

López J.P., Barriga M.M., Lecea D., Parada C., Stephens G. Ophthalmology examination during well-child visits in primary care health centres: Knowledge and difficulties experienced by health workers. Archivos de la Sociedad Española de Oftalmología. 2020 Oct 13
doi: 10.1016/j.oftal.2020.05.029
https://pubmed.ncbi.nlm.nih.gov/33067032/

Luo Y., Zhou C., He F., Fan J., Wen X., Ding Y. etc. Contemporary update of retinoblastoma in China: Three-decade changes in epidemiology, clinical features, treatments and outcomes. Am J Ophthalmol. 2021 Oct 6:S0002-9394(21)00498-0.
doi: 10.1016/j.ajo.2021.09.026

Lu X., Tu H., Tang D., Huang X., Sun F. miR-130a-3p Enhances the Chemosensitivity of Y79 Retinoblastoma Cells to Vincristine by Targeting PAX6 Expression. Curr Eye Res. 2021 Sep 30:1-8.
doi: 10.1080/02713683.2021.1984537

Lumbroso-Le Rouic L., Blanc R., Saint Martin C., Savignoni A., Brisse H.J., Pierrat N., Lévy-Gabriel C., Matet A., Doz F., Aerts I., Cassoux N. Selective Ophthalmic Artery Chemotherapy with Melphalan in the Management of Unilateral Retinoblastoma: A Prospective Study. Ophthalmol Retina. 2021 Aug;5(8):e30-e37.
doi: 10.1016/j.oret.2021.05.007

M

Ma H., Nie C., Chen Y., Li J., Xie Y., Tang Z., Gao Y., Ai S., Mao Y., Sun Q., Lu R. Therapeutic targeting PLK1 by ON-01910.Na is effective in local treatment of retinoblastoma. Oncology research. 2021 Feb 11.
doi: 10.3727/096504021X16130322409507
https://pubmed.ncbi.nlm.nih.gov/33573708/

Ma H., Nie C., Chen Y., Li J., Xie Y., Tang Z., Gao Y., Ai S., Mao Y., Sun Q., Lu R. Therapeutic Targeting PLK1 by ON-01910.Na Is Effective in Local Treatment of Retinoblastoma. Oncol Res. 2021 Sep 7;28(7):745-761.
doi: 10.3727/096504021X16130322409507
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420894/

Maloney S.M., Williams B.K. Jr., Shields C.L. Resolution of Nystagmus Following Treatment for Retinoblastoma. JAMA Ophthalmology. 2020 Apr 1
DOI: 10.1001/jamaophthalmol.2019.0382
https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2763886

Mandigo A.C., Shafi A.A., McCann J.J., Yuan W., Laufer T.S., Bogdan D., Gallagher L., Dylgjeri E., Semenova G., Vasilevskaya I.A., Schiewer M.J., McNair C., de Bono J.S., Knudsen K.E. Novel oncogenic transcription factor cooperation in RB-deficient cancer. Cancer Res. 2021 Oct 8:canres.1159.2021.
doi: 10.1158/0008-5472.CAN-21-1159

Mandigo A.C., Tomlins S.A., Kelly W.K., Knudsen K.E. Relevance of pRB Loss in Human Malignancies. Clin Cancer Res. 2021 Aug 18.
doi: 10.1158/1078-0432.CCR-21-1565

Manukonda R., Pujar A., Ramappa G., Vemuganti G.K., Kaliki S. Identification of novel RB1 genetic variants in Retinoblastoma patients and their impact on clinical outcome. Ophthalmic Genet. 2021 Oct 13:1-9.
doi: 10.1080/13816810.2021.1989602

Mao Y., Nie Q., Yang Y., Mao G. Identification of co‑expression modules and hub genes of retinoblastoma via co‑expression analysis and protein‑protein interaction networks. Molecular medicine reports. 2020 Aug
doi: 10.3892/mmr.2020.11189
https://pubmed.ncbi.nlm.nih.gov/32468072/

Mao Y., Sun Y., Wu Z., Zheng J., Zhang J., Zeng J., Lee C., Kim J.K. Targeting of histone methyltransferase DOT1L plays a dual role in chemosensitization of retinoblastoma cells and enhances the efficacy of chemotherapy. Cell Death Dis. 2021 Dec 9;12(12):1141.
doi: 10.1038/s41419-021-04431-y

Marathe S., Shadambikar G., Mehraj T., Sulochana S.P., Dudhipala N., Majumdar S. Development of α-Tocopherol Succinate-Based Nanostructured Lipid Carriers for Delivery of Paclitaxel. Pharmaceutics. 2022 May 11;14(5):1034. doi: 10.3390/pharmaceutics14051034


Martínez-Sánchez M., Hernandez-Monge J., Rangel M., Olivares-Illana V. Retinoblastoma: from discovery to clinical management. The FEBS journal. 27 May. 2021
doi:10.1111/febs.16035
https://pubmed.ncbi.nlm.nih.gov/34042282/

Martínez-Sánchez M., Moctezuma-Dávila M., Hernandez-Monge J., Rangel-Charqueño M., Olivares-Illana V. Analysis of the p53 pathway in peripheral blood of retinoblastoma patients; potential biomarkers. PloS one. Jun 5.
doi: 10.1371/journal.pone.0234337
https://pubmed.ncbi.nlm.nih.gov/32502182/

Maryam D., Wu L.M., Su Y.C., Hsu M.T., Harianto S. The journey of embracing life: Mothers' perspectives of living with their children with retinoblastoma. J Pediatr Nurs. 2022 Jun 16:S0882-5963(22)00149-X. Epub ahead of print. PMID: 35718669.
doi: 10.1016/j.pedn.2022.06.004

Masoomian B., Pefkianaki M., Ghassemi F., Riazi-Esfahani H. A New Rapidly Growing Dome-Shaped Choroidal Lesion in an Eye with Treated Retinoblastoma. Case Rep Ophthalmol Med. 2021 Jun 14;2021:6678779.
doi: 10.1155/2021/6678779

Matet A., Kaspi M., Garcin T. Multimodal imaging of a unilateral large retinoma. J Fr Ophtalmol. 2022 May;45(5):e227-e230.
doi: 10.1016/j.jfo.2021.06.019

Mattosinho C., Moura A.T., Grigorovski N., Araújo L.H., Ferman S., Ribeiro K. Socioeconomic status and retinoblastoma survival: Experience of a tertiary cancer center in Brazil. Pediatric Blood and Cancer. 2020 Oct 22.
doi: 10.1002/pbc.28757
https://pubmed.ncbi.nlm.nih.gov/33089657/

Ma X., Jin L., Lei X., Tong J., Wang R. MicroRNA‑363‑3p inhibits cell proliferation and induces apoptosis in retinoblastoma cells via the Akt/mTOR signaling pathway by targeting PIK3CA.Oncology reports. 2020 May.
DOI: 10.3892/or.2020.7544
https://pubmed.ncbi.nlm.nih.gov/32323827/?from_term=retinoblastoma&from_sort=date&from_page=7&from_pos=2

Meel R, Kashyap S, Bakhshi S, Singh Bajaj M, Wadhwani M. Retinoblastoma in Children Older than 6 Years of Age. Ocul Oncol Pathol. 2020 Dec;6(6):395-404.
doi: 10.1159/000509040
https://pubmed.ncbi.nlm.nih.gov/33447589/

Mehyar M., Mosallam M., Tbakhi A., Saab A., Sultan I., Deebajah R., Jaradat I., AlJabari R., Mohammad M., Al Nawaiseh I., Al-Hussaini M., Yousef Y.A. Impact of RB1 gene mutation type in retinoblastoma patients on clinical presentation and management outcome. // Hematology/Oncology and Stem Cell Therapy. 2020 Mar 23
DOI: 10.1016/j.hemonc.2020.02.006
https://pubmed.ncbi.nlm.nih.gov/32222358/?from_term=retinoblastoma&from_sort=date&from_pos=4

Mejia-Rodriguez F., Flores-Aldana M.E., Quezada-Sánchez A.D., Shamah-Levy T., Villalpando S., Contreras-Manzano A., Bhatt-Carreño S., Orjuela-Grimm M. Association between Predictors of Vitamin D Serum Levels and Risk of Retinoblastoma in Children: A Case-Control Study. Nutrients. 2021 Jul 23;13(8):2510.
doi: 10.3390/nu13082510

Mendonça V., Evangelista A.C., P Matta B., M Moreira M.Â., Faria P., Lucena E., Seuánez H.N. Molecular alterations in retinoblastoma beyond RB1. Exp Eye Res. 2021 Oct;211:108753.
doi: 10.1016/j.exer.2021.108753

Meng N., Zhao Z., Shi C., Xia L. Inhibiting the Progression of Human Retinoblastoma Cell by Downregulation of MMP-2/MMP-9 Using Short Hairpin RNAs (shRNAs) In Vitro. Journal of ophthalmology. 2020 May 13.
doi: 10.1155/2020/4912347
https://pubmed.ncbi.nlm.nih.gov/32509341/

Meng X., Zhang Y., Hu Y., Zhong J., Jiang C., Zhang H. LncRNA CCAT1 sponges miR-218-5p to promote EMT, cellular migration and invasion of retinoblastoma by targeting MTF2. Cell Signal. 2021 Oct;86:110088.
doi: 10.1016/j.cellsig.2021.110088

Meredith D.M., Charville G.W., Fletcher C.D.M., Hornick J.L. Distantly Metastatic Retinoblastoma to Soft Tissue and Bone: A Challenging Diagnosis Highlighting the Utility of CRX. The American journal of surgical pathology. 2020 Nov 5.
doi: 10.1097/PAS.0000000000001620
https://pubmed.ncbi.nlm.nih.gov/33165094/

Meredith D.M., Charville G.W., Fletcher C.D.M., Hornick J.L. Distantly Metastatic Retinoblastoma to Soft Tissue and Bone: A Challenging Diagnosis Highlighting the Utility of CRX. The American journal of surgical pathology. 2021 Jun 1;45(6):820-824.
doi: 10.1097/PAS.0000000000001620
https://pubmed.ncbi.nlm.nih.gov/33165094/

Miracco C., Toti P., Gelmi M.C., Aversa S., Baldino G., Galluzzi P., De Francesco S., Petrelli F., Sorrentino E., Belmonte G., Galimberti D., Bracco S., Hadjistilianou T.
Retinoblastoma Is Characterized by a Cold, CD8+ Cell Poor, PD-L1- Microenvironment, Which Turns Into Hot, CD8+ Cell Rich, PD-L1+ After Chemotherapy. Investigative ophthalmology & visual science. 2021 Feb 1;62(2):6.
doi: 10.1167/iovs.62.2.6
https://pubmed.ncbi.nlm.nih.gov/33538768/

Mirzayev I., Gündüz A.K., Biçer Ö., Tarlan B. The Final Diagnosis: Retinoblastoma or Pseudoretinoblastoma. Journal of pediatric ophthalmology and strabismus. May-Jun 2021;58(3):161-167.
doi:10.3928/01913913-20210108-01
https://pubmed.ncbi.nlm.nih.gov/34039153/

Mirzayev I., Gündüz A.K., Özalp Ateş F.S., Tetik D. Pseudoretinoblastoma: Distribution based on gender, age, and laterality. Eur J Ophthalmol. 2022 May 16:11206721221100627.
doi: 10.1177/11206721221100627

Mirzayev I., Gündüz A.K., Yavuz K., Şekkeli M.Z., Özalp Ateş F.S., Ünal E., Taçyıldız N. Secondary intra-arterial chemotherapy and/or intravitreal chemotherapy as salvage treatment for retinoblastoma.
European journal of ophthalmology. 2020 Sep 22
doi: 10.1177/1120672120957587
https://pubmed.ncbi.nlm.nih.gov/32962409/

Mndeme F.G., Mmbaga B.T, Kim M.J., Sinke L., Allen L., Mgaya E., Bastawrous A., MacLeod D., Burton M.J., Gilbert C., Bowman R. Red reflex examination in reproductive and child health clinics for early detection of paediatric cataract and ocular media disorders: cross-sectional diagnostic accuracy and feasibility studies from Kilimanjaro, Tanzania. Eye. 2020 Jun 16
doi: 10.1038/s41433-020-1019-5
https://pubmed.ncbi.nlm.nih.gov/32546747/

Mohanan A., Meel R., Venkatesh P., Kashyap S. Retinal tumour outcome with IVC in retinoblastoma. Eye. 2020 Jul 14
doi: 10.1038/s41433-020-1076-9
https://pubmed.ncbi.nlm.nih.gov/32665672/

Mokánszki A., Chang Chien Y.C., Mótyán J.A., Juhász P., Bádon E.S., Madar L., Szegedi I., Kiss C., Méhes G. Novel RB1 and MET Gene Mutations in a Case with Bilateral Retinoblastoma Followed by Multiple Metastatic Osteosarcoma. Diagnostics. 2020 Dec 25;11(1):E28.
doi: 10.3390/diagnostics11010028
https://pubmed.ncbi.nlm.nih.gov/33375764/

Monroe E.J., Chick J.F.B., Stacey A.W., Millard N.E., Geyer J.R., Ramoso L.R., Ghodke B.V., Hallam D.K. Radiation dose reduction during intra-arterial chemotherapy for retinoblastoma: a retrospective analysis of 96 consecutive pediatric interventions using five distinct protocols.Pediatric radiology. 2020 Nov 24.
doi: 10.1007/s00247-020-04892-x
https://pubmed.ncbi.nlm.nih.gov/33231717/

Monroe E.J., Chick J.F.B., Stacey A.W., Millard N.E., Geyer J.R., Ramoso L.R., Ghodke B.V., Hallam D.K. Radiation dose reduction during intra-arterial chemotherapy for retinoblastoma: a retrospective analysis of 96 consecutive pediatric interventions using five distinct protocols. Pediatric radiology. 2021 Apr;51(4):649-657.
doi: 10.1007/s00247-020-04892-x
https://pubmed.ncbi.nlm.nih.gov/33231717

Moradi S., Mokhtari-Dizaji M., Ghassemi F., Sheibani S., Asadi Amoli F. Increasing the efficiency of the retinoblastoma brachytherapy protocol with ultrasonic hyperthermia and gold nanoparticles: A rabbit model. International journal of radiation biology. 2020 Oct 19:1-34.
doi: 10.1080/09553002.2020.1838657
https://pubmed.ncbi.nlm.nih.gov/33074061/

Moradi S., Mokhtari-Dizaji M., Ghassemi F., Sheibani S., Asadi Amoli F. Increasing the efficiency of the retinoblastoma brachytherapy protocol with ultrasonic hyperthermia and gold nanoparticles: a rabbit model. International journal of radiation biology. 2020 Nov 9:1-14.
doi: 10.1080/09553002.2020.1838657
https://pubmed.ncbi.nlm.nih.gov/33074061/

Morales-de la Cruz X., Mandujano-Chávez A., Browne D.R., Devarenne T.P., Sánchez-Segura L., López M.G., Lozoya-Gloria E. In Silico and Cellular Differences Related to the Cell Division Process between the A and B Races of the Colonial Microalga Botryococcus braunii. Biomolecules. 2021 Oct 5;11(10):1463.
doi: 10.3390/biom11101463

Morozova E.V., Rudakova T.A., Vlasova J.J., et al. Pre- and post-transplantation factors associated with primary graft failure and severe poor graft function after allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia. Cell Ther Transplant 2022; 11(1): 13-23.
doi:10.18620/ctt-1866-8836-2022-11-1-13-23

Moses C., Flegg K., Dimaras H. Patient knowledge, experiences and preferences regarding retinoblastoma and research: A qualitative study.
https://doi.org/10.1111/hex.13043
https://onlinelibrary.wiley.com/doi/full/10.1111/hex.13043

Mostaghimi H., Ahmadabad F.G., Rezaei H. Super-selective intra-arterial platinum-based chemotherapy concurrent with low-dose-rate plaque brachytherapy in the treatment of retinoblastoma: A simulation study. Journal of cancer research and therapeutics. 2021 Jan-Mar;17(1):130-135.
doi: 10.4103/jcrt.JCRT_340_19
https://pubmed.ncbi.nlm.nih.gov/33723143/

Mouawad R., Himadewi P., Kadiyala D., Arnosti D.N. Selective repression of the Drosophila cyclin B promoter by retinoblastoma and E2F proteins.Biochimica et Biophysica Acta - Gene Regulatory Mechanisms. 2020 Apr 7
DOI: 10.1016/j.bbagrm.2020.194549
https://pubmed.ncbi.nlm.nih.gov/32275964/?from_term=retinoblastoma&from_sort=date&from_pos=8

Moulay Lakhdar I., Ferlazzo M.L., Al Choboq J., Berthel E., Sonzogni L., Devic C., Granzotto A., Thariat J., Foray N. Fibroblasts from Retinoblastoma Patients Show Radiosensitivity Linked to Abnormal Localization of the ATM Protein. Current eye research. 2020 Aug 30
doi: 10.1080/02713683.2020.1808998
https://pubmed.ncbi.nlm.nih.gov/32862699/

Moulin A., Pica A., Munier F., Schalenbourg A., Nobile A., Asana A., Astaras C., Hamedani M. Proton Therapy of a Conjunctival Carcinoma in the Anophthalmic Socket, 41 Years after Enucleation for a Sporadic Retinoblastoma. A Case Report and Review of the Literature. Klin Monbl Augenheilkd. 2021 Apr;238(4):361-364. English.
doi: 10.1055/a-1384-1159.

Moulin A.P., Stathopoulos C., Marcelli F., Schoumans Pouw J., Beck-Popovic M., Munier F.L. Secondary enucleated retinoblastoma with MYCN amplification. Ophthalmic Genetics. 2021 Apr 19:1-6.
doi: 10.1080/13816810.2021.1897847
https://pubmed.ncbi.nlm.nih.gov/33870828/

Mudigunda S.V., Pemmaraju D.B., Paradkar S., Puppala E.R., Gawali B., Upadhyayula S.M., Vegi Gangamodi N., Rengan A.K. Multifunctional Polymeric Nanoparticles for Chemo/Phototheranostics of Retinoblastoma. ACS Biomater Sci Eng. 2021 Dec 22.
doi: 10.1021/acsbiomaterials.1c01234

Munier F.L., Beck-Popovic M., Chantada G.L., Cobrinik D., Kivelä T.T., Lohmann D., Maeder P., Moll A.C., Carcaboso A.M., Moulin A., Schaiquevich P., Bergin C., Dyson P.J., Houghton S., Puccinelli F., Vial Y., Gaillard M.C., Stathopoulos C. Corrigendum to "Conservative management of retinoblastoma: Challenging orthodoxy without compromising the state of metastatic grace. "Alive, with good vision and no comorbidity"" [Prog. Retina Eye Res. 73 (2019) 100764] Progress in Retinal and Eye Research.. 2020 Apr 8
DOI: 10.1016/j.preteyeres.2020.100857
https://pubmed.ncbi.nlm.nih.gov/32278633/?from_term=retinoblastoma&from_sort=date&from_pos=3

Mustafi D., Waligorski N., Paulson V., Cole B., Crotty E.E., Stacey A.W. Pineoblastoma Without Retinal Tumors in a Patient With a Mosaic Retinoblastoma Pathogenic Variant. JAMA Ophthalmol. 2022 Mar 17. Epub ahead of print. PMID: 35297960.
doi: 10.1001/jamaophthalmol.2022.0170

Muthukumaran S., Sulochana K.N., Umashankar V. Structure based design of inhibitory peptides targeting ornithine decarboxylase dimeric interface and in vitro validation in human retinoblastoma Y79 cells. J Biomol Struct Dyn. 2021 Sep;39(14):5261-5275.
doi: 10.1080/07391102.2020.1785331

Mu Y.T., Feng H.H., Yu J.Q., Liu Z.K., Wang Y., Shao J., Li R.H., Li D.K. Correction to: Curcumin suppressed proliferation and migration of human retinoblastoma cells through modulating NF-κB pathway. International ophthalmology. 2021 Jun;41(6):2301.
doi: 10.1007/s10792-020-01675-z
https://pubmed.ncbi.nlm.nih.gov/33945061/

Mu Y.T., Feng H.H., Yu J.Q., Liu Z.K., Wang Y., Shao J., Li R.H., Li D.K. Curcumin suppressed proliferation and migration of human retinoblastoma cells through modulating NF-κB pathway. International ophthalmology. 2020 May 12.
DOI: 10.1007/s10792-020-01406-4
https://pubmed.ncbi.nlm.nih.gov/32399774/?from_term=retinoblastoma&from_sort=date&from_page=4&from_pos=2

N

Nadelmann J., Francis J.H., Brodie S.E., Muca E., Abramson D.H. Is intravitreal topotecan toxic to retinal function? The British journal of ophthalmology. 2020 Jul 14
doi: 10.1136/bjophthalmol-2020-316588
https://pubmed.ncbi.nlm.nih.gov/32665221/

Nair R.M., Revu N.V.L., Gali S., Kallamadi P.R., Prabhu V., Manukonda R., Nemani H., Kaliki S., Vemuganti G.K. A short-term chick embryo in vivo xenograft model to study retinoblastoma cancer stem cells. Indian J Ophthalmol. 2022 May;70(5):1703-1711.
doi: 10.4103/ijo.IJO_2348_21

Nakamura S., Murakami N., Suzuki S., Ito K., Takemori M., Nakayama H., Kaga K., Chiba T., Iijima K., Takahashi K., Goka T., Itami J., Okamoto H., Igaki H. Monte Carlo simulation of tilted contact plaque brachytherapy placement for juxtapapillary retinoblastoma. Radiat Oncol. 2022 Jan 24;17(1):16.
doi: 10.1186/s13014-022-01986-8

Narang S., Sindhu M., Jinagal J., Handa U., Kochhar S. Unusual presentation of Retinoblastoma. European journal of ophthalmology. 2020 Jul 2
doi: 10.1177/1120672120939388
https://pubmed.ncbi.nlm.nih.gov/32613860/

Narayana R.V.L., Jana P., Tomar N., Prabhu V., Nair R.M., Manukonda R., Kaliki S., Coupland S.E., Alexander J., Kalirai H., Kondapi A.K., Vemuganti G.K. Carboplatin- and Etoposide-Loaded Lactoferrin Protein Nanoparticles for Targeting Cancer Stem Cells in Retinoblastoma In Vitro. Invest Ophthalmol Vis Sci. 2021 Nov 1;62(14):13.
doi: 10.1167/iovs.62.14.13

Naser A.Y., Alrawashdeh H.M., Alwafi H., Alyami H.S., Dahmash E.Z., Ghoul I., Shishtawi A.A., Abdelwahab G.M., Qadus S., Taybeh E., Abuthawabeh R., Hassanin F., Alhartani Y.J., Alyami M.H., Salawati E.M., Alwan S.S. Knowledge and awareness of the general population and healthcare providers about retinoblastoma: It is time to know the glow. Int J Clin Pract. 2021 Aug;75(8):e14298.
doi: 10.1111/ijcp.14298

Naser A.Y., Alrawashdeh H.M., Alwafi H., Alyami H.S., Dahmash E.Z., Ghoul I., Shishtawi A.A., Abdelwahab G.M., Qadus S., Taybeh E., Abuthawabeh R., Hassanin F., Alhartani Y.J., Alyami M.H., Salawati E.M., Alwan S.S. Knowledge and awareness of the general population and healthcare providers about retinoblastoma: it is time to know the glow. International journal of clinical practice. 2021 Apr 30:e14298.
doi: 10.1111/ijcp.14298
https://pubmed.ncbi.nlm.nih.gov/33928718/

Naseripour M., Sedaghat A., Mirshahi R., Abdolalizadeh P., Koushki A., Faranoush M., Ghorbani M., Kashkouli M.B., Sadeghipour A., Chaibakhsh S., Mehrvar A. Targeted chemotherapy in retinoblastoma: A step forward from patient survival to globe survival. Eur J Ophthalmol. 2022 Apr 13:11206721221093018. Epub ahead of print.
PMID: 35414292.
doi: 10.1177/11206721221093018

Nazha B., Inal C., Owonikoko T.K. Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy. Frontiers in oncology. 2020 Jul 7
doi: 10.3389/fonc.2020.01000
https://pubmed.ncbi.nlm.nih.gov/32733795/

Nguyen M., Blair K. Red Reflex. 2021 Sep 1. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–.
PMID: 31985932

Nguyen M., Saunders J., Pacheco M.C., Stacey A.W. Progressive Preretinal Fibrosis with Late, Ossifying, Proliferative Retinopathy following Treatment for Retinoblastoma. Ocular oncology and pathology. 2021 Mar;7(1):44-47.
doi: 10.1159/000509809. Epub 2020 Sep 25
https://pubmed.ncbi.nlm.nih.gov/33796516/

Ni H., Chai P., Yu J., Xing Y., Wang S., Fan J., Ge S., Wang Y., Jia R., Fan X. LncRNA CANT1 suppresses retinoblastoma progression by repellinghistone methyltransferase in PI3Kγ promoter. Cell death & disease. 2020 May 4.
DOI: 10.1038/s41419-020-2524-y
https://pubmed.ncbi.nlm.nih.gov/32366932/?from_term=retinoblastoma&from_sort=date&from_page=5&from_pos=7

Nie C., Ma H., Gao Y., Li J., Tang Z., Chen Y., Lu R. RNA Sequencing and Bioinformatic Analysis on Retinoblastoma Revealing Cell Cycle Deregulation being a Key Process in Retinoblastoma Tumorigenesis. // Acta Ophthalmologica. 2020 Mar 6.
DOI: 10.1159/000506993
https://www.ncbi.nlm.nih.gov/pubmed/32146475

Nindyastuti H., Rusmawatiningtyas D., Makrufardi F., Supriyadi E. Lag time to diagnosis as a predictor of mortality in children with extraocular retinoblastoma: Experience from a developing country. Asia Pac J Clin Oncol. 2022 Mar 28. Epub ahead of print. PMID: 35347866.
doi: 10.1111/ajco.13767

Nishida K., Morimoto T., Suzuki S., Iwahashi C., Imai H., Kuniyoshi K., Kusaka S. Pars plana vitrectomy for vitreoretinal complications in only seeing eyes after treatment for retinoblastoma. Am J Ophthalmol Case Rep. 2022 Feb 2;25:101367. PMID: 35243141; PMCID: PMC8859804.
doi: 10.1016/j.ajoc.2022.101367

Ni W., Li Z., Ai K. lncRNA ZFPM2-AS1 promotes retinoblastoma progression by targeting microRNA miR-511-3p/paired box protein 6 (PAX6) axis. Bioengineered. 2022 Jan;13(1):1637-1649.
doi: 10.1080/21655979.2021.2021346

Norrie J.L., Nityanandam A., Lai K., Chen X., Wilson M., Stewart E., Griffiths L., Jin H., Wu G., Orr B., Tran Q., Allen S., Reilly C., Zhou X., Zhang J., Newman K., Johnson D., Brennan R., Dyer M.A. Retinoblastoma from human stem cell-derived retinal organoids. Nature communications. 2021 Jul 27;12(1):4535. PMID: 34315877; PMCID: PMC8316454.
doi: 10.1038/s41467-021-24781-7
https://pubmed.ncbi.nlm.nih.gov/34315877/

Nowak M.S., Romanowska-Dixon B., Grabska-Liberek I., Żurek M. Incidence and Characteristics of Retinoblastoma in Poland: The First Nationwide Study 2010-2017. Int J Environ Res Public Health. 2021 Jun 17;18(12):6539.
doi: 10.3390/ijerph18126539

Nummi K., Kivelä T. Retinoblastoma in Finland, 1964-2014: incidence and survival. // British Journal of Ophthalmology. 2020 Mar 25
DOI: 10.1136/bjophthalmol-2019-315744
https://pubmed.ncbi.nlm.nih.gov/32217545/?from_term=retinoblastoma&from_sort=date&from_pos=9

Nummi K., Kivelä T.T. Retinoblastoma in Finland, 1964-2014: incidence and survival. Br J Ophthalmol. 2021 Jan;105(1):63-69.
doi: 10.1136/bjophthalmol-2019-315744
https://pubmed.ncbi.nlm.nih.gov/32217545/

O

Oatess T.L., Chen P.H., Daniels A.B., Himmel L.E. Severe Periocular Edema after Intraarterial Carboplatin Chemotherapy for Retinoblastoma in a Rabbit (Oryctolagus cuniculus) Model. // Comparative Medicine. 2020 Mar 11.
DOI: 10.30802/AALAS-CM-18-000146
https://www.ncbi.nlm.nih.gov/pubmed/32160941

Ohan H., Minassian G., Minassian H., Farooq T., Zdilla M.J. Retinoblastoma in Infancy with Subsequent Bladder Leiomyosarcoma in Adulthood: Genomic Considerations.Urology. 2020 Mar 19
DOI: 10.1016/j.urology.2020.03.010
https://pubmed.ncbi.nlm.nih.gov/32197986/?from_term=retinoblastoma&from_sort=pubdate&from_size=50&from_pos=33

Oke I., Diller L.R., Gonzalez E. Advanced retinoblastoma presenting with cataract in a child with limited access to primary care. J Pediatr. 2022 May 13:S0022-3476(22)00427-9. doi: 10.1016/j.jpeds.2022.05.019

Omidakhsh N, Hansen J, Ritz B, Coleman AL, McKean-Cowdin R, Olsen J, Heck JE. Parental Occupation and Risk of Childhood Retinoblastoma in Denmark. J Occup Environ Med. 2021 Mar 1;63(3):256-261.
doi: 10.1097/JOM.0000000000002120

Ophthalmic surgery, lasers & imaging retina. 2020 Dec 1;51(12):732.
doi: 10.3928/23258160-20201202-09
https://pubmed.ncbi.nlm.nih.gov/33339056/

Opitz M., Bos D., Deuschl C., Radbruch A., Zensen S., Sirin S., Forsting M., Bechrakis N., Biewald E., Bornfeld N., Ketteler P., Timmermann B., Stuschke M., Guberina M., Wetter A., Göricke S., Guberina N. Estimation of radiation exposure of children undergoing superselective intra-arterial chemotherapy for retinoblastoma treatment: assessment of local diagnostic reference levels as a function of age, sex, and interventional success. Neuroradiology. 2020 Aug 29.
doi: 10.1007/s00234-020-02540-7
https://pubmed.ncbi.nlm.nih.gov/32862237/

Opitz M., Wetter A., Guberina N. Thoughts on "Estimation of radiation exposure of children undergoing superselective, intra-arterial chemotherapy for retinoblastoma treatment: Assessment of Local Diagnostic Reference Levels as a function of age, sex and interventional success". Neuroradiology. 2020 Nov 3.
doi: 10.1007/s00234-020-02594-7
https://pubmed.ncbi.nlm.nih.gov/33141236/

Oporto J.I., Zúñiga P., Ossandón D., Zanolli M., Pérez V., López J.P., Stetcher X., Rodríguez A., Puentes Á., Rustom S., Lobos J. Intra-arterial chemotherapy for retinoblastoma treatment in Chile: experience and results 2013-2020.
Archivos de la Sociedad Española de Oftalmología. 2020 Dec 2:S0365-6691(20)30391-9.
doi: 10.1016/j.oftal.2020.10.002
https://pubmed.ncbi.nlm.nih.gov/33279354/

Oporto J.I., Zúñiga P., Ossandón D., Zanolli M., Pérez V., López J.P., Stetcher X., Rodríguez A., Puentes Á., Rustom S., Lobos J. Intra-arterial chemotherapy for retinoblastoma treatment in Chile: Experience and results 2013-2020. Archivos de la Sociedad Española de Oftalmología. 2021 Jun;96(6):288-292.
doi: 10.1016/j.oftale.2020.10.003
https://pubmed.ncbi.nlm.nih.gov/34092282/

Oronowicz J., Reinhard J., Reinach P.S., Ludwiczak S., Luo H., Omar Ba Salem M.H., Kraemer M.M., Biebermann H., Kakkassery V., Mergler S. Ascorbate-induced oxidative stress mediates TRP channel activation and cytotoxicity in human etoposide-sensitive and -resistant retinoblastoma cells. Laboratory investigation; a journal of technical methods and pathology. 2020 Sep 18.
doi: 10.1038/s41374-020-00485-2
https://pubmed.ncbi.nlm.nih.gov/32948812/

Orjuela-Grimm M., Carreño S.B., Liu X., Ruiz A., Medina P., Ramirez Ortiz M.A., Rendon J.R., Molina N.C.L., Pinilla H., Hinojosa D., Rodriguez L., Connor A.O., Rodriguez F.M., Castañeda M.V.P., Cabrera-Muñoz L. Sunlight exposure in infancy decreases risk of sporadic retinoblastoma, extent of intraocular disease.
Cancer Reports. 2021 May 7:e1409.
doi: 10.1002/cnr2.1409
https://pubmed.ncbi.nlm.nih.gov/33960746/

Osuna-Marco M.P., López-Barahona M., López-Ibor B., Tejera Á.M. Ten Reasons Why People With Down Syndrome are Protected From the Development of Most Solid Tumors -A Review. Front Genet. 2021 Nov 5;12:749480.
doi: 10.3389/fgene.2021.749480

Outtaleb F.Z., Kora L., Jabrane G., Serbati N., El Maaloum L., Allali B., El Kettani A., Dehbi H. 13q interstitial deletion in a moroccan child with hereditary retinoblastoma and intellectual disability: A case report. Annals of medicine and surgery. 2020 Nov 7;60:334-337.
doi: 10.1016/j.amsu.2020.10.063
https://pubmed.ncbi.nlm.nih.gov/33224486/

Özdemir Özdoğan G., Kaya H. Next-Generation Sequencing Data Analysis on Pool-Seq and Low-Coverage Retinoblastoma Data. Interdisciplinary sciences, computational life sciences. 2020 Jun 9.
doi: 10.1007/s12539-020-00374-8
https://pubmed.ncbi.nlm.nih.gov/32519123/

P

Pacheco R.R., Vaidya S., Shields C.L. Benefit of Patching Therapy to Minimize Amblyopia After Retinoblastoma Treatment. Ophthalmology. Retina. 2020 Jun;4.
doi: 10.1016/j.oret.2020.01.013
https://pubmed.ncbi.nlm.nih.gov/32507274/

Panthagani J., Montecinos P., López J.P., Parulekar M. Cystoid macular edema following intravitreal chemotherapy treatment for retinoblastoma. Pediatric blood & cancer. 2020 Jul 7.
doi: 10.1002/pbc.28348
https://pubmed.ncbi.nlm.nih.gov/32634267/

Passos Gibson V., Mouna Derbali R., Trong Phan H., Tahiri H., Allen C., Hardy P., Leblond Chain J. Survivin silencing improved the cytotoxicity of carboplatin and melphalan in Y79 and primary retinoblastoma cells. International journal of pharmaceutics. 2020 Aug 27
doi: 10.1016/j.ijpharm.2020.119824
https://pubmed.ncbi.nlm.nih.gov/32861768/

Patel J.M., Goss A., Garber J.E., Torous V., Richardson E.T., Haviland M.J., Hacker M.R., Freeman G.J., Nalven T., Alexander B., Lee L., Collins L.C., Schnitt S.J., Tung N. Retinoblastoma protein expression and its predictors in triple-negative breast cancer. NPJ breast cancer. 2020 Jun 5.
doi: 10.1038/s41523-020-0160-4
https://pubmed.ncbi.nlm.nih.gov/32550264/

Patel S., Vogel J., Bradley K., Chuba P.J., Buchsbaum J., Krasin M.J. Rare tumors: Retinoblastoma, nasopharyngeal cancer, and adrenocorticoid tumors. Pediatric blood & cancer. 2021 May;68 Suppl 2:e28253.
doi: 10.1002/pbc.28253
https://pubmed.ncbi.nlm.nih.gov/33818883/

PDQ Pediatric Treatment Editorial Board. Retinoblastoma Treatment (PDQ®): Patient Version. 2021 Mar 22. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002–.
https://pubmed.ncbi.nlm.nih.gov/26389197/

Peck T., Gervasio K.A., Zhang P.JL., Shields C.L., Lally S.E., Eagle R.C. Jr, Milman T. Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma with Myxoid Stroma in a Hereditary Retinoblastoma Survivor. Ocular Oncology and Pathology. 2020 Mar 6
DOI: 10.1159/000501523
https://pubmed.ncbi.nlm.nih.gov/32258014/?from_term=retinoblastoma&from_sort=date&from_page=2&from_pos=5

Peeler C.E., Gonzalez E. Retinoblastoma. N Engl J Med. 2022 Jun 23;386(25):2412. PMID: 35731655.
doi: 10.1056/NEJMicm2118356

Persaud Y., Seddiq M., Wu Y.M., Robinson D.R., Poulik J., Altinok D., Roarty J.D., Mody R., Taub J.W. Unusual clinical behavior of a very late retinoblastoma relapse in a patient with a germline RB mutation. Pediatric blood & cancer. 2021 May 18:e29064.
doi: 10.1002/pbc.29064
https://pubmed.ncbi.nlm.nih.gov/34003562/

PLOS ONE Editors. Expression of Concern: RNAi Mediated Tiam1 Gene Knockdown Inhibits Invasion of Retinoblastoma. PLoS One. 2021 May 26;16(5):e0252495.
doi: 10.1371/journal.pone.0252495
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0252495

Polski A., Xu L., Prabakar R.K., Kim J.W., Shah R., Jubran R., Kuhn P., Cobrinik D., Hicks J., Berry J.L. Cell-Free DNA Tumor Fraction in the Aqueous Humor Is Associated With Therapeutic Response in Retinoblastoma Patients. Translational vision science & technology. 2020 Sep 30
doi: 10.1167/tvst.9.10.30
https://pubmed.ncbi.nlm.nih.gov/33062393/

Polski A., Xu L., Prabakar R.K., Gai X., Kim J.W., Shah R., Jubran R., Kuhn P., Cobrinik D., Hicks J., Berry J.L. Variability in retinoblastoma genome stability is driven by age and not heritability. Genes, chromosomes & cancer. 2020 May 11.
DOI: 10.1002/gcc.22859
https://pubmed.ncbi.nlm.nih.gov/32390242/?from_term=retinoblastoma&from_sort=date&from_page=4&from_pos=7

Prajantawanich K., Sanpakit K., Narkbunnam N., Vathana N., Takpradit C., Phuakpet K., Pongtanakul B., Atchaneeyasakul L.O., Sinlapamongkolkul P., Buaboonnam J. Clinical Outcomes and Prognostic Factors of Thai Retinoblastoma Patients. Pediatrics international : official journal of the Japan Pediatric Society. 2020 Oct 6.
doi: 10.1111/ped.14498
https://pubmed.ncbi.nlm.nih.gov/33022851/

Privitera F., Calonaci A., Doddato G., Papa F.T., Baldassarri M., Pinto A.M., Mari F., Longo I., Caini M., Galimberti D., Hadjistilianou T., De Francesco S., Renieri A., Ariani F. 13q Deletion Syndrome Involving RB1: Characterization of a New Minimal Critical Region for Psychomotor Delay. Genes (Basel). 2021 Aug 26;12(9):1318.
doi: 10.3390/genes12091318

Price E.A., Patel R., Scheimberg I., Kotiloglu Karaa E., Sagoo M.S,, Reddy M.A., Onadim Z. MYCN amplification levels in primary retinoblastoma tumors analyzed by Multiple Ligation-dependent Probe Amplification. Ophthalmic genetics. 2021 May 18:1-8.
doi: 10.1080/13816810.2021.1923038
https://pubmed.ncbi.nlm.nih.gov/34003079/

Price E.A., Patel R., Scheimberg I., Kotiloglu Karaa E., Sagoo M.S., Reddy M.A., Onadim Z. MYCN amplification levels in primary retinoblastoma tumors analyzed by Multiple Ligation-dependent Probe Amplification. Ophthalmic Genet. 2021 Oct;42(5):604-611.
doi: 10.1080/13816810.2021.1923038

Q

Qahtani Al. M., AlMasfer S., Khandekar R. Health related quality of life of patients treated with bilateral enucleation for retinoblastoma. Eur J Ophthalmol. 2021 Aug16:11206721211035637.
doi: 10.1177/11206721211035637

R

Raguraman R., Parameswaran S., Kanwar J.R., Vasudevan M., Chitipothu S., Kanwar R.K., Krishnakumar S. Gene expression profiling of tumor stroma interactions in retinoblastoma. Experimental eye research. 2020 June 22.
doi: 10.1016/j.exer.2020.108067
https://pubmed.ncbi.nlm.nih.gov/32585195/

Raizis A.M., Racher H.M., Foucal A., Dimaras H., Gallie B.L., George P.M. DNA hypermethylation/boundary control loss identified in retinoblastomas associated with genetic and epigenetic inactivation of the RB1 gene promoter. Epigenetics. 2020 Dec 1:1-15.
doi: 10.1080/15592294.2020.1834911
https://pubmed.ncbi.nlm.nih.gov/33258708/

Raizis A.M., Racher H.M., Foucal A., Dimaras H., Gallie B.L., George P.M. DNA hypermethylation/boundary control loss identified in retinoblastomas associated with genetic and epigenetic inactivation of the RB1 gene promoter. Epigenetics. 2021 Sep;16(9):940-954.
doi: 10.1080/15592294.2020.1834911

Rajeshuni N., Whittemore A.S., Ludwig C.A., Mruthyunjaya P., Moshfeghi D.M. Reply to Comment on: Racial, Ethnic, and Socioeconomic Disparities in Retinoblastoma Enucleation: A Population-Based Study, SEER 18 2000-2014. American journal of ophthalmology. 2020 Jul 10.
doi: 10.1016/j.ajo.2020.04.038
https://pubmed.ncbi.nlm.nih.gov/32660706/

Rakhshan R., Atashi H.A., Hoseinian M., Jafari A., Haghighi A., Ziyadloo F., Razizadeh N., Ghasemian H., Nia M.M.K., Sefidi A.B., Arani H.Z. The Synergistic Cytotoxic and Apoptotic Effect of Resveratrol and Naringenin on Y79 Retinoblastoma Cell Line. Anti-cancer agents in medicinal chemistry. 2021 Jan 12.
doi: 10.2174/1871520621666210112121051
https://pubmed.ncbi.nlm.nih.gov/33438556/

Ramanujan A., Bansal S., Guha M., Pande N.T., Tiwari S. LxCxD motif of the APC/C coactivator subunit FZR1 is critical for interaction with the retinoblastoma protein. Exp Cell Res. 2021 Jul 15;404(2):112632. Epub 2021 May 8.
doi: 10.1016/j.yexcr.2021.112632

Randhawa J.K., Kim M.E., Polski A., Reid M.W., Mascarenhas K., Brown B., Fabian I.D., Kaliki S., Stacey A.W., Burner E., Sayegh C.S., Poblete R.A., Ji X., Zou Y., Sultana S., Rashid R., Sherief S.T., Cassoux N., Garcia J., Coronado R.D., López A.M.Z., Ushakova T., Polyakov V.G., Roy S.R., Ahmad A., Reddy M.A., Sagoo M.S., Al Harby L., Astbury N.J., Bascaran C., Blum S., Bowman R., Burton M.J., Gomel N., Keren-Froim N., Madgar S., Zondervan M., Berry J.L. The Effects of Breastfeeding on Retinoblastoma Development: Results from an International Multicenter Retinoblastoma Survey. Cancers (Basel). 2021 Sep 24;13(19):4773.
doi: 10.3390/cancers13194773

Rastogi N., Kapoor R., Yadav S.P. Haploidentical Hematopoietic Stem Cell Transplantation for Relapsed Metastatic Retinoblastoma. Journal of pediatric hematology/oncology. 2020 Nov;42(8):499.
doi: 10.1097/MPH.0000000000001955
https://pubmed.ncbi.nlm.nih.gov/33003140/

Ratna H. Heritable Retinoblastoma and Risk of Developing Second Primary Cancer. JAMA Network Open. 2020 Oct 1.
doi: 10.1001/jamanetworkopen.2020.22569
https://pubmed.ncbi.nlm.nih.gov/33090221/

Raval V., Bowen R.C., Soto H., Singh A. Chemotherapy for Retinoblastoma: Impact of Intravitreal Chemotherapy. Asia-Pacific journal of ophthalmology. 2020 Sep 9.
doi: 10.1097/APO.0000000000000322
https://pubmed.ncbi.nlm.nih.gov/32925294/

Raval V., Bowen R.C., Soto H., Singh A. Intravenous Chemotherapy for Retinoblastoma in the Era of Intravitreal Chemotherapy: A Systematic Review. Ocul Oncol Pathol. 2021 Mar;7(2):142-148. Epub 2020 Dec 16.
doi: 10.1159/000510506

Raval V., DeBenedictis M., Bowen R., Soto H., Davanzo J., Singh A. Retinoblastoma in twins: Risk assessment of genotypic variants. Indian journal of ophthalmology. 2021 May;69(5):1230-1233.
doi: 10.4103/ijo.IJO_2811_20
https://pubmed.ncbi.nlm.nih.gov/33913866/

Raval V., Kaliki S. Cavitary retinoblastoma: A review of literature. Surv Ophthalmol. 2021 Oct 11:S0039-6257(21)00188-0.
doi: 10.1016/j.survophthal.2021.10.002

Raval V., Racher H., Wrenn J., Singh A.D. Aqueous humor as a surrogate biomarker for retinoblastoma tumor tissue. J AAPOS. 2022 May 13:S1091-8531(22)00102-1.
doi: 10.1016/j.jaapos.2022.03.005

Ravishankar H., Mangani A.S., Phoebe Moses G.L., Mani S.P., Parameswaran S., Khetan V., Ganesan S., Krishnakumar S. Serum exosomal miRNA as biomarkers for Retinoblastoma.
Experimental eye research.. 2020 Aug 11
doi: 10.1016/j.exer.2020.108184
https://pubmed.ncbi.nlm.nih.gov/32795526/

Recommendations for Long-Term Follow-up of Adults with Heritable Retinoblastoma
DOI:https://doi.org/10.1016/j.ophtha.2020.05.024

Reddy M.A., Butt M., Hinds A.M., Duncan C., Price E.A., Sagoo M.S., Onadim Z. Prognostic information for known genetic carriers of RB1 pathogenic variants (germline and mosaic).
Ophthalmology. Retina. 2020 Aug 21
doi: 10.1016/j.oret.2020.08.010
https://pubmed.ncbi.nlm.nih.gov/32835838/

Reinhard J., Wagner N., Krämer M.M., Jarocki M., Joachim S.C., Dick H.B., Faissner A., Kakkassery V. Expression Changes and Impact of the Extracellular Matrix on Etoposide Resistant Human Retinoblastoma Cell Lines. International journal of molecular sciences. 2020 Jun 17.
doi: 10.3390/ijms21124322
https://pubmed.ncbi.nlm.nih.gov/32560557/

Ren H., Guo X., Li F., Xia Q., Chen Z., Xing Y. Four Autophagy-Related Long Noncoding RNAs Provide Coexpression and ceRNA Mechanisms in Retinoblastoma through Bioinformatics and Experimental Evidence. ACS Omega. 2021 Nov 29;6(49):33976-33984.
doi: 10.1021/acsomega.1c05259

Reschke M.; Biewald E.; Bronstein L.; Brecht I.B.; Dittner-Moormann S.; Driever F.; Ebinger M.; Fleischhack G.; Grabow D.; Geismar D. et al. Eye Tumors in Childhood as First Sign of Tumor Predisposition Syndromes: Insights from an Observational Study Conducted in Germany and Austria. Special Issue Retinoblastoma - Current Therapeutic Challenges and Promising New Approaches. Cancers 2021, 13, 1876.
https://doi.org/10.3390/cancers13081876

Reynolds M., Lueder G., Gordon M., Hayashi R.J. Developmental Delay and School Performance Among Retinoblastoma Survivors: Development/school morbidity among retinoblastoma survivors. American journal of ophthalmology. 2021 May 6:S0002-9394(21)00224-5.
doi: 10.1016/j.ajo.2021.04.025
https://pubmed.ncbi.nlm.nih.gov/33965417/

Reynolds M.M., Sein J., Hayashi R., Lueder G. Treatment of small and medium retinoblastoma tumors with Iris diode laser. European journal of ophthalmology. 2021 Feb 2:1120672121991390.
doi: 10.1177/1120672121991390
https://pubmed.ncbi.nlm.nih.gov/33530736/

Riazi-Esfahani H., Masoomian B., Ghassemi F. Intra-Arterial Chemotherapy: New Hope for Adult Retinoblastoma Treatment-A Case Report and Brief Review. Case reports in ophthalmological medicine. 2021 Jul 9;2021:6639900. PMID: 34336323; PMCID: PMC8289600.
doi: 10.1155/2021/6639900
https://pubmed.ncbi.nlm.nih.gov/34336323/

Rishi P. Commentary: Current standards in retinoblastoma care. Indian journal of ophthalmology. 2020 Nov;68(11):2367.
doi: 10.4103/ijo.IJO_3198_20
https://pubmed.ncbi.nlm.nih.gov/33120618/

Ristevski I., Kiew J., Hendry M., Prunier M., Noronha R., Al-Hammadi M., Flegg K., Gallie B.L., Paton K., Dimaras H.; Canadian Retinoblastoma Research Advisory Board. The Retinoblastoma Research Booklet: A Catalyst for Patient Involvement in Retinoblastoma Research. Healthc Q. 2022 Apr;24(SP):61-68.
PMID: 35467513.
doi: 10.12927/hcq.2022.26772

Ristevski I., Robert J., Baddeliyanage R., Noronha R., Gelkopf M., Flegg K., Low L., Steeves J., Crooks B., Gallie B.L., Dimaras H.; Canadian Retinoblastoma Research Advisory Board. EMPOWER Retinoblastoma: Engaging Patient Partners in Solving the Top 10 Priorities for Eye Cancer Research in Canada. Healthc Q. 2022 Apr;24(SP):11-17.
PMID: 35467505
doi: 10.12927/hcq.2022.26780

Rokaya D., Kritsana J., Amornvit P., Dhakal N., Khurshid Z., Zafar M.S., Saonanon P. Magnification of Iris through Clear Acrylic Resin in Ocular Prosthesis. J Funct Biomater. 2022 Mar 11;13(1):29. PMID: 35323229; PMCID: PMC8952227.
doi: 10.3390/jfb13010029

Rong J., Li Z., Xu L., Lang L., Zheng G. microRNA-362-3p targets USP22 to retard retinoblastoma growth via reducing deubiquitination of LSD1. Cell Cycle. 2021 Feb;20(3):298-307. Epub 2021 Jan 21.
doi: 10.1080/15384101.2021.1874685

Roufayel R., Mezher R., Storey K.B. The Role of Retinoblastoma Protein in Cell Cycle Regulation: An Updated Review. Current molecular medicine. 2021 Jan 3.
doi: 10.2174/1566524020666210104113003
https://pubmed.ncbi.nlm.nih.gov/33397238/

Roy S.R., Kaliki S. Retinoblastoma: A Major Review. Mymensingh Med J. 2021 Jul;30(3):881-895.

Rozanska A., Cerna-Chavez R., Queen R., Collin J., Zerti D., Dorgau B., Beh C.S., Davey T., Coxhead J., Hussain R., Al-Aama J., Steel D.H., Benvenisty N., Armstrong L., Parulekar M., Lako M. pRB-Depleted pluripotent stem cell retinal organoids recapitulate cell state transitions of retinoblastoma development and suggest an important role for pRB in retinal cell differentiation. Stem Cells Transl Med. 2022 Mar 23:szac008. PMID: 35325233. Epub ahead of print.
doi: 10.1093/stcltm/szac008

Ruben M., Eiger-Moscovich M., Yaghy A., Tadepalli S., Shields C.L. Iodine-125 Plaque Radiotherapy for Retinoblastoma Recurrence Following Intra-arterial Chemotherapy. J Pediatr Ophthalmol Strabismus. 2021 Dec 20:1-8.
doi: 10.3928/01913913-20210903-01

Ruben M., Yaghy A., Shields C.L. Retinoblastoma Vitreous Seeds Captured on OCT. Ophthalmology. Retina. 2020 Nov;4(11):1117.
doi: 10.1016/j.oret.2020.05.004
https://pubmed.ncbi.nlm.nih.gov/33131675/

Runnels J., Acosta G., Rose A., Haynes M., Nikolaidis D., Wong A., Fiani B. The role for intra-arterial chemotherapy for refractory retinoblastoma: a systematic review. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2021 Apr 7.
doi: 10.1007/s12094-021-02610-z
https://pubmed.ncbi.nlm.nih.gov/33826082/

Runnels J., Acosta G., Rose A., Haynes M., Nikolaidis D., Wong A., Fiani B. The role for intra-arterial chemotherapy for refractory retinoblastoma: a systematic review. Clin Transl Oncol. 2021 Oct;23(10):2066-2077.
doi: 10.1007/s12094-021-02610-z

Russo I., Levy-Gabriel C., Dupont A., Lumbroso-Le Rouic L., Cassoux N., Desjardins L., Bertozzi A.I., Coze C., Doz F., Savignoni A., Aerts I. Prospective phase II study of children affected by bilateral intraocular retinoblastoma with macular involvement of both eyes or in the only preserved eye. Macular tumor control, eye preservation rate, and visual outcome. Pediatric blood & cancer. 2020 Oct 24
doi: 10.1002/pbc.28721
https://pubmed.ncbi.nlm.nih.gov/33098751/

S

Saal-Zapata G., Rodríguez R., Rodriguez-Calienes A., Cordero R. Contralateral catheterization of the ophthalmic artery to deliver intra-arterial chemotherapy in retinoblastoma. The neuroradiology journal. 2021 Jun 13:19714009211024632.
doi: 10.1177/19714009211024632
https://pubmed.ncbi.nlm.nih.gov/34121503/

Saal-Zapata G., Rodríguez R., Rodriguez-Calienes A., Cordero R. Contralateral catheterization of the ophthalmic artery to deliver intra-arterial chemotherapy in retinoblastoma. Neuroradiol J. 2021 Aug;34(4):370-372.
doi: 10.1177/19714009211024632

Saengwimol D., Chittavanich P., Laosillapacharoen N., Srimongkol A., Chaitankar V., Rojanaporn D., Aroonroch R., Suktitipat B., Saisawang C., Svasti S., Hongeng S., Kaewkhaw R. Silencing of the Long Noncoding RNA MYCNOS1 Suppresses Activity of MYCN-Amplified Retinoblastoma Without RB1 Mutation. Investigative ophthalmology & visual science. 2020 Dec 1;61(14):8.
doi: 10.1167/iovs.61.14.8
https://pubmed.ncbi.nlm.nih.gov/33270844/

Saluja G., Lomi N., Kashyap S. Unilateral retinal dysplasia simulating retinoblastoma. BMJ case reports. 2020 Sep 16;
doi: 10.1136/bcr-2020-238463
https://pubmed.ncbi.nlm.nih.gov/32938657/

Salviat F., Gauthier-Villars M., Carton M., Cassoux N., Lumbroso-Le Rouic L., Dehainault C., Levy C., Golmard L., Aerts I., Doz F., Bonnet-Serrano F., Hayek S., Savignoni A., Stoppa-Lyonnet D., Houdayer C. Association Between Genotype and Phenotype in Consecutive Unrelated Individuals With Retinoblastoma. JAMA ophthalmology. 2020 Jun 18
doi: 10.1001/jamaophthalmol.2020.2100
https://pubmed.ncbi.nlm.nih.gov/32556071/

Samuel J., Singh N., Kanwar J.R., Krishnakumar S., Kanwar R.K..
Corrigendum to Upregulation of sodium iodide symporter (NIS) protein expression by an innate immunity component: Promising potential for targeting radiosensitive retinoblastoma [Exp. Eye Res. 139 (2015) 108e114]. Experimental eye research. 2020 Aug 11
doi: 10.1016/j.exer.2020.108145
https://pubmed.ncbi.nlm.nih.gov/32797940/

Sanati-Mehrizy A., Ghosh T., Peterson E., Starke R.M., Harbour J.W., Corrales-Medina F.F. Hematologic Complications Associated With Intra-arterial Chemotherapy for Retinoblastoma Treatment: A Single Institution Experience. J Pediatr Hematol Oncol. 2022 May 1;44(4):181-185.
doi: 10.1097/MPH.0000000000002451

Santapuram P.R., Schremp E.A., Friedman D.L., Koyama T., Froehler M.T., Daniels A.B. Adverse Events, Burden and Outcomes of IV vs. Intra-arterial Chemotherapy for RB. Ophthalmology Retina. 2020 Sep 10
doi: 10.1016/j.oret.2020.09.006
https://pubmed.ncbi.nlm.nih.gov/32920208/

Sari N.M., Hadiputri R., Kuntorini M.S., Agustina H., Mardianty F. High-Risk Histopathologic Features of Retinoblastoma Treated at a Tertiary Hospital in West Java, Indonesia. Ocul Oncol Pathol. 2021 Oct;7(5):353-360.
doi: 10.1159/000517100

Sarver A.L., Xie C., Riddle M.J., Forster C.L., Wang X., Lu H., Wagner W., Tolar J., Hallstrom T.C. Retinoblastoma tumor cell proliferation is negatively associated with an immune gene expression signature and increased immune cells.
Laboratory investigation; a journal of technical methods and pathology. 2021 Mar 3.
doi: 10.1038/s41374-021-00573-x
https://pubmed.ncbi.nlm.nih.gov/33658609/

Schaiquevich P., Francis J.H., Cancela M.B., Carcaboso A.M., Chantada G.L., Abramson D.H. Treatment of Retinoblastoma: What Is the Latest and What Is the Future. Front Oncol. 2022 Apr 1;12:822330. PMID: 35433448; PMCID: PMC9010858. doi: 10.3389/fonc.2022.822330

Schefler A.C., Kim R.S. Recent advancements in the management of retinoblastoma and uveal melanoma. Fac Rev. 2021 May 28;10:51.
doi: 10.12703/r/10-51

Schieffer K.M., Feldman A.Z., Kautto E.A., McGrath S., Miller A.R., Hernandez-Gonzalez M.E., LaHaye S., Miller K.E., Koboldt D.C., Brennan P., Kelly B., Wetzel A., Agarwal V., Shatara M., Conley S., Rodriguez D.P., Abu-Arja R., Shaikhkhalil A., Snuderl M., Orr B.A., Finlay J.L., Osorio D.S., Drapeau A.I., Leonard J.R., Pierson C.R., White P., Magrini V., Mardis E.R., Wilson R.K., Cottrell C.E., Boué D.R..
Molecular classification of a complex structural rearrangement of the RB1 locus in an infant with sporadic, isolated, intracranial, sellar region retinoblastoma.
Acta neuropathologica communications. 2021 Apr 7;9(1):61.
doi: 10.1186/s40478-021-01164-z
https://pubmed.ncbi.nlm.nih.gov/33827698/

Schofield D., Zeppel M.J.B, Staffieri S., Shrestha R.N., Jelovic D., Lee E., Jamieson R.V. Preimplantation genetic diagnosis for retinoblastoma survivors: a cost-effectiveness study. Reproductive biomedicine & society online. 2020 May 11.
doi: 10.1016/j.rbms.2020.03.001
https://pubmed.ncbi.nlm.nih.gov/32577540/

Schonfeld S.J, Kleinerman R.A., Abramson D.H., Seddon J.M., Tucker M.A., Morton L.M. Long-term risk of subsequent cancer incidence among hereditary and nonhereditary retinoblastoma survivors.
British journal of cancer. 2021 Jan 21.
doi: 10.1038/s41416-020-01248-y
https://pubmed.ncbi.nlm.nih.gov/33473166/

Selvarajah A., Flegg K., Sim W., Hu J.B., Gallie B.L., Shaikh F., Soliman S.E., Dimaras H. Clinical audit of retinoblastoma management: a retrospective single-institution study. Canadian journal of ophthalmology. 2021 May 30:S0008-4182(21)00163-0.
doi: 10.1016/j.jcjo.2021.04.019
https://pubmed.ncbi.nlm.nih.gov/34077747/

Selvin S.S.T., Kuriakose T. An uncommon presentation of a refractory case of retinoblastoma. Orbit. 2020 Sep 2
doi: 10.1080/01676830.2020.1817950
https://pubmed.ncbi.nlm.nih.gov/32873110/

Sepúlveda-Sánchez J.M., Gil-Gil M., Alonso-García M., Vaz Salgado M.Á., Vicente E., Mesía Barroso C., Rodríguez Sánchez Á., Durán G., De Las Peñas R., Muñoz-Langa J., Velasco G., Hernández-Laín A., Hilario A., Navarro Martín M., Benavides M., Oleaga L., Cantero Montenegro D., Ruano Y., Sánchez-Gómez P., Martín-Soberón M.C., Morales-Llombart R., Pachón V., Pineda E. Phase II Trial of Palbociclib in Recurrent Retinoblastoma-Positive Anaplastic Oligodendroglioma: A Study from the Spanish Group for Research in Neuro-Oncology (GEINO). Targeted oncology. 2020 Oct;15(5):613-622.
doi: 10.1007/s11523-020-00754-6
https://pubmed.ncbi.nlm.nih.gov/33025213/

Sergeenko K.A., Dokuchaeva Y.Y., Kostareva I.O. Aliev T.Z., Elfimova A.Yu., Stepanian N.G., Lozovan Y.V., Burlaka N.A., Sidorova N.V., Machneva E.B., Gorbunova T.V., Ushakova T.L., Polyakov V.G., Kirgizov K.I., Varfolomeeva S.R. High-dose chemotherapy with autologous hemopoietic stem cell transplantation in children with retinoblastoma. Literature review and case series // Cellular Therapy and Transplantation. 2022. Vol. 11. No 1. P. 6-12.
doi: 10.18620/ctt-1866-8836-2022-11-1-6-12

Shah A., Shrestha M., Shrestha S.M., Khatri A., Shrestha P.K. Pathologic Risk Factor in Retinoblastoma: An Institutional Experience Based on Analysis of Enucleated Eyes. Nepal J Ophthalmol. 2021 Jan;13(25):91-97.
doi: 10.3126/nepjoph.v13i1.31139
PMID: 33981102.

Shakeel O., Pace N., Chambers T.M., Scheurer M.E., Ganguly A.A., Lupo P.J., Bunin G.R. Medical radiation exposure and risk of sporadic retinoblastoma.
Pediatric blood & cancer. 2020 Aug 2
doi: 10.1002/pbc.28633
https://pubmed.ncbi.nlm.nih.gov/32743912/

Shanmugam P.M. Commentary: Retinoblastoma management-Where are we and where do we go from here? Indian journal of ophthalmology. 2020 Nov;68(11):2365-2366.
doi: 10.4103/ijo.IJO_1954_20
https://pubmed.ncbi.nlm.nih.gov/33120618/

Shanthini T., Balaji S., Kim U., Muthukkaruppan V., Vanniarajan A. Genetic characterization of a patient with an unusual presentation of Waardenburg syndrome Type 4 and retinoblastoma. Pediatric blood & cancer. 2020 Jul 16
doi: 10.1002/pbc.28553
https://pubmed.ncbi.nlm.nih.gov/32672397/

Shapira Y., Worrell E., Litwin A.S., Malhotra R. The UK National Artificial Eye Questionnaire Study: predictors of artificial eye wearers' experience Part 2: visual function and quality of life. Eye (Lond). 2022 Jan;36(1):140-147. Epub 2021 Mar 1.
doi: 10.1038/s41433-021-01459-4

Shapira Y., Worrell E., Ullrich K., Litwin A., Malhotra R. UK National Artificial Eye Questionnaire study: comparisons between cosmetic shell and artificial eye users. Part 1: demographics, comfort and satisfaction. Br J Ophthalmol. 2021 Oct;105(10):1346-1351.
doi: 10.1136/bjophthalmol-2020-317015

Sheehan A.P. Retinoblastoma: Early Diagnosis is Crucial. Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners. 2020 Aug 24
doi: 10.1016/j.pedhc.2020.06.006
https://pubmed.ncbi.nlm.nih.gov/32855014/

Sheng J., Kohno S., Okada N., Okahashi N., Teranishi K., Matsuda F., Shimizu H., Linn P., Nagatani N., Yamamura M., Harada K., Horike SI., Inoue H., Yano S., Kumar S., Kitajima S., Ajioka I., Takahashi C. Treatment of Retinoblastoma 1-Intact Hepatocellular Carcinoma With Cyclin-Dependent Kinase 4/6 Inhibitor Combination Therapy. Hepatology. 2021 Oct;74(4):1971-1993.
doi: 10.1002/hep.31872

Shields C.L., Bas Z., Laiton A., Silva A.M.V., Sheikh A., Lally S.E., Shields J.A. Retinoblastoma: emerging concepts in genetics, global disease burden, chemotherapy outcomes, and psychological impact. Eye (Lond). 2022 Feb 25:1–8. Epub ahead of print.
doi: 10.1038/s41433-022-01980-0

Shields C.L., Bas Z., Tadepalli S., Dalvin L.A., Rao R., Schwendeman R., Lally S.E., Shields J.A., Shah A., Leahey A. Long-term (20-year) real-world outcomes of intravenous chemotherapy (chemoreduction) for retinoblastoma in 964 eyes of 554 patients at a single centre. Br J Ophthalmol. 2020 Feb 12.
DOI: 10.1136/bjophthalmol-2019-315572
Singh N., DeBenedictis M.J., Singh A.D. An Online Application for Retinoblastoma Surveillance. Ocular oncology and pathology. 2020 Oct; 6.
doi: 10.1159/000505751
https://pubmed.ncbi.nlm.nih.gov/33123532/

Shields C.L., Dockery P.W., Yaghy A., Duffner E.R., Levin H.J., Taylor O.S., Sajjadi Z., Lally S.E., Shields J.A., Rosenwasser R., Tjoumakaris S., Jabbour P. Intra-arterial chemotherapy for retinoblastoma in 341 consecutive eyes (1,292 infusions): comparative analysis of outcomes based on patient age, race, and sex. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus, S1091-8531(21)00112-9. 24 May. 2021. doi:10.1016/j.jaapos.2020.12.006
https://pubmed.ncbi.nlm.nih.gov/34044113/

Shields C.L., Dockery P., Ruben M., Yaghy A., Sunday M.A., Duffner E.R., Levin H.J., Taylor O.S., Calotti M., Lally S.E., Shields J.A. Likelihood of Germline Mutation With Solitary Unilateral Retinoblastoma Based on Patient Age at Presentation: Analysis of 482 Consecutive Patients. Journal of pediatric ophthalmology and strabismus. 2021 Jun 1:1-10.
doi: 10.3928/01913913-20210414-02
https://pubmed.ncbi.nlm.nih.gov/34180289/

Shields C.L., Srinivasan A., Lucio-Alvarez J.A., Shields J.A. Retinocytoma/retinoma: comparative analysis of clinical features in 78 tumors and rate of transformation into retinoblastoma over 20 years. Journal of AAPOS: the official publication of the American Association for Pediatric Ophthalmology and Strabismus. 2021 May 26:S1091-8531(21)00132-4.
doi: 10.1016/j.jaapos.2020.11.024
https://pubmed.ncbi.nlm.nih.gov/34051357/

Shi J., Sun J., Liu L., Shan T., Meng H., Yang T., Wang S., Wei T., Chen B., Ma Y., Wang Q., Wang H., Liu J., Wang L. P16ink4a overexpression ameliorates cardiac remodeling of mouse following myocardial infarction via CDK4/pRb pathway. Biochem Biophys Res Commun. 2022 Jan 22;595:62-68. Epub ahead of print.
doi: 10.1016/j.bbrc.2022.01.077

Shi K., Zhu X., Wu J., Chen Y., Zhang J., Sun X. Centromere protein E as a novel biomarker and potential therapeutic target for retinoblastoma. Bioengineered. 2021 Dec;12(1):5950-5970.
doi: 10.1080/21655979.2021.1972080

Silva-Teixeira R., Laranjo M., Lopes B., Almeida-Ferreira C., Gonçalves A.C., Rodrigues T., Matafome P., Sarmento-Ribeiro A.B., Caramelo F., Botelho M.F. Plasma activated media and direct exposition can selectively ablate retinoblastoma cells. Free radical biology & medicine. 2021 May 20;171:302-313.
doi: 10.1016/j.freeradbiomed.2021.05.027
https://pubmed.ncbi.nlm.nih.gov/34022401/

Silva-Teixeira R., Laranjo M., Lopes B., Almeida-Ferreira C., Gonçalves A.C., Rodrigues T., Matafome P., Sarmento-Ribeiro A.B., Caramelo F., Botelho M.F. Plasma activated media and direct exposition can selectively ablate retinoblastoma cells. Free Radic Biol Med. 2021 Aug 1;171:302-313.
doi: 10.1016/j.freeradbiomed.2021.05.027

Silvera V.M., Guerin J.B., Brinjikji W., Dalvin L.A. Retinoblastoma: What the Neuroradiologist Needs to Know. AJNR. American journal of neuroradiology. 2021 Jan 28.
doi: 10.3174/ajnr.A6949
https://pubmed.ncbi.nlm.nih.gov/33509920/

Singh L., Singh M.K., Rizvi M.A., Bakhshi S., Meel R., Lomi N., Sen S., Kashyap S. Clinical relevance of the comparative expression of immune checkpoint markers with the clinicopathological findings in patients with primary and chemoreduced retinoblastoma.
DOI: 10.1007/s00262-020-02529-4

Skalet A.H., Allen R.C., Shields C.L., Wilson M.W., Mruthyunjaya P., Gombos D.S. Considerations for the Management and Triage of Ocular Oncology Cases during the COVID-19 Pandemic. Ocular oncology and pathology. 2020 Apr 21.
DOI: 10.1159/000507734
https://pubmed.ncbi.nlm.nih.gov/32411697/?from_term=retinoblastoma&from_sort=date&from_page=3&from_pos=6

Skalet A.H., Campbell J.P., Jian Y. Ultrawide-field OCT for Retinoblastoma. Ophthalmology. 2022 Jun;129(6):718. PMID: 35598905.
doi: 10.1016/j.ophtha.2021.11.012

Skilton A.M., Low L.G., Dimaras H. Patients, Public and Service Users are Experts by Experience: An Overview from Ophthalmology Research in Canada, UK and Beyond. Ophthalmol Ther. 2020 Feb 29.
DOI: 10.1007/s40123-020-00237-x
https://link.springer.com/arti…/10.1007%2Fs40123-020-00237-x

Solana-Altabella A., Valero S., Balaguer J., Escobar-Cava P., Barranco H., López E., Ribes-Artero H., Poveda J.L. Intravitreal melphalan therapy for vitreous seeds in retinoblastoma: Implementation and outcomes of a new chemotherapy protocol. J Oncol Pharm Pract. 2020 Feb 17:1078155220904410.
DOI: 10.1177/1078155220904410

Soliman S.E., Martínez S., De Nicola M.L., Kiehl R., Krema H. Molecular analysis confirms retinoblastoma diagnosis in a histologically undifferentiated retinal tumor in an adult. Ophthalmic genetics. 2020 Jun 16.
doi: 10.1080/13816810.2020.1765398
https://pubmed.ncbi.nlm.nih.gov/32543965/

Soliman S.E., Bansal A., De Nicola M.L., Bhambhwani V., Laperriere N., Gallie B.L., Krema H. Applications of iodine-125 plaque radiotherapy for residual or recurrent retinoblastoma. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2021 Jan 23:S0008-4182(21)00001-6.
doi: 10.1016/j.jcjo.2020.12.016
https://pubmed.ncbi.nlm.nih.gov/33493457/

Soliman S.E., Bansal A., De Nicola M.L., Bhambhwani V., Laperriere N., Gallie B.L., Krema H. Applications of iodine-125 plaque radiotherapy for residual or recurrent retinoblastoma. Can J Ophthalmol. 2021 Oct;56(5):317-324.
doi: 10.1016/j.jcjo.2020

Soliman S.E., Vanden Hoven C., MacKeen L.D., Gallie B.L. Secondary Prevention of Retinoblastoma Revisited: Laser Photocoagulation of Invisible New Retinoblastoma. Ophthalmology. 2020 Jan;127(1):122-127.
DOI: 10.1016/j.ophtha.2019.08.011
https://www.aaojournal.org/a…/S0161-6420(19)31933-5/fulltext

Soliman S., Feng Z.X., Gallie B. Primary laser therapy as monotherapy for discrete retinoblastoma. The British journal of ophthalmology. 2021 Feb 3:bjophthalmol-2020-317885.
doi: 10.1136/bjophthalmol-2020-317885
https://pubmed.ncbi.nlm.nih.gov/33536230/

Soltani S., Tabibzadeh A., Yousefi P., Zandi M., Zakeri A., Akhavan Rezayat S., Ramezani A., Esghaei M., Farahani A. HPV infections in retinoblastoma: a systematic review. J Clin Lab Anal. 2021 Aug 30:e23981.
doi: 10.1002/jcla.23981
https://onlinelibrary.wiley.com/doi/10.1002/jcla.23981

Song J., Zhang Z. Long non‑coding RNA SNHG20 promotes cell proliferation, migration and invasion in retinoblastoma via the miR‑335‑5p/E2F3 axis. Mol Med Rep. 2021 Aug;24(2):543.
doi: 10.3892/mmr.2021.12182

Song K., Li B., Chen Y.Y., Wang H., Liu K.C., Tan W., Zou J. LRPPRC regulates metastasis and glycolysis by modulating autophagy and the ROS/HIF1-α pathway in retinoblastoma. Mol Ther Oncolytics. 2021 Jun 24;22:582-591.
doi: 10.1016/j.omto.2021.06.009
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450181/

Song L., Huang Y., Zhang X., Han S., Hou M., Li H. Downregulation of microRNA-224-3p Hampers Retinoblastoma Progression via Activation of the Hippo-YAP Signaling Pathway by Increasing LATS2. Investigative Ophthalmology & Visual Science.. 2020 Mar 9
DOI: 10.1167/iovs.61.3.32
https://pubmed.ncbi.nlm.nih.gov/32186675/?from_term=retinoblastoma&from_sort=pubdate&from_size=50&from_pos=49

Song L., Wang Y., Cui J., Zhang W., Zhang D., Wang X., Wang Z., Zhao Y., Zhang C., Duan C., Sun T., Zhang L., Yang X. Characteristics of Myelogram in Patients with Extraocular Metastatic Retinoblastoma and Morphological Analysis of Tumor Cells in Bone Marrow and Cerebrospinal Fluid.
Ophthalmologica. 2020 Oct 12.
doi: 10.1159/000512193
https://pubmed.ncbi.nlm.nih.gov/33045702/

Song W.P., Zheng S., Yao H.J., Zhou X.F., Li R., Zhang C.Y., Zhao J.Y., Wang L.W., Shao R.G., Li L. Different transcriptome profiles between human retinoblastoma Y79 cells and an etoposide-resistant subline reveal a chemoresistance mechanism. // BMC Ophthalmology. 2020 Mar 6.
DOI: 10.1186/s12886-020-01348-6
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060629/

Sradhanjali S., Rout P., Tripathy D., Kaliki S., Rath S., Modak R., Mittal R., Chowdary T.K., Reddy M.M.. The Oncogene MYCN Modulates Glycolytic and Invasive Genes to Enhance Cell Viability and Migration in Human Retinoblastoma. Cancers (Basel). 2021 Oct 19;13(20):5248.
doi: 10.3390/cancers13205248
PMID: 34680394; PMCID: PMC8533785.

Stacey A.W., Bowman R., Foster A., Kivelä T.T., Munier F.L., Cassoux N., Fabian I.D.; Global Retinoblastoma Study Group, Al Harby L., Alarcón Portabella S., Alia D.B., All-Eriksson C., Antonino R., Astbury N.J., Balaguer J., Balwierz W., Barranco H., Bascaran C., Beck Popovic M., Biewald E.M., Bobrova N., Bornfeld N., Brichard B.G., Blum S., Capra M., Castela G., Català-Mora J., Chantada G.L., Chernodrinska V.S., Cieslik K., Comsa C., Correa Llano M.G., Csóka M., De Potter P., Desjardins L., Dragomir M.D., Fernández-Teijeiro A., García Aldana D., Gregersen P.A., Gomel N., Hadjistilianou T., Hederova S., Hummlen M., Husakova K., Ida R., Ilic V.R., Jenkinson H., Kapelushnik N., Kardava T., Keren-Froim N., Kepak T., Khotenashvili Z., Klett A., Krivaitiene D., Latinović S., Lumbroso L., Lysytsia L., Maka E., Martín Begue N., Midena E., Moll A.C., Murgoi G., Naumenko L., Neroev V., Nikitovic M., Olechowski A., Papyan R., Parrozzani R., Parulekar M.V., Pawinska-Wasikowska K., Perić S., Pochop P., Polyakov V.G., Reddy M.A., Ritter-Sovinz P., Saakyan S., Sagoo M.S., San Román Pacheco S., Seregard S., Silva S., Sorochynska T., Stathopoulos C., Stirn Kranjc B., Svojgr K., Tamamyan G., Tandili A., Tateshi B., Tekavcic Pompe M., Urbak S.F., Ushakova T.L., Valeina S., van Hoefen Wijsard M., Veleva-Krasteva N.V., Viksnins M., Wackernagel W., Wolley Dod C., Yarovaya V.A., Yarovoy A.A., Zhilyaeva K., Zondervan M.
Incidence of retinoblastoma has increased: results from 40 European countries.
Ophthalmology. 2021 Jan 25:S0161-6420(21)00072-5.
doi: 10.1016/j.ophtha.2021.01.024
https://pubmed.ncbi.nlm.nih.gov/33508429/

Stacey A.W., Bowman R., Foster A., Kivelä T.T., Munier F.L., Cassoux N., Fabian I.D.; Global Retinoblastoma Study Group. Incidence of Retinoblastoma Has Increased: Results from 40 European Countries. Ophthalmology. 2021 Sep;128(9):1369-1371.
doi: 10.1016/j.ophtha.2021.01.024

Stacey A.W., De Francesco S., Borri M., Hadjistilianou T. The addition of topotecan to melphalan in the treatment of retinoblastoma with intra-arterial chemotherapy. Ophthalmology. Retina. 2020 Nov 19:S2468-6530(20)30459-0.
doi: 10.1016/j.oret.2020.11.007
https://pubmed.ncbi.nlm.nih.gov/33221516/

Stacey A.W., De Francesco S., Borri M., Hadjistilianou T. The Addition of Topotecan to Melphalan in the Treatment of Retinoblastoma with Intra-arterial Chemotherapy. Ophthalmol Retina. 2021 Aug; 5(8):824-830.
doi: 10.1016/j.oret.2020.11.007
https://www.sciencedirect.com/science/article/abs/pii/S2468653020304590?via%3Dihub

Stacey A.W., Tsukikawa M., Fabian I.D., Turner S., Jenkinson H., Smith V., Naeem Z., Morland B., Ainsworth J.R., Reddy M.A., Parulekar M., Sagoo M.S. Adjuvant use of laser in eyes with macular retinoblastoma treated with primary intravenous chemotherapy. The British journal of ophthalmology. 2020 Sep 15
doi: 10.1136/bjophthalmol-2020-316862
https://pubmed.ncbi.nlm.nih.gov/32933939/

Stacey A.W., Tsukikawa M., Fabian I.D., Turner S., Jenkinson H., Smith V., Naeem Z., Morland B., Ainsworth J.R., Reddy M.A., Parulekar M., Sagoo M.S. Adjuvant use of laser in eyes with macular retinoblastoma treated with primary intravenous chemotherapy. Br J Ophthalmol. 2021 Nov;105(11):1599-1603.
doi: 10.1136/bjophthalmol-2020-316862

Stathopoulos C., Bartolini B., Marie G., Beck-Popovic M., Saliou G., Munier F.L. Risk factors for acute choroidal ischemia after intra-arterial melphalan for retinoblastoma: the role of the catheterization approach. Ophthalmology. 2020 Sep 18
doi: 10.1016/j.ophtha.2020.09.021
https://pubmed.ncbi.nlm.nih.gov/32956742/

Stathopoulos C., Lumbroso-Le Rouic L., Moll A.C., Parulekar M., Maeder P., Doz F., Jenkinson H., Beck Popovic M., Chantada G., Munier F.L. Current Indications of Secondary Enucleation in Retinoblastoma Management: A Position Paper on Behalf of the European Retinoblastoma Group (EURbG). Cancers (Basel). 2021 Jul 6;13(14):3392.
PMID: 34298608; PMCID: PMC8303810.
https://doi.org/10.3390/cancers13143392

Stathopoulos C., Sergenti J., Gaillard M.C., Munier F.L., Daruich A. Pars plana vitrectomy under melphalan irrigation for recurrent retinal detachment in eyes treated for retinoblastoma: a case report. BMC Ophthalmol. 2020 Jan 28;20(1):34.
DOI: 10.1186/s12886-020-1315-7

Strijbis V.I.J., de Bloeme C.M., Jansen R.W., Kebiri H., Nguyen H.G., de Jong M.C., Moll A.C., Bach-Cuadra M., de Graaf P., Steenwijk M.D. Multi-view convolutional neural networks for automated ocular structure and tumor segmentation in retinoblastoma. Sci Rep. 2021 Jul 16;11(1):14590.
doi: 10.1038/s41598-021-93905-2

Stuart K.V., Shepherd D.J., Kruger M., Singh E. The Incidence of Retinoblastoma in South Africa: Findings from the South African National Cancer Registry (2004-2018). Ophthalmic Epidemiol. 2021 Dec 22:1-7.
doi: 10.1080/09286586.2021.2013900

Sujjitjoon J., Sayour E., Tsao S.T., Uiprasertkul M., Sanpakit K., Buaboonnam J., Yenchitsomanus P.T., Atchaneeyasakul L.O., Chang L.J. GD2-specific chimeric antigen receptor-modified T cells targeting retinoblastoma - assessing tumor and T cell interaction. Translational oncology. 2020 Dec 12;14(2):100971.
doi: 10.1016/j.tranon.2020.100971
https://pubmed.ncbi.nlm.nih.gov/33321428/

Suleiman D.E., Iliyasu Y., Ahmed S.A., Liman A.A. Histopathologic spectrum of paediatric eye and ocular adnexal tumours: A 10-year review from a referral centre in Nigeria. Nigerian journal of clinical practice. 2020 May;23
DOI: 10.4103/njcp.njcp_389_19
https://pubmed.ncbi.nlm.nih.gov/32367872/?from_term=retinoblastoma&from_sort=date&from_page=5&from_pos=5

Sun J., Feng D., Xi H., Luo J., Zhou Z., Liu Q., Chen Y., Shao Q. CD24 blunts the sensitivity of retinoblastoma to vincristine by modulating autophagy. Molecular oncology. 2020 May 12.
DOI: 10.1002/1878-0261.12708
https://pubmed.ncbi.nlm.nih.gov/32394616/?from_term=retinoblastoma&from_sort=date&from_page=4&from_pos=5

Sun J., Xi H.Y., Shao Q., Liu Q.H. Biomarkers in retinoblastoma Int J Ophthalmol. 2020 Feb 18;13(2):325-341.
DOI: 10.18240/ijo.2020.02.18. eCollection 2020.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7013786/

Sun S., Wang R., Yi S., Li S., Wang L., Wang J. Roles of the microRNA‑338‑3p/NOVA1 axis in retinoblastoma. Molecular medicine reports. 2021 May;23(5):394.
doi: 10.3892/mmr.2021.12033
https://pubmed.ncbi.nlm.nih.gov/33760207/

Sun X., Shen H., Liu S., Gao J., Zhang S. Long noncoding RNA SNHG14 promotes the aggressiveness of retinoblastoma by sponging microRNA‑124 and thereby upregulating STAT3.International Journal of Molecular Medicine. 2020 Mar 20
DOI: 10.3892/ijmm.2020.4547
https://pubmed.ncbi.nlm.nih.gov/32236565/?from_term=retinoblastoma&from_sort=date&from_page=3&from_pos=5

Sun Z., Zhang A., Hou M., Jiang T. Circular RNA hsa_circ_0000034 promotes the progression of retinoblastoma via sponging microRNA-361-3p. Bioengineered. 2020 Dec;11(1):949-957.
doi: 10.1080/21655979.2020.1814670
https://pubmed.ncbi.nlm.nih.gov/32892696/

Sweid A., El Naamani K., Sajja K.C., Hammoud B., Knapp M.D., Moylan D.D., Joffe D., Morse C.E., Habbal D., Weinberg J.H., Tjoumakaris S.I., Shields C.L., Lezama D.A., Lim L.S., Dalvin L.A., Rosenwasser R., Jabbour P. Incidence and predictors of ophthalmic artery occlusion in intra-arterial chemotherapy for retinoblastoma. Journal of neurointerventional surgery. 2020 Oct 29
doi: 10.1136/neurintsurg-2020-016759
https://pubmed.ncbi.nlm.nih.gov/33122349/

Sweid A., Hammoud B., Texakalidis P., Xu V., Shivashankar K., Baldassari M.P., Das S., Tjoumakaris S., Shields C.L., Ancona-Lezama D., Lim L.S., Dalvin L.A., Maamari D.J., Jabbour P. The Use of Alternative Routes for the Delivery of Intra-Arterial Chemotherapy for Retinoblastoma.
Neurosurgery online. 2020 May 12.
DOI: 10.1093/neuros/nyaa142
https://pubmed.ncbi.nlm.nih.gov/32396190/?from_term=retinoblastoma&from_sort=date&from_page=4&from_pos=4

Sweid A., Hammoud B., Weinberg J.H., Texakalidis P., Xu V., Shivashankar K., Baldassari M.P., Das S., Ramesh S., Tjoumakaris S., Shields C.L., Ancona-Lezama D., Lim L.S., Dalvin L.A., Jabbour P. Intra-Arterial Chemotherapy for Retinoblastoma in Infants ≤10 Kg: 74 Treated Eyes With 222 IAC Sessions. American journal of neuroradiology. 2020 June 25.
doi: 10.3174/ajnr.A6590
https://pubmed.ncbi.nlm.nih.gov/32586963/

Sweid A., Hammoud B., Weinberg J.H., Texakalidis P., Xu V., Shivashankar K., Baldassari M.P., Das S., Tjoumakaris S.I., Shields C.L., Lezama D.A., Lim L.S., Dalvin L.A., El Naamani K., Jabbour P. Ophthalmic artery catheterization for retinoblastoma treatment: does reflux affect tumor response? Journal of NeuroInterventional Surgery. 2020 Apr 9
DOI: 10.1136/neurintsurg-2019-015597
https://pubmed.ncbi.nlm.nih.gov/32277036/?from_term=retinoblastoma&from_sort=date&from_pos=7

Sweid A., Jabbour P. Intra-arterial chemotherapy for retinoblastoma: transradial and transfemoral approach. Journal of neurointerventional surgery. 2020 May 15/
DOI: 10.1136/neurintsurg-2019-015627
https://pubmed.ncbi.nlm.nih.gov/32414893/?from_term=retinoblastoma&from_sort=date&from_page=3&from_pos=4

T

Tandon S., Prasad M., Vora T., Chinnaswamy G., Shetye N. A Rare Association of Retinoblastoma With Incontinentia Pigmenti. Journal of Pediatric Hematology/Oncology. 2020 Apr 13.
DOI: 10.1097/MPH.0000000000001797
https://pubmed.ncbi.nlm.nih.gov/32287098/?from_term=retinoblastoma&from_sort=date&from_page=2&from_pos=10

Taneja S., Aldoais T., Kaliki S. Primary Orbital Polymethylmethacrylate Implant Following Primary Enucleation for Retinoblastoma: A Study of 321 Cases. Orbit. 2020 Apr 7
DOI: 10.1080/01676830.2020.1750040
https://pubmed.ncbi.nlm.nih.gov/32252576/?from_term=retinoblastoma&from_sort=date&from_page=2&from_pos=9

Taneja S., Aldoais T., Kaliki S. Primary orbital polymethylmethacrylate implant following primary enucleation for retinoblastoma: a study of 321 cases. Orbit. 2021 Apr;40(2):127-132.
doi: 10.1080/01676830.2020.1750040
https://pubmed.ncbi.nlm.nih.gov/32252576/

Tang H., Long Q., Zhuang K., Han K., Zhang X., Guo H., Lu X. Retinoblastoma tumor suppressor gene 1 enhances 5-Fluorouracil chemosensitivity through SDF-1/CXCR4 axis by regulating autophagy in gastric cancer. Pathol Res Pract. 2021 Aug;224:153532.
doi: 10.1016/j.prp.2021.153532

Tang L., Fu Y., Song J., Hu T, Li K, Li Z. mTOR inhibition by TAK-228 is effective against growth, survival and angiogenesis in preclinical retinoblastoma models. Pharmacol Res Perspect. 2022 Feb;10(1):e00930. PMID: 35142090
doi: 10.1002/prp2.930

Tang W., Zhang L., Li J., Guan Y. AFAP1 antisense RNA 1 promotes retinoblastoma progression by sponging microRNA miR-545-3p that targets G protein subunit beta 1. Bioengineered. 2022 Mar;13(3):5638-5652. PMID: 35193469.
doi: 10.1080/21655979.2022.2033464

Tanwar M., Balaji S., Vanniarajan A., Kim U., Chowdhury G. Parental age and retinoblastoma-a retrospective study of demographic data and genetic analysis. Eye (Lond). 2021 Nov 19.
doi: 10.1038/s41433-021-01771-z

Tarlan B., Gunaydin B., Veyselov O., Gungor I., Konuk O. Surgical treatment of huge orbital retinoblastoma under general anesthesia in a three-year old child. Braz J Anesthesiol. 2022 Apr 6:S0104-0014(22)00039-2. Epub ahead of print. PMID: 35398150.
doi: 10.1016/j.bjane.2022.03.009

Ting S.C., Kiefer T., Ehlert K., Goericke S.L., Hinze R., Ketteler P., Bechrakis N.E., Schildhaus H.U. Bone metastasis of retinoblastoma five years after primary treatment. American journal of ophthalmology case reports. 2020 Jul 17
doi: 10.1016/j.ajoc.2020.100834
https://pubmed.ncbi.nlm.nih.gov/32715161/

Toli A., Perente A., Labiris G. Evaluation of the red reflex: An overview for the pediatrician. World J Methodol. 2021 Sep 20;11(5):263-277.
doi: 10.5662/wjm.v11.i5.263
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472546/

Tomar A.S., Finger P.T., Gallie B., Kivelä T.T., Mallipatna A., Zhang C., Zhao J., Wilson M.W., Brenna R.C., Burges M., Kim J., Khetan V., Ganesan S., Yarovoy A., Yarovaya V., Kotova E., Yousef Y.A., Nummi K., Ushakova T.L., Yugay O.V., Polyakov V.G., Ramirez-Ortiz M.A., Esparza-Aguiar E., Chantada G., Schaiquevich P., Fandino A., Yam J.C., Lau W.W., Lam C.P., Sharwood P., Moorthy S., Long Q.B., Essuman V.A., Renner L.A., Semenova E., Català J., Correa-Llano G., Carreras E.; American Joint Committee on Cancer Ophthalmic Oncology Task Force.
Global Retinoblastoma Treatment Outcomes: Association with National Income Level. Ophthalmology. 2021 May;128(5):740-753.
doi: 10.1016/j.ophtha.2020.09.032
https://pubmed.ncbi.nlm.nih.gov/33007338/

Tomar A.S., Finger P.T., Gallie B., Kivelä T., Mallipatna A., Zhang C., Zhao J., Wilson M., Brennan R., Burges M., Kim J., Berry J.L., Jubran R., Khetan V., Ganeshan S., Yarovoy A., Yarovaya V., Kotova E., Volodin D., Yousef Y., Nummi K., Ushakova T.L., Yugay O.V., Polyakov V.G., Ramirez-Ortiz M.A., Esparza-Aguiar E., Chantada G.L., Schaiquevich P., Fandiño A.C., Yam J.C., Lau W.W., Lam C.P., Sharwood P., Moorthy S., Long Q.B., Essuman V.A., Renner L.A., Semenova E., Català-Mora J., Correa Llano M., Carreras E.; American Joint Committee on Cancer Ophthalmic Oncology Task Force; American Joint Committee on Cancer Ophthalmic Oncology Task. Retinoblastoma seeds: impact on American Joint Committee on Cancer clinical staging. Br J Ophthalmol. 2021 Aug 2:bjophthalmol-2021-318892.
doi: 10.1136/bjophthalmol-2021-318892
https://bjo.bmj.com/content/early/2021/08/01/bjophthalmol-2021-318892.long

Tomar A.S., Finger P.T., Gallie B., Mallipatna A., Kivelä T.T., Zhang C., Zhao J., Wilson M.W., Brenna R.C., Burges M., Kim J., Khetan V., Ganesan S., Yarovoy A., Yarovaya V., Kotova E., Yousef Y.A., Nummi K, Ushakova T.L., Yugay O.V., Polyakov V.G., Ramirez-Ortiz M.A., Esparza-Aguiar E., Chantada G., Schaiquevich P., Fandino A., Yam J.C., Lau W.W., Lam C.P., Sharwood P., Moorthy S., Long Q.B., Essuman V.A., Renner L.A., Semenova E., Català J., Correa-Llano G., Carreras-Bertran E.; American Joint Committee on Cancer Ophthalmic Oncology Task Force. A Multicenter, International Collaborative Study for AJCC-Staging of Retinoblastoma: Treatment Success and Globe Salvage. Ophthalmology. 2020 Jun 8.
doi: 10.1016/j.ophtha.2020.05.051
https://pubmed.ncbi.nlm.nih.gov/32526306/

Tomar A.S., Finger P.T., Gallie B., Kivelä T.T., Mallipatna A., Zhang C., Zhao J., Wilson M.W., Brennan R.C., Burges M., Kim J., Berry J.L., Jubran R., Khetan V., Ganesan S., Yarovoy A., Yarovaya V., Kotova E., Volodin D., Yousef Y.A., Nummi K., Ushakova T.L., Yugay O.V., Polyakov V.G., Ramirez-Ortiz M.A., Esparza-Aguiar E., Chantada G., Schaiquevich P., Fandino A., Yam J.C., Lau W.W., Lam C.P., Sharwood P., Moorthy S., Long Q.B., Essuman V.A., Renner L.A., Semenova E., Català-Mora J., Correa-Llano G., Carreras E.; American Joint Committee on Cancer Ophthalmic Oncology Task Force. High-Risk Pathology Based on Presenting Features in Advanced Intraocular Retinoblastoma: A Multicenter, International Data-Sharing AJCC Study. Ophthalmology. 2022 Apr 15:S0161-6420(22)00284-6. Epub ahead of print. PMID: 35436535.
doi: 10.1016/j.ophtha.2022.04.006

Tomita T., Huibregtse J.M., Matouschek A. A Masked Initiation Region in Retinoblastoma Protein Regulates Its Proteasomal Degradation. Nature Communications. 2020 Apr 24
DOI: 10.1038/s41467-020-16003-3
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181824/

Tonorezos E.S., Friedman D.N., Barnea D., Bosscha M.I., Chantada G., Dommering C.J., de Graaf P., Dunkel I.J., Fabius A.W.M., Francis J.H., Greer M.C., Kleinerman R.A., Kors W.A., Laughlin S., Moll A.C., Morton L.M., Temming P., Tucker M.A., van Leeuwen F.E., Walsh M.F., Oeffinger K.C., Abramson D.H. Recommendations for long-term follow-up of adults with heritable retinoblastoma. Ophthalmology. 2020 May 15.
DOI: 10.1016/j.ophtha.2020.05.024
https://pubmed.ncbi.nlm.nih.gov/32422154/?from_term=retinoblastoma&from_sort=date&from_page=3&from_pos=1

Tsimpida M., Dharmaraj S., Luthert P.J., Reddy M.A., Sagoo M.S. Retinal neuronal ectopia: a new entity in the differential diagnosis of retinoblastoma. Retin Cases Brief Rep. 2022 Mar 1;16(2):204-206. PMID: 31800504.
doi: 10.1097/ICB.0000000000000950

Tu J., Huo Z., Yu Y., Zhu D., Xu A., Huang M.F., Hu R., Wang R., Gingold J.A., Chen Y.H., Tsai K.L., Forcioli-Conti N.R., Huang S.X.L., Webb T.R., Su J., Bazer D.A., Jia P. etc. Hereditary retinoblastoma iPSC model reveals aberrant spliceosome function driving bone malignancies. Proc Natl Acad Sci U S A. 2022 Apr 19;119(16):e2117857119. Epub 2022 Apr 11. PMID: 35412907.
doi: 10.1073/pnas.2117857119

Turchiello R.F., Oliveira C.S., Fernandes A.U., Gómez S.L., Baptista M.S. Methylene blue-mediated Photodynamic Therapy in human retinoblastoma cell lines. Journal of photochemistry and photobiology. B, Biology. 2021 Jul 16;222:112260. PMID: 34304071.
doi: 10.1016/j.jphotobiol.2021.112260.
https://pubmed.ncbi.nlm.nih.gov/34304071/

Turchiello R.F., Oliveira C.S., Fernandes A.U., Gómez S.L., Baptista M.S. Methylene blue-mediated Photodynamic Therapy in human retinoblastoma cell lines. J Photochem Photobiol B. 2021 Sep;222:112260.
doi: 10.1016/j.jphotobiol.2021.112260

Turkoglu E.B., Erol M.K., Karaca B.O. Coexistence of torpedo maculopathy and retinoblastoma: Differentiation the lesions with hand-held optical coherence tomography. Photodiagnosis and photodynamic therapy. 2021 May 4;34:102331.
doi: 10.1016/j.pdpdt.2021.102331
https://pubmed.ncbi.nlm.nih.gov/33962056/

Turkoglu E.B., Erol M.K. Optical coherence tomography findings in a case with cavitary retinoblastoma. Journal français d'ophtalmologie. 2020 Dec 1:S0181-5512(20)30536-2.
doi: 10.1016/j.jfo.2020.05.008
https://pubmed.ncbi.nlm.nih.gov/33277083/

U

Ueda T., Koga Y., Yoshikawa H., Tanabe M., Yamana K., Oba U., Nakashima K., Ono H., Ichimura T., Hasegawa S., Kato W., Kobayashi T., Nakayama H., Sakai Y., Yoshitake T., Ohga S., Oda Y., Suzuki S., Sonoda K.H., Ohga S. Survival and ocular preservation in a long-term cohort of Japanese patients with retinoblastoma. BMC Pediatr. 2020 Jan 28;20(1):37.
DOI: 10.1186/s12887-020-1923-7
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986142/

V

van Hoefen Wijsard M., Serné S.H., Otten R.H., Bosscha M.I., Dommering C.J., Fabius A.W., Moll A.C. At What Age Could Screening for Familial Retinoblastoma Be Discontinued? A Systematic Review. Cancers. 2021 Apr 17;13(8):1942.
doi: 10.3390/cancers13081942
https://pubmed.ncbi.nlm.nih.gov/33920538/

van Hoefen Wijsard M., Schonfeld S.J., van Leeuwen F.E., Moll A.C., Fabius A.W., Abramson D.H., Seddon J.M., Francis J.H., Tucker M.A., Kleinerman R.A., Morton L.M. Benign Tumors in Long-Term Survivors of Retinoblastoma. Cancers. 2021 Apr 8;13(8):1773.
doi: 10.3390/cancers13081773
https://pubmed.ncbi.nlm.nih.gov/33917779/

Vaz M., Fahrenkrog B. The Retinoblastoma Tumor Suppressor Is Required for the NUP98-HOXA9-Induced Aberrant Nuclear Envelope Phenotype. Cells. 2021 Oct 22;10(11):2851.
doi: 10.3390/cells10112851

Vempuluru V.S., Jakati S., Kaliki S. Delayed metastasis in patients with intraocular retinoblastoma: A review of three cases. European journal of ophthalmology. 2020 Jul 24.
doi: 10.1177/1120672120946285
https://pubmed.ncbi.nlm.nih.gov/32703017/

Vempuluru V.S, Jakati S., Krishnamurthy R., Senthil S., Kaliki S. Glaucoma as the presenting sign of intraocular tumors: beware of the masquerading sign. // International Ophthalmology. 2020 Mar 20.
DOI: 10.1007/s10792-020-01348-x
https://pubmed.ncbi.nlm.nih.gov/32198607/?from_term=retinoblastoma&from_sort=date&from_pos=5

Vempuluru V.S., Kaliki S. Screening for Retinoblastoma: A Systematic Review of Current Strategies. Asia-Pacific journal of ophthalmology. 2021 Mar-Apr 01;10(2):192-199.
doi: 10.1097/APO.0000000000000378
https://pubmed.ncbi.nlm.nih.gov/33793441/

Vemuganti G.K. Viral etiology in retinoblastoma. Indian J Ophthalmol. 2021 Aug;69(8):1990.
doi: 10.4103/ijo.IJO_1801_21 г
https://journals.lww.com/ijo/Fulltext/2021/08000/Viral_etiology_in_retinoblastoma.6.aspx

Venkatesh R., Agrawal S., Reddy N.G., Pereira A. Multimodal imaging in a classic case of unilateral retinocytoma. BMJ Case Rep. 2021 Aug 5;14(8):e244167.
doi: 10.1136/bcr-2021-244167

Ventura E., Iannuzzi C.A., Pentimalli F., Giordano A., Morrione A. RBL1/p107 Expression Levels Are Modulated by Multiple Signaling Pathways. Cancers (Basel). 2021 Oct 8;13(19):5025.
doi: 10.3390/cancers13195025

Villanueva G., Sampor C., Moreno F., Alderete D., Moresco A., Pinto N., Szijan I., Schaiquevich P., Felice M.S., Rose A., Zubizarreta P., Sgroi M., Fandiño A., Chantada G. Subsequent malignant neoplasms in the pediatric age in retinoblastoma survivors in Argentina. Pediatr Blood Cancer. 2022 Apr 21:e29710. Epub ahead of print.
PMID: 35451226.
doi: 10.1002/pbc.29710

Vincent A., Natarajan V., Khetan V., Krishnakumar S., Parameswaran S. Retinoblastoma patient-derived stem cells-an in vivo model to study the role of RB1 in adipogenesis. Histochem Cell Biol. 2022 Apr 21. Epub ahead of print. PMID: 35445864.
doi: 10.1007/s00418-022-02105-0

W

Waddell K., Matua M., Bidwell C., Atwine R., Onyango J., Picton S.V., Simmons I., Stahlschmidt J., Johnston W.T., Newton R. A ten-year study of Retinoblastoma in Uganda: An approach to improving outcome with limited resources. Cancer epidemiology. 2020 Jul 10
doi: 10.1016/j.canep.2020.101777
https://pubmed.ncbi.nlm.nih.gov/32660850/

Waddell K., Matua M., Bidwell C., Atwine R., Onyango J., Picton S.V., Simmons I., Stahlschmidt J., Johnston W.T., Newton R. A ten-year study of Retinoblastoma in Uganda: An approach to improving outcome with limited resources. Cancer Epidemiology. 2021 Apr;71(Pt B):101777.
doi: 10.1016/j.canep.2020.101777
https://pubmed.ncbi.nlm.nih.gov/32660850/

Wagner R.S. The Genetics of Unilateral Retinoblastoma Clarified. J Pediatr Ophthalmol Strabismus. 2021 Nov-Dec;58(6):344.
doi: 10.3928/01913913-20211012-01

Wang H., Li M., Cui H., Song X., Sha Q. CircDHDDS/miR-361-3p/WNT3A Axis Promotes the Development of Retinoblastoma by Regulating Proliferation, Cell Cycle, Migration, and Invasion of Retinoblastoma Cells. Neurochemical research. 2020 Aug 31.
doi: 10.1007/s11064-020-03112-0
https://pubmed.ncbi.nlm.nih.gov/32865704/

Wang H., Liu Z., Sun Z., Zhou D., Mao H., Deng G. Ubiquitin specific peptidase 33 promotes cell proliferation and reduces apoptosis through regulation of the SP1/PI3K/AKT pathway in retinoblastoma. Cell Cycle. 2021 Sep 1:1-11.
doi: 10.1080/15384101.2021.1970305

Wang H., Yang J., Pan H., Tai M.C., Maher M.H., Jia R., Ge S., Lu L. Dinutuximab Synergistically Enhances the Cytotoxicity of Natural Killer Cells to Retinoblastoma Through the Perforin-Granzyme B Pathway. OncoTargets and therapy.2020 May 8.
DOI: 10.2147/OTT.S228532
https://pubmed.ncbi.nlm.nih.gov/32440155/?from_term=retinoblastoma&from_sort=date&from_pos=6

Wang J., Dong Y., Li Q. Neferine induces mitochondrial dysfunction to exert anti-proliferative and anti-invasive activities on retinoblastoma. Experimental biology and medicine / Society for Experimental Biology and Medicine. 2020 May 28
DOI: 10.1177/1535370220928933
https://pubmed.ncbi.nlm.nih.gov/32460625/?from_term=retinoblastoma&from_sort=date&from_pos=2

Wang J., Wang S., Chen L., Tan J. SCARA5 suppresses the proliferation and migration, and promotes the apoptosis of human retinoblastoma cells by inhibiting the PI3K/AKT pathway.Molecular medicine reports. 2021 Mar;23(3):202.
doi: 10.3892/mmr.2021.11841. Epub 2021 Jan 26
https://pubmed.ncbi.nlm.nih.gov/33495818/

Wang L., Chen N., Cheng H. Fisetin inhibits vascular endothelial growth factor-induced angiogenesis in retinoblastoma cells. Oncology letters. 2020 Aug.
doi: 10.3892/ol.2020.11679
https://pubmed.ncbi.nlm.nih.gov/32724364/

Wang L., Wang C., Wu T., Sun F. Long non-coding RNA TP73-AS1 promotes TFAP2B-mediated proliferation, metastasis and invasion in retinoblastoma via decoying of miRNA-874-3p. Journal of Cell Communication and Signaling. Feb-2020.
DOI: 10.1007/s12079-020-00550-x
https://link.springer.com/arti…/10.1007%2Fs12079-020-00550-x

Wang L., Zhang Y., Xin X. Long Non-Coding RNA MALAT1 Aggravates Human Retinoblastoma by Sponging miR-20b-5p to Upregulate STAT3. Pathology, Research and Practice. 2020 Apr 18.
DOI: 10.1016/j.prp.2020.152977
https://pubmed.ncbi.nlm.nih.gov/32336590/?from_term=retinoblastoma&from_sort=date&from_pos=5

Wang X., Su Y., Yin C. Long non-coding RNA (lncRNA) five prime to Xist (FTX) promotes retinoblastoma progression by regulating the microRNA-320a/with-nolysine kinases 1 (WNK1) axis. Bioengineered. 2021 Nov 1.
doi: 10.1080/21655979.2021.1994718

Wang X., Su Y., Yin C. Long non-coding RNA (lncRNA) five prime to Xist (FTX) promotes retinoblastoma progression by regulating the microRNA-320a/with-no-lysine kinases 1 (WNK1) axis. Bioengineered. 2021 Dec;12(2):11622-11633.
doi: 10.1080/21655979.2021.1994718

Wang Y., Sun D., Sheng Y., Guo H., Meng F., Song T. XIST promotes cell proliferation and invasion by regulating miR-140-5p and SOX4 in retinoblastoma // World Journal of Surgical Oncology. 2020 Mar 3.
DOI: 10.1186/s12957-020-01825-8
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055023/

Wang Y., Wang J., Hao H., Luo X. lncRNA KCNQ1OT1 promotes the proliferation, migration and invasion of retinoblastoma cells by upregulating HIF-1alpha via sponging miR-153-3p. Journal of investigative medicine : the official publication of the American Federation for Clinical Research. 2020 Dec;68(8):1349-1356.
doi: 10.1136/jim-2020-001431
https://pubmed.ncbi.nlm.nih.gov/33051357/

Wang Y., Xin D., Zhou L. LncRNA LINC00152 Increases the Aggressiveness of Human Retinoblastoma and Enhances Carboplatin and Adriamycin Resistance by Regulating MiR-613/Yes-Associated Protein 1 (YAP1) Axis. Medical science monitor : international medical journal of experimental and clinical research.2020 Jun 15.
doi: 10.12659/MSM.920886
https://pubmed.ncbi.nlm.nih.gov/32541644/

Wang Y.Z., Zhang Y., Huang D.S., Shi J.T., Ma J.M., Li B., Xu X.L., Zhou Y., Gu H.L.
Clinical characteristics, treatment and prognosis of children with unilateral retinoblastoma and intracranial segment of Retrobulbar optic nerve invasion.
BMC Ophthalmol. 2021 Jan 14;21(1):38.
doi: 10.1186/s12886-020-01768-4
https://pubmed.ncbi.nlm.nih.gov/33446150/

Wang Z., Chen N., Liu C., Cao G., Ji Y., Yang W., Jiang Q. UBE2T is a prognostic biomarker and correlated with Th2 cell infiltrates in retinoblastoma. Biochem Biophys Res Commun. 2022 May 6;614:138-144.
doi: 10.1016/j.bbrc.2022.04.096

Wan T., Fu M., Wu Z., Gao X., Zhou S. Advances in the role of autophagy in the development of retinoblastoma. Oncol Lett. 2021 Aug;22(2):632.
doi: 10.3892/ol.2021.12893
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258627/

Wan W., Wan W., Long Y., Li Q., Jin X., Wan G., Zhang F., Lv Y., Zheng G., Li Z., Zhu Y. Corrigendum to "MiR-25-3p promotes malignant phenotypes of retinoblastoma by regulating PTEN/Akt pathway" [Biomed. Pharmacother. 118 (2019) 109111]. Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie. 2020 Oct 19:110842.
doi: 10.1016/j.biopha.2020.110842
https://pubmed.ncbi.nlm.nih.gov/33092949/

Warda O., Naeem Z., Roelofs K.A., Sagoo M.S., Reddy M.A. Retinoblastoma and vision. Eye (Lond). 2022 Jan 5. Epub ahead of print.
doi: 10.1038/s41433-021-01845-y

Wei T., Grace M., Uberoi A., Romero-Masters J.C., Lee D., Lambert P.F., Munger K. The Mus musculus Papillomavirus Type 1 E7 Protein Binds to the Retinoblastoma Tumor Suppressor: Implications for Viral Pathogenesis. mBio. 2021 Aug 31;12(4):e0227721.
doi: 10.1128/mBio.02277-21

Wendt S.P., Barrett D.A., Chang E.Y., Schefler A.C. Segmental Scleral Buckle Surgical Technique for Repair of a Rhegmatogenous Retinal Detachment in Retinoblastoma: A Case and Review of the Literature. Ocul Oncol Pathol. 2021 Mar;7(2):91-96.
doi: 10.1159/000508721

Weng P.Y., Chen S.H., Kao L.Y., Tsai Y.J., Yang S.H., Tseng C.K., Tsay P.K., Jaing T.H. Clinical spectrum and treatment outcome of retinoblastoma with Group D and E diseases: A single institution retrospective review. Medicine. 2020 Sep 18;
doi: 10.1097/MD.0000000000022201
https://pubmed.ncbi.nlm.nih.gov/32957352/

Wen S., Hu M., Xiong Y. Effect of Eriodictyol on Retinoblastoma via the PI3K/Akt Pathway. J Healthc Eng. 2021 Nov 11;2021:6091585.
doi: 10.1155/2021/6091585

Willard V.W., Qaddoumi I., Pan H., Hsu C.W., Brennan R.C., Wilson M.W., Rodriguez-Galindo C., Goode K., Parris K., Phipps S. Cognitive and Adaptive Functioning in Youth With Retinoblastoma: A Longitudinal Investigation Through 10 Years of Age. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2021 Apr 23:JCO2003422.
doi: 10.1200/JCO.20.03422
https://pubmed.ncbi.nlm.nih.gov/33891476/

Willard V.W., Qaddoumi I., Pan H., Hsu C.W., Brennan R.C., Wilson M.W., Rodriguez-Galindo C., Goode K., Parris K., Phipps S. Cognitive and Adaptive Functioning in Youth With Retinoblastoma: A Longitudinal Investigation Through 10 Years of Age. J Clin Oncol. 2021 Aug 20;39(24):2676-2684.
doi: 10.1200/JCO.20.03422

Winter U., Ganiewich D., Ottaviani D., Zugbi S., Aschero R., Sendoya J.M., Cafferata E.G., Mena M., Sgroi M., Sampor C., Lubieniecki F., Fandiño A., Abba M.C., Doz F., Podhjacer O., Montero Carcaboso A., Letouzé E., Radvanyi F., Chantada G.L., Llera A.S., Schaiquevich P. Genomic and Transcriptomic Tumor Heterogeneity in Bilateral Retinoblastoma // JAMA Ophthalmology. 2020 Mar 19.
DOI: 10.1001/jamaophthalmol.2020.0427
https://pubmed.ncbi.nlm.nih.gov/32191268/?from_term=retinoblastoma&from_sort=date&from_pos=1

Wiwatwongwana D., Kulniwatcharoen P., Mahanupab P., Visrutaratna P., Wiwatwongwana A. Accuracy of Computed Tomography and Magnetic Resonance Imaging for Detection of Pathologic Risk Factors in Patients Diagnosed with Retinoblastoma. Current eye research. 2021 Mar 22:1-7.
doi: 10.1080/02713683.2021.1901938
https://pubmed.ncbi.nlm.nih.gov/33752572/

Wong E.S., Choy R.W., Zhang Y., Chu W.K., Chen L.J., Pang C.P., Yam J.C. Global retinoblastoma survival and globe preservation: a systematic review and meta-analysis of associations with socioeconomic and health-care factors. Lancet Glob Health. Epub ahead of print. 2022 Jan 27:S2214-109X(21)00555-6.
doi: 10.1016/S2214-109X(21)00555-6.

Wong E.Y., Xu L., Shen L., Kim M.E., Polski A., Prabakar R.K., Shah R., Jubran R., Kim J.W., Biegel J.A., Gai X., Kuhn P., Hicks J., Berry J.L. Inter-eye genomic heterogeneity in bilateral retinoblastoma via aqueous humor liquid biopsy. NPJ precision oncology. 2021 Jul 27;5(1):73. PMID: 34316014; PMCID: PMC8316348.
doi: 10.1038/s41698-021-00212-0
https://pubmed.ncbi.nlm.nih.gov/34316014/

Wong K.M., King D.A., Schwartz E.K., Herrera R.E, Morrison A.J. Retinoblastoma protein regulates carcinogen susceptibility at heterochromatic cancer driver loci. Life Sci Alliance. 2022 Jan 4;5(4):e202101134.
PMID: 34983823; PMCID: PMC8739494.
doi: 10.26508/lsa.202101134

Wu C., Shang X.Q., You Z.P., Jin Q.F., Zhang Y.L., Zhou Y., Zhang Y.Z., Shi K. TRIM59 Promotes Retinoblastoma Progression by Activating the p38-MAPK Signaling Pathway. Investigative ophthalmology & visual science. 2020 Aug 3
doi: 10.1167/iovs.61.10.2
https://pubmed.ncbi.nlm.nih.gov/32744597/

Wu C., Yang J., Xiao W., Jiang Z., Chen S., Guo D., Zhang P., Liu C., Yang H., Xie Z. Single-cell characterization of malignant phenotypes and microenvironment alteration in retinoblastoma. Cell Death Dis. 2022 May 6;13(5):438.
PMID: 35523772; PMCID: PMC9076657.
doi: 10.1038/s41419-022-04904-8

Wu J., Qian D., Sun X. Long noncoding RNAs as potential biomarkers in retinoblastoma: a systematic review and meta-analysis. Cancer cell international. 2020 May 29.
doi: 10.1186/s12935-020-01281-0
https://pubmed.ncbi.nlm.nih.gov/32514246/

Wu L., Xiang X., Guo H., Tan H. The effect of non-pharmacological interventions on psychological stress and quality of life of parents of children with retinoblastoma: A protocol for systematic review and meta-analysis. Medicine (Baltimore). 2021 Dec 23;100(51):e28148.
doi: 10.1097/MD.0000000000028148

Wu N., Chen S., Luo Q., Jiang Z., Wang X., Li Y., Qiu J., Yu K., Yang Y., Zhuang J. Kruppel-like factor 2 acts as a tumor suppressor in human retinoblastoma. Exp Eye Res. 2022 Jan 21:108955. Epub ahead of print.
doi: 10.1016/j.exer.2022.108955

Wu Z., Chen L., Zhang C., Liu Y. miR-4319 inhibited retinoblastoma cells proliferation, migration, invasion and EMT progress via suppressing CD147 mediated MMPs expression. Journal of molecular histology. 2021 Jan 20.
doi: 10.1007/s10735-020-09946-w
https://pubmed.ncbi.nlm.nih.gov/33474692/

X

Xia Y., Deng Y., Zhou Y., Li D., Sun X., Gu L., Chen Z., Zhao Q. TSPAN31 suppresses cell proliferation in human cervical cancer through down-regulation of its antisense pairing with CDK4. // Cell Biochemistry & Function. 2020 Mar 23
DOI: 10.1002/cbf.3526
https://pubmed.ncbi.nlm.nih.gov/32207169/?from_term=retinoblastoma&from_sort=date&from_pos=2

Xiao W., Ji X., Ye H., Zeng H., Gao Y., Chen R., Chen X., Mao Y., Yang H. Parent Knowledge of Screening and Genetic Testing in Retinoblastoma. Journal of ophthalmology. 2020 Apr 8
DOI: 10.1155/2020/3839792
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171634/

Xie Y., Xu X.L., Wei W.B. The RB1 Mutation Spectrum and Genetic Management Consultation in Pediatric Patients with Retinoblastoma in Beijing, China. Risk Manag Healthc Policy. 2021 Aug 21;14:3453-3463.
doi: 10.2147/RMHP.S322373

Xu H.K., Wang X.D., Wang D.G., Wei D.D., Liang L., Liu CH. miR-340 Exerts Suppressive Effect on Retinoblastoma Progression by Targeting KIF14. Curr Eye Res. 2021 Feb;46(2):232-238.
doi: 10.1080/02713683.2020.1795202

Xu K., Liu J., Zhang C. Intra-arterial chemotherapy combined with VEC intravenous chemotherapy in the treatment of advanced retinoblastoma. Journal of B.U.ON. : official journal of the Balkan Union of Oncology. Mar-Apr 2020.
https://jbuon.com/archive/25-2-1199.pdf

Xu L., Kim M.E., Polski A., Prabakar R.K., Shen L., Peng C.C., Reid M.W, Chévez-Barrios P, Kim J.W., Shah R., Jubran R., Kuhn P., Cobrinik D., Biegel J.A., Gai X., Hicks J., Berry J.L. Establishing the Clinical Utility of ctDNA Analysis for Diagnosis, Prognosis, and Treatment Monitoring of Retinoblastoma: The Aqueous Humor Liquid Biopsy. Cancers. 2021 Mar 13;13(6):1282.
doi: 10.3390/cancers13061282
https://pubmed.ncbi.nlm.nih.gov/33805776/

Xu L., Long H., Zhou B., Jiang H., Cai M. CircMKLN1 Suppresses the Progression of Human Retinoblastoma by Modulation of miR-425-5p/PDCD4 Axis. Current eye research. 2021 May 14:1-11.
doi: 10.1080/02713683.2021.1927110
https://pubmed.ncbi.nlm.nih.gov/33988065/

Xu L., Polski A., Prabakar R.K., Reid M.W., Chevez-Barrios P., Jubran R., Kim J.W., Kuhn P., Cobrinik D., Hicks J., Berry J.L. Chromosome 6p amplification in aqueous humor cell-free DNA is a prognostic biomarker for retinoblastoma ocular survival. Molecular cancer research : MCR. 2020 May 20.
DOI: 10.1158/1541-7786.MCR-19-1262
https://pubmed.ncbi.nlm.nih.gov/32434859/?from_term=retinoblastoma&from_sort=date&from_pos=9

Xu L., Shen L., Polski A., Prabakar R.K., Shah R., Jubran R., Kim J.W., Biegel J., Kuhn P., Cobrinik D., Hicks J., Gai X., Berry J.L. Simultaneous identification of clinically relevant RB1 mutations and copy number alterations in aqueous humor of retinoblastoma eyes.
Ophthalmic genetics. 2020 Aug 17
doi: 10.1080/13816810.2020.1799417
https://pubmed.ncbi.nlm.nih.gov/32799607/

Xu L., Zhu S., Tang A., Liu W. LncRNA MBLN1-AS1 inhibits the progression of retinoblastoma through targeting miR-338-5p-Wnt/beta-catenin signaling pathway. Inflammation research : official journal of the European Histamine Research Society ... [et al.].. 2021 Jan 16.
doi: 10.1007/s00011-020-01432-z
https://pubmed.ncbi.nlm.nih.gov/33454803/

Xu Q. The Potential Tumor Promotional Role of circVAPA in Retinoblastoma via Regulating miR-615-3p and SMARCE1. OncoTargets and therapy. 2020 Aug 5
doi: 10.2147/OTT.S254925
https://pubmed.ncbi.nlm.nih.gov/32848418/

Xu X., Zhao Y., Duan G., Du B. Downregulation of MIAT reduces the proliferation and migratory and invasive abilities of retinoblastoma cells by sponging miR-665 and regulating LASP1. Exp Ther Med. 2021 Nov;22(5):1342.
doi: 10.3892/etm.2021.10777
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495550/

Xu Y., Fu Z., Gao X., Wang R., Li Q. Long non-coding RNA XIST promotes retinoblastoma cell proliferation, migration, and invasion by modulating microRNA-191-5p/brain derived neurotrophic factor. Bioengineered. 2021 Dec;12(1):1587-1598.
doi: 10.1080/21655979.2021.1918991

Y

Yang G., Zeng C., Liu Y., Li D., Cui J. ZNRD1-AS1 knockdown alleviates malignant phenotype of retinoblastoma through miR-128-3p/BMI1 axis. Am J Transl Res. 2021 Jun 15;13(6):5866-5879

Yang H., Huang Y., He J., Chai G., Di Y., Wang A., Gui D. MiR-486-3p Inhibits the Proliferation, Migration and Invasion of Retinoblastoma Cells by Targeting ECM1.2020 May 13. Bioscience reports.
DOI: 10.1042/BSR20200392
https://pubmed.ncbi.nlm.nih.gov/32401301/?from_term=retinoblastoma&from_sort=date&from_page=3&from_pos=9

Yang J., Li Y., Han Y., Feng Y., Zhou M., Zong C., He X., Jia R., Xu X., Fan J. Single-cell transcriptome profiling reveals intratumoural heterogeneity and malignant progression in retinoblastoma. Cell Death Dis. 2021 Nov 23;12(12):1100.
doi: 10.1038/s41419-021-04390-4

Yang J., Li Y., Zong C., Zhang Q., Ge S., Ma L., Fan J., Zhang J., Jia R. Xanthatin Selectively Targets Retinoblastoma by Inhibiting the PLK1-Mediated Cell Cycle. Invest Ophthalmol Vis Sci. 2021 Dec 1;62(15):11.
doi: 10.1167/iovs.62.15.11

Yang L., Fang X., Jin M., Chen J., Zhang C., Mou J., Zhao J., Ni X. Analysis of Cause-Specific Mortality in Patients with Retinoblastoma. J Ophthalmol. 2022 Mar 4;2022:2470890. PMID: 35282141; PMCID: PMC8916902.
doi: 10.1155/2022/2470890

Yang L., Zhang L., Lu L., Wang Y. miR-214-3p Regulates Multi-Drug Resistance and Apoptosis in Retinoblastoma Cells by Targeting ABCB1 and XIAP. Onco Targets Ther. 2020 Jan 28;13:803-811.
DOI: 10.2147/OTT.S235862. eCollection 2020.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995305/

Yang M.K., Lee M.J., Kim N., Choung H., Khwarg S.I. Outcomes of enucleation and porous polyethylene orbital implant insertion in patients with paediatric retinoblastoma: a long-term follow-up study. The British journal of ophthalmology. 2020 Dec 8:bjophthalmol-2020-317934.
doi: 10.1136/bjophthalmol-2020-317934
https://pubmed.ncbi.nlm.nih.gov/33293268/

Yang M., Yao P., Lang X., Li X., Zhang D. Ribonucleotide reductase subunit M2 promotes proliferation and epithelial-mesenchymal transition via the JAK2/STAT3 signaling pathway in retinoblastoma. Bioengineered. 2021 Dec;12(2):12800-12811.
doi: 10.1080/21655979.2021.2001241

Yang W., Jiang X.X., Zhao X.Y., Mao P.A. Treatment of RB-deficient retinoblastoma with Aurora-A kinase inhibitor. Kaohsiung J Med Sci. 2021 Nov 6.
doi: 10.1002/kjm2.12469

Yang X.L., Hao Y.J., Wang B., Gu X.L., Wang X.X., Sun J.F. Long noncoding RNA NORAD promotes the progression of retinoblastoma by sponging miR-136-5p/PBX3 axis. Eur Rev Med Pharmacol Sci. 2020 Jan;24(3):1278-1287.
DOI: 10.26355/eurrev_202001_20185
https://www.europeanreview.org/article/20185

Yang X., Sun H., Tang T., Zhang W., Li Y. Netrin-1 promotes retinoblastoma-associated angiogenesis. Ann Transl Med. 2021 Nov;9(22):1683.
doi: 10.21037/atm-21-5560

Yang Y.L., Zhou H., Yue L.R., Shen H. Spleen tyrosine kinase expression and its correlation with necrosis and high-risk histopathologic features in retinoblastoma. Chinese medical journal. 2020 Jul 20.
doi: 10.1097/CM9.0000000000000889
https://pubmed.ncbi.nlm.nih.gov/32649521/

Yan J., Deng Y.X., Cai Y.L., Cong W.D. LncRNA MIR17HG promotes the proliferation, migration, and invasion of retinoblastoma cells by up-regulating HIF-1α expression via sponging miR-155-5p. Kaohsiung J Med Sci. 2022 Mar 7. Epub ahead of print. PMID: 35253975.
doi: 10.1002/kjm2.12523

Yao L., Yang L., Song H., Liu T.G., Yan H. Silencing of lncRNA XIST Suppresses Proliferation and Autophagy and Enhances Vincristine Sensitivity in Retinoblastoma Cells by Sponging miR-204-5p. European review for medical and pharmacological sciences. 2020 Apr 24.
DOI: 10.26355/eurrev_202004_20812
https://pubmed.ncbi.nlm.nih.gov/32329826/?from_term=retinoblastoma&from_sort=date&from_pos=8

Yao X., Shen H., Peng Q., Yu J. TP53/miR-129/MDM2/4/TP53 feedback loop modulates cell proliferation and apoptosis in retinoblastoma. Cell Cycle. 2021 Mar-Mar;20(5-6):603-615.
doi: 10.1080/15384101.2021.1892321
https://pubmed.ncbi.nlm.nih.gov/33678118/

Yaqoob N., Zia N., Hamid A., Kaleem B., Jamal S., Amin S., Qaddoumi I., Jamal S. Correlation of clinical and radiological predictors of retinoblastoma with high-risk histopathological features. Pediatr Blood Cancer. 2022 May;69(5):e29625. Epub 2022 Mar 6. PMID: 35253344.
doi: 10.1002/pbc.29625

Yazici H., Wu H.C., Tigli H., Yilmaz E.Z., Kebudi R., Santella R.M. High levels of global genome methylation in patients with retinoblastoma. Oncology letters. 2020 Jul
doi: 10.3892/ol.2020.11613
https://pubmed.ncbi.nlm.nih.gov/32565997/

Yin D.F., Zhou X.J., Li N., Liu H.J., Yuan H. Long non-coding RNA SND1-IT1 accelerates cell proliferation, invasion and migration via regulating miR-132-3p/SMAD2 axis in retinoblastoma. Bioengineered. 2021 Dec;12(1):1189-1201.
doi: 10.1080/21655979.2021.1909962

Yin W., Gao F., Zhang S. MicroRNA‑34a inhibits the proliferation and promotes the chemosensitivity of retinoblastoma cells by downregulating Notch1 expression. Molecular medicine reports. 2020 Aug;22
doi: 10.3892/mmr.2020.11238
https://pubmed.ncbi.nlm.nih.gov/32626991/

Yi X., Sun J., Qian J., Guo J., Xue K. Quantitative evaluation of retinal microvasculature and retrobulbar vessels after intravenous chemotherapy for retinoblastoma. BMC Ophthalmol. 2021 Nov 26;21(1):405.
doi: 10.1186/s12886-021-02170-4

Yousef Y.A., Al Jboor M., Mohammad M., Mehyar M., Toro M.D., Nazzal R., Alzureikat Q.H., Rejdak M., Elfalah M., Sultan I., Rejdak R., Al-Hussaini M., Al-Nawaiseh I. Safety and Efficacy of Intravitreal Chemotherapy (Melphalan) to Treat Vitreous Seeds in Retinoblastoma. Frontiers in pharmacology. 2021 Jul 12;12:696787. PMID: 34322023; PMCID: PMC8311556.
doi: 10.3389/fphar.2021.696787
https://pubmed.ncbi.nlm.nih.gov/34322023/

Yousef Y.A., Mohammad M., Mehyar M., Sultan I., Al-Hussaini M., Alhourani J., Halalsheh H., Khzouz J., Jaradat I., Qaddoumi I., Al-Nawaiseh I. The Predictive Value of the Eighth Edition of the Clinical TNM Staging System for the Likelihood of Eye Salvage for Intraocular Retinoblastoma by Systemic Chemotherapy and Focal Therapy. J Pediatr Hematol Oncol. 2021 Aug 1;43(6):e841-e847.
doi: 10.1097/MPH.0000000000002144

Yu B., Zhao J., Dong Y. Circ_0000527 Promotes Retinoblastoma Progression through Modulating miR-98-5p/XIAP Pathway. Curr Eye Res. 2021 Sep;46(9):1414-1423.
doi: 10.1080/02713683.2021.1891255

Yu X., Li X., Xing Y., Lu S., Tanumiharjo S., Ma J. Effectiveness of intravitreal chemotherapy-assisted endoresection in monocular patients with group D retinoblastoma. BMC Cancer. 2020 Aug 26
doi: 10.1186/s12885-020-07314-1
https://pubmed.ncbi.nlm.nih.gov/32847550/

Yin X., Liao Y., Xiong W., Zhang Y., Zhou Y., Yang Y. Hypoxia-induced lncRNA ANRIL promotes cisplatin resistance in retinoblastoma cells through regulating ABCG2 expression.
Clinical and Experimental Pharmacology & Physiology.. 2020 Mar 15.
DOI: 10.1111/1440-1681.13279
https://pubmed.ncbi.nlm.nih.gov/32173903/?from_term=retinoblastoma&from_sort=pubdate&from_size=50&from_pos=41

Yousef Y.A., Alkhoms A., AlJabari R., AlJboor M., Mohammad M., Lahlouh M, Deebajah R, Halalsheh H, Al-Hussaini M, Jaradat I, Shawagfeh M, Sultan I, Mehyar M, AlNawaiseh I. Programmed screening for retinoblastoma enhances early diagnosis and improves management outcome for high-risk children. Ophthalmic genetics. 2020 May 20
DOI: 10.1080/13816810.2020.1766085
https://pubmed.ncbi.nlm.nih.gov/32432497/?from_term=retinoblastoma&from_sort=date&from_page=2&from_pos=1

Yousef Y.A., Al-Nawaiseh I., Mehyar M, Sultan I., Al-Hussaini M., Jaradat I., Mohammad M., AlJabari R., Abu-Yaghi N., Rodriguez-Galindo C., Qaddoumi I., Wilson M. How Telemedicine and Centralized Care Changed the Natural History of Retinoblastoma in a Developing Country: Analysis of 478 Patients. Ophthalmology. 2020 Jul 16.
doi: 10.1016/j.ophtha.2020.07.026
https://pubmed.ncbi.nlm.nih.gov/32682835/

Yousef Y.A., Mohammad M., Jaradat I., Shatnawi R., Banat S., Mehyar M., Al-Nawaiseh I. The role of external beam radiation therapy for retinoblastoma after failure of combined chemoreduction and focal consolidation therapy. Ophthalmic Genet. 2020 Feb 19:1-6.
DOI: 10.1080/13816810.2020.1719519

Yousef Y.A., Mohammad M., Mehyar M., Sultan I., Al-Hussaini M., Alhourani J., Halalsheh H, Khzouz J., Jaradat I., Qaddoumi I., Al-Nawaiseh I. The Predictive Value of the Eighth Edition of the Clinical TNM Staging System for the Likelihood of Eye Salvage for Intraocular Retinoblastoma by Systemic Chemotherapy and Focal Therapy. Journal of pediatric hematology/oncology. 2021 Mar 23.
doi: 10.1097/MPH.0000000000002144
https://pubmed.ncbi.nlm.nih.gov/33769386/

Yu B., Zhao J., Dong Y. Circ_0000527 Promotes Retinoblastoma Progression through Modulating miR-98-5p/XIAP Pathway. Current eye research. 2021 Feb 25:1-10.
doi: 10.1080/02713683.2021.1891255
https://pubmed.ncbi.nlm.nih.gov/33629639/

Z

Zanolli M., Oporto J.I., Verdaguer J.I., López J.P., Zacharías S., Romero P., Ossandón D., Denk O., Acuña O., López J.M., Stevenson R., Álamos B., Iturriaga H. Genetic testing for inherited ocular conditions in a developing country. // Ophthalmic Genetics. 2020 Mar 6.
DOI: 10.1080/13816810.2020.1734944
https://www.ncbi.nlm.nih.gov/pubmed/32141364

Zeng C., Cao W., Zhao T., Li L., Hou L. Hope level and associated factors among parents of retinoblastoma patients during COVID-19 pandemic: a cross-sectional study. BMC Psychiatry. 2021 Aug 6;21(1):391.
doi: 10.1186/s12888-021-03401-0
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343352/

Zeng Q., Wang S., Tan J., Chen L., Wang J. The methylation level of TFAP2A is a potential diagnostic biomarker for retinoblastoma: an analytical validation study. PeerJ. 2021 Mar 2;9:e10830.
doi: 10.7717/peerj.10830
https://pubmed.ncbi.nlm.nih.gov/33717678/

Zeng Y., He T., Liu J., Li Z., Xie F., Chen C. Xing Y. Bioinformatics analysis of multi-omics data identifying molecular biomarker candidates and epigenetically regulatory targets associated with retinoblastoma. Medicine. 2020 Nov 20;99(47):e23314.
doi: 10.1097/MD.0000000000023314
https://pubmed.ncbi.nlm.nih.gov/33217867/

Zhang C., Feng Z.X., Li L., Solarte C.E., Ma X. Retinoblastoma in a child with tuberous sclerosis complex. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2020 Aug 18
doi: 10.1016/j.jcjo.2020.05.014
https://pubmed.ncbi.nlm.nih.gov/32822658/

Zhang C., Wu S. MicroRNA -378a-3p Restrains the Proliferation of Retinoblastoma Cells but Promotes Apoptosis of Retinoblastoma Cells via Inhibition of FOXG1.
Investigative ophthalmology & visual science. 2020 May 11
DOI: 10.1167/iovs.61.5.31
https://pubmed.ncbi.nlm.nih.gov/32428232/?from_term=retinoblastoma&from_sort=date&from_page=2&from_pos=7

Zhang G., Yang W., Li D., Li X., Huang J., Huang R., Luo J. lncRNA FEZF1‑AS1 promotes migration, invasion and epithelial‑mesenchymal transition of retinoblastoma cells by targeting miR‑1236‑3p. Molecular medicine reports. 2020 Sep 2
doi: 10.3892/mmr.2020.11478
https://pubmed.ncbi.nlm.nih.gov/32901841/

Zhang H., Qiu X., Song Z., Lan L., Ren X., Ye B. CircCUL2 suppresses retinoblastoma cells by regulating miR-214-5p/E2F2 Axis. Anticancer Drugs. 2021 Aug 11.
doi: 10.1097/CAD.0000000000001190

Zhang H., Qiu X., Song Z., Lan L., Ren X., Ye B. CircCUL2 suppresses retinoblastoma cells by regulating miR-214-5p/E2F2 Axis. Anticancer Drugs. 2022 Jan 1;33(1):e218-e227.
doi: 10.1097/CAD.0000000000001190

Zhang H., Yang X., Xu Y., Li H. KCNQ1OT1 regulates the retinoblastoma cell proliferation, migration and SIRT1/JNK signaling pathway by targeting miR-124/SP1 axis. Bioscience reports. 2020 Dec 21:BSR20201626.
doi: 10.1042/BSR20201626
https://pubmed.ncbi.nlm.nih.gov/33345272/

Zhang H., Zhang P., Long C., Ma X., Huang H., Kuang X., Du H., Tang H., Ling X., Ning J., Liu H., Deng X., Zou Y., Wang R., Cheng H., Lin S., Zhang Q., Yan J., Shen H. m(6)A methyltransferase METTL3 promotes retinoblastoma progression via PI3K/AKT/mTOR pathway. Journal of cellular and molecular medicine. 2020 Oct 8.
doi: 10.1111/jcmm.15736
https://pubmed.ncbi.nlm.nih.gov/33090698/

Zhang J., Liu Z.N., Deng G.H. Anticancer Activity of New Na(I) Complex on Retinoblastoma Cells via Inhibiting PI3K/AKT/mTOR Pathway. J Oncol. 2021 Nov 18;2021:9403333.
doi: 10.1155/2021/9403333

Zhang L.J., Wang F., Qi P.Y., Zhou W.Y., Wang B. miR-513b-5p inhibits the proliferation and promotes apoptosis of retinoblastoma cells by targeting TRIB1. Open Med (Wars). 2021 Sep 9;16(1):1364-1371.
doi: 10.1515/med-2021-0343
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423897/

Zhang L., Wu J., Li Y., Jiang Y., Wang L., Chen Y., Lv Y., Zou Y., Ding X.
Circ_0000527 promotes the progression of retinoblastoma by regulating miR-646/LRP6 axis. Cancer cell international. 2020 Jul 10
doi: 10.1186/s12935-020-01396-4
https://pubmed.ncbi.nlm.nih.gov/32669977/
https://cancerci.biomedcentral.com/articles/10.1186/s12935-020-01396-4

Zhang Q., Zhong C., Duan S. The tumorigenic function of LINC00858 in cancer. Biomed Pharmacother. 2021 Nov;143:112235.
doi: 10.1016/j.biopha.2021.112235

Zhang R., Song Y.N., Duo X., Guo Z., Sun Y., Zhang Z., Lu Y., Miao B., Yang P.C., Nie G. Retinoblastoma cell-derived Twist protein promotes regulatory T-cell development. Cancer immunology, immunotherapy: CII. 2020 Oct 27.
doi: 10.1007/s00262-020-02744-z
https://pubmed.ncbi.nlm.nih.gov/33108472/

Zhang S., Long J., Hu Y. Long noncoding RNA LINC00205 enhances the malignant characteristics of retinoblastoma by acting as a molecular sponge of microRNA-665 and consequently increasing HMGB1 expression. // Biochemical and Biophysical Research Communication. 2020 Mar 26.
DOI: 10.1016/j.bbrc.2020.03.083
https://pubmed.ncbi.nlm.nih.gov/32223925/?from_term=retinoblastoma&from_sort=date&from_pos=1

Zhang T., Yang J., Gong F., Li L., Li A. Long non-coding RNA CASC9 promotes the progression of retinoblastoma via interacting with miR-145-5p. Cell Cycle. 2020 Aug 10.
doi: 10.1080/15384101.2020.1802813
https://pubmed.ncbi.nlm.nih.gov/32772636/

Zhang X., Song L., Huang Y., Han S., Hou M., Li H. Downregulation of MST4 Underlies a Novel Inhibitory Role of MicroRNA Let-7a in the Progression of Retinoblastoma.
Investigative ophthalmology & visual science. 2020 Jun 3.
doi: 10.1167/iovs.61.6.28
https://pubmed.ncbi.nlm.nih.gov/32539131/

Zhang Y., Dou X., Kong Q., Li Y., Zhou X. Circ_0075804 promotes the malignant behaviors of retinoblastoma cells by binding to miR-138-5p to induce PEG10 expression. Int Ophthalmol. 2021 Oct 11.
doi: 10.1007/s10792-021-02067-7

Zhang Y., Duan S., Jang A., Mao L., Liu X., Huang G. JQ1, a selective inhibitor of BRD4, suppresses retinoblastoma cell growth by inducing cell cycle arrest and apoptosis. Experimental eye research. 2020 Oct 17.
doi: 10.1016/j.exer.2020.108304
https://pubmed.ncbi.nlm.nih.gov/33080301/

Zhang Y., Jing X., Li Z., Tian Q., Wang Q., Chen X. Investigation of the role of the miR17-92 cluster in BMP9-induced osteoblast lineage commitment. J Orthop Surg Res. 2021 Oct 30;16(1):652.
doi: 10.1186/s13018-021-02804-9

Zhang Y., Wang Y., Huang D., Ma J., Zhang W., Gu H., Zhou Y., Yi Y., Zhang P. Correlation between Family RB1 Gene Pathogenic Variant with Clinical Features and Prognosis of Retinoblastoma under 5 Years Old. Disease markers. 2021 Jul 12;2021:9981028. PMID: 34336010; PMCID: PMC8292087.
doi: 10.1155/2021/9981028
https://pubmed.ncbi.nlm.nih.gov/34336010/

Zhang Z., Xiao Y.S., Shen R., Jiang H.C., Tan L., Li R.Q., Yang X.H., Gu H.Y., He W.J., Ma J. Next generation sequencing of RB1gene for the molecular diagnosis of ethnic minority with retinoblastoma in Yunnan. BMC medical genetics. 2020 Nov 23;21(1):230.
doi: 10.1186/s12881-020-01150-7
https://pubmed.ncbi.nlm.nih.gov/33225895/

Zhang Y., Zheng A. MiR-142-5p promotes retinoblastoma cell proliferation, migration and invasion by targeting PTEN. J Biochem. 2021 Oct 11;170(2):195-202.
doi: 10.1093/jb/mvaa121

Zhao H., Wan J., Zhu Y. Carboplatin Inhibits the Progression of Retinoblastoma Through IncRNA XIST/miR-200a-3p/NRP1 Axis. Drug design, development and therapy. 2020 Aug 21
doi: 10.2147/DDDT.S256813
https://pubmed.ncbi.nlm.nih.gov/32904674/

Zhao J., Feng Z., Gallie B.L. Natural History of Untreated Retinoblastoma. Cancers (Basel). 2021 Jul 21;13(15):3646.
doi: 10.3390/cancers13153646

Zhao J., Feng Z., Leung G., Gallie B.L. Retinoblastoma Survival Following Primary Enucleation by AJCC Staging. Cancers (Basel). 2021 Dec 13;13(24):6240.
doi: 10.3390/cancers13246240

Zhao J., Li Q., Feng Z.X., Zhang J., Wu S., Jin L., Gallie B.L. Tylectomy Safety in Salvage of Eyes with Retinoblastoma. Cancers (Basel). 2021 Nov 22;13(22):5862.
doi: 10.3390/cancers13225862

Zhao N.O., Pak D., El-Hadad C., Debnam J.M., Ning J., Esmaeli B. Characteristics and Survival Outcomes of Second Primary Cancers in Long-term Retinoblastoma Survivors. Asia-Pacific journal of ophthalmology. 2021 Jan 19.
doi: 10.1097/APO.0000000000000361
https://pubmed.ncbi.nlm.nih.gov/33481394/

Zhao N., Zhou L., Lu Q., Wang S., Sun Y., Ding Y., Liu M., He H., Lang T. SOX2 maintains the stemness of retinoblastoma stem-like cells through Hippo/YAP signaling pathway. Exp Eye Res. 2021 Dec 7;214:108887.
doi: 10.1016/j.exer.2021.108887

Zhao X.M., Li Y.B., Sun P., Pu Y.D., Shan M.J., Zhang Y.M. Bioinformatics analysis of key biomarkers for retinoblastoma. The Journal of international medical research. 2021 Jun;49(6):3000605211022210.
doi: 10.1177/03000605211022210
https://pubmed.ncbi.nlm.nih.gov/34187205/

Zhao Y, Wang Z, Gao M, Wang X, Feng H, Cui Y, Tian X. lncRNA MALAT1 regulated ATAD2 to facilitate retinoblastoma progression via miR-655-3p. Open Med (Wars). 2021 Jun 24;16(1):931-943.
doi: 10.1515/med-2021-0290

Zheng T., Chen W., Wang X., Cai W., Wu F., Lin C. Circular RNA circ-FAM158A promotes retinoblastoma progression by regulating miR-138-5p/SLC7A5 axis. Experimental eye research. 2021 Jun 5:108650.
doi: 10.1016/j.exer.2021.108650
https://pubmed.ncbi.nlm.nih.gov/34102206/

Zheng T., Chen W., Wang X., Cai W., Wu F., Lin C. Circular RNA circ-FAM158A promotes retinoblastoma progression by regulating miR-138-5p/SLC7A5 axis. Exp Eye Res. 2021 Oct;211:108650.
doi: 10.1016/j.exer.2021.108650

Zheng Q., Zhu Q., Li C., Hao S., Li J., Yu X., Qi D., Pan Y. Sinomenine can inhibit the growth and invasion ability of retinoblastoma cell through regulating PI3k/AKT signaling pathway. Biological & pharmaceutical bulletin. 2020 Aug 4.
doi: 10.1248/bpb.b20-00387
https://pubmed.ncbi.nlm.nih.gov/32759601/

Zheng Y., Froehler M.T., Friedman D., Daniels A. Intra-arterial chemotherapy (IAC) as primary treatment for cavitary retinoblastoma: Excellent response in 8 tumors. Ophthalmology. Retina. 2020 Aug 24
doi: 10.1016/j.oret.2020.08.011
https://pubmed.ncbi.nlm.nih.gov/32853834/

Zheng Y., Froehler M.T., Friedman D.L., Daniels A.B. Intra-arterial Chemotherapy as Primary Treatment for Cavitary Retinoblastoma: Excellent Response in Eight Tumors. Ophthalmology Retina. 2021 May;5(5):479-485.
doi: 10.1016/j.oret.2020.08.011
https://pubmed.ncbi.nlm.nih.gov/32853834/

Zheng Q., Zhu Q., Li C., Hao S., Li J., Yu X., Qi D., Pan Y. microRNA-144 functions as a diagnostic and prognostic marker for retinoblastoma. Clinics. 2020 Aug 19.
doi: 10.6061/clinics/2020/e1804
https://pubmed.ncbi.nlm.nih.gov/32844953/

Zhou C., Wen X., Ding Y., Ding J., Jin M., Liu Z., Wang S., Han M., Yuan H., Xiao Y., Wu L., Wang J., Li Y., Yu J., Wen Y., Ye J., Liu R., Chen Z., Xue S., Lu W., Liao H., Cui J., Zhu D., Lu F., Tang S., Wu Y., Yangkyi T., Zhang G., Wubuli M., Guo H., Wang X., He Y., Sheng X., Wang Q., Luo Y., Fan J., Qi J., Yu Z., Tan J., Liang J., Sun X., Jin L., Yang X., Zhang J., Ji X., Zhao J., Jia R., Fan X. Eye-preserving therapies for advanced retinoblastoma: a multicenter cohort of 1678 patients in China. Ophthalmology. 2021 Sep 15:S0161-6420(21)00683-7.
doi: 10.1016/j.ophtha.2021.09.002

Zhou L., Ng D.S., Yam J.C., Chen L.J., Tham C.C., Pang C.P., Chu W.K. Post-translational modifications on the retinoblastoma protein. J Biomed Sci. 2022 Jun 1;29(1):33. PMID: 35650644; PMCID: PMC9161509.
doi: 10.1186/s12929-022-00818-x

Zhou L., Zhu X.H., Zhang K., Hu R., Myers F. Case Report: Adult Retinoblastoma Progression in 19 Months. Optometry and vision science: official publication of the American Academy of Optometry. 2020 Oct 26.
doi: 10.1097/OPX.0000000000001602
https://pubmed.ncbi.nlm.nih.gov/33110028/

Zhou L., Zhu X.H., Zhang K., Hu R., Myers F. Case Report: Adult Retinoblastoma Progression in 19 Months. Optometry and vision science : official publication of the American Academy of Optometry. 2020 Nov;97(11):1010-1016.
doi: 10.1097/OPX.0000000000001602
https://pubmed.ncbi.nlm.nih.gov/33110028/

Zhou M., Wen X., Jia S., Han Y., He X., Han M., Xu W., Fan J., Jia R., Fan X. Risk factors for ophthalmic artery stenosis and occlusion in patients with retinoblastoma treated with intra-arterial chemotherapy. The British journal of ophthalmology. 26 May. 2021
doi:10.1136/bjophthalmol-2021-319118
https://pubmed.ncbi.nlm.nih.gov/34039564/

Zhou S., Lu S., Guo S., Zhao L., Han Z., Li Z. Protective Effect of Ginsenoside Rb1 Nanoparticles Against Contrast-Induced Nephropathy by Inhibiting High Mobility Group Box 1 Gene/Toll-Like Receptor 4/NF-κB Signaling Pathway. J Biomed Nanotechnol. 2021 Oct 1;17(10):2085-2098.
doi: 10.1166/jbn.2021.3163

Zhou W., Guan W., Zhou Y., Rao Y., Ji X., Li J. Weighted genes associated with the progression of retinoblastoma: Evidence from bioinformatic analysis. Exp Eye Res. 2021 Oct;211:108730.
doi: 10.1016/j.exer.2021.108730

Zhou Y., Cai S., Jin M., Jiang C., Xu N., Duan C., Peng X., Zhao J., Ma X. Economic burden for retinoblastoma patients in China. Journal of medical economics. 2020 Oct 27:1-5.
doi: 10.1080/13696998.2020.1831518
https://pubmed.ncbi.nlm.nih.gov/33000977/

Zhou Z., Jiang H., Xia J., Zhang J. Comparison of the therapeutic effects of lobaplatin and carboplatin on retinoblastoma in vitro and in vivo. International journal of oncology. 2020 Jun 22.
doi: 10.3892/ijo.2020.5085
https://pubmed.ncbi.nlm.nih.gov/32582992/

Zhuang H., Xu Y.N., Zheng H.H., Huan Y.R., Zheng N.X., Lin L., Zhang W.Z., Xu W. Carboplatin-loaded surface modified-PLGA nanoparticles confer sustained inhibitory effect against retinoblastoma cell in vitro. Arq Bras Oftalmol. 2022 Feb 14:S0004-27492022005002204. Epub ahead of print. PMID: 35170632.
doi: 10.5935/0004-2749.20220075

Zhu X.Y., Li J., Guan W.B., Chen C.L., Ji X.D., Zhao P.Q. Pathologic comparisons of enucleated eyes with retinoblastoma after superselective ophthalmic arterial chemotherapy with or without intravenous chemotherapy. International journal of ophthalmology. 2020 Nov 18;13(11):1794-1799.
doi: 10.18240/ijo.2020.11.17
https://pubmed.ncbi.nlm.nih.gov/33215012/

Zhu X., Yu M., Wang K., Zou W., Zhu L. FoxM1 affects adhesive, migratory, and invasive abilities of human retinoblastoma Y-79 cells by targeting matrix metalloproteinase 2. // Acta Biochimica et Biophysica Sinica. 2020 Mar 10.
DOI: 10.1093/abbs/gmz160
https://www.ncbi.nlm.nih.gov/pubmed/32152631

Zhu Y., Hao F. Knockdown of long non‑coding RNA HCP5 suppresses the malignant behavior of retinoblastoma by sponging miR‑3619‑5p to target HDAC9. International journal of molecular medicine. 2021 May;47(5):74.
doi: 10.3892/ijmm.2021.4907
https://pubmed.ncbi.nlm.nih.gov/33693951/

Zluhan-Martínez E., Pérez-Koldenkova V., Ponce-Castañeda M.V., Sánchez M.P., García-Ponce B., Miguel-Hernández S., Álvarez-Buylla E.R., Garay-Arroyo A. Beyond What Your Retina Can See: Similarities of Retinoblastoma Function between Plants and Animals, from Developmental Processes to Epigenetic Regulation. International journal of molecular sciences. 2020 Jul 12
doi: 10.3390/ijms21144925
https://pubmed.ncbi.nlm.nih.gov/32664691/

Zocchi L., Wu S.C., Benavente C.A. Heavenly HELLS? A potential new therapeutic target for retinoblastoma. Oncoscience. 2020 May 1.
DOI: 10.18632/oncoscience.502
https://pubmed.ncbi.nlm.nih.gov/32426419/?from_term=retinoblastoma&from_sort=date&from_page=2&from_pos=10

Zomor El. H., Nour R., Saad A., Taha H., Shelil AE., Aleieldin A., Saad Zaghloul M., Alfaar AS. Unilateral retinoblastoma; natural history and an age-based protocol in 248 patients. Eye (Lond). 2021 Sep;35(9):2564-2572. doi: 10.1038/s41433-020-01275-2. Epub 2020 Nov 13.
PMID: 33188294; PMCID: PMC8377076
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377076/

Zou Y., Li J., Hua P., Liang T., Ji X., Zhao P. Spectrum of germline mutations in RB1 in Chinese patients with retinoblastoma: Application of targeted next-generation sequencing.
Molecular vision. 2021 Jan 6;27:1-16.
https://pubmed.ncbi.nlm.nih.gov/33456302/

Zschoche M., Skosyrski S., Babst N., Ranjbar M., Rommel F., Kurz M., Tura A., Joachim S.C., Kociok N., Kakkassey V. Islet Co-Expression of CD133 and ABCB5 in Human Retinoblastoma Specimens. Klin Monbl Augenheilkd. 2021 Sep 27. English.
doi: 10.1055/a-1525-2588

Zugbi S., Ganiewich D., Bhattacharyya A., Aschero R., Ottaviani D., Sampor C., Cafferata E.G. etc. Clinical, Genomic, and Pharmacological Study of MYCN-Amplified RB1 Wild-Type Metastatic Retinoblastoma. Cancers. 2020 Sep 22
doi: 10.3390/cancers12092714
https://pubmed.ncbi.nlm.nih.gov/32971811/

Zuo X., Fu C., Xie J., Wang X., Yan Z. Hsa_circ_0000527 Downregulation Suppresses the Development of Retinoblastoma by Modulating the miR-27a-3p/HDAC9 Pathway. Curr Eye Res. 2021 Nov 25:1-12.
doi: 10.1080/02713683.2021.1925697